
<html lang="en"     class="pb-page"  data-request-id="3d0ea012-69ec-4a52-8994-1540ab20e461"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-8;article:article:10.1021/acs.jmedchem.6b00200;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs)" /></meta><meta name="dc.Creator" content="Qiang  Wang" /></meta><meta name="dc.Creator" content="Feiyang  Liu" /></meta><meta name="dc.Creator" content="Beilei  Wang" /></meta><meta name="dc.Creator" content="Fengming  Zou" /></meta><meta name="dc.Creator" content="Cheng  Chen" /></meta><meta name="dc.Creator" content="Xiaochuan  Liu" /></meta><meta name="dc.Creator" content="Aoli  Wang" /></meta><meta name="dc.Creator" content="Shuang  Qi" /></meta><meta name="dc.Creator" content="Wenchao  Wang" /></meta><meta name="dc.Creator" content="Ziping  Qi" /></meta><meta name="dc.Creator" content="Zheng  Zhao" /></meta><meta name="dc.Creator" content="Zhenquan  Hu" /></meta><meta name="dc.Creator" content="Wei  Wang" /></meta><meta name="dc.Creator" content="Li  Wang" /></meta><meta name="dc.Creator" content="Shanchun  Zhang" /></meta><meta name="dc.Creator" content="Yuexiang  Wang" /></meta><meta name="dc.Creator" content="Jing  Liu" /></meta><meta name="dc.Creator" content="Qingsong  Liu" /></meta><meta name="dc.Description" content="c-KIT kinase is a validated drug discovery target for gastrointestinal stromal tumors (GISTs). Clinically used c-KIT kinase inhibitors, i.e., Imatinib and Sunitinib, bear other important targets su..." /></meta><meta name="Description" content="c-KIT kinase is a validated drug discovery target for gastrointestinal stromal tumors (GISTs). Clinically used c-KIT kinase inhibitors, i.e., Imatinib and Sunitinib, bear other important targets su..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 14, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00200" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00200" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00200" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00200" /></link>
        
    
    

<title>Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00200" /></meta><meta property="og:title" content="Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0017.jpeg" /></meta><meta property="og:description" content="c-KIT kinase is a validated drug discovery target for gastrointestinal stromal tumors (GISTs). Clinically used c-KIT kinase inhibitors, i.e., Imatinib and Sunitinib, bear other important targets such as ABL or FLT3 kinases. Here we report our discovery of a more selective c-KIT inhibitor, compound 13 (CHMFL-KIT-110), which completely abolished ABL and FLT3 kinase activity. KinomeScan selectivity profiling (468 kinases) of 13 exhibited a high selectivity (S score (1) = 0.01). 13 displayed great antiproliferative efficacy against GISTs cell lines GIST-T1 and GIST-882 (GI50: 0.021 and 0.043 μM, respectively). In the cellular context, it effectively affected c-KIT-mediated signaling pathways and induced apoptosis as well as cell cycle arrest. In addition, 13 possessed acceptable bioavailability (36%) and effectively suppressed the tumor growth in GIST-T1 cell inoculated xenograft model without apparent toxicity. 13 currently is undergoing extensive preclinical evaluation and might be a potential drug candidate for GISTs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00200"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00200">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00200&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00200&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00200&amp;href=/doi/10.1021/acs.jmedchem.6b00200" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3964-3979</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00132" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00209" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiang++Wang">Qiang Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feiyang++Liu">Feiyang Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beilei++Wang">Beilei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fengming++Zou">Fengming Zou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Chen">Cheng Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaochuan++Liu">Xiaochuan Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aoli++Wang">Aoli Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuang++Qi">Shuang Qi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenchao++Wang">Wenchao Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ziping++Qi">Ziping Qi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Zhao">Zheng Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhenquan++Hu">Zhenquan Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Wang">Wei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Wang">Li Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shanchun++Zhang">Shanchun Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuexiang++Wang">Yuexiang Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Liu">Jing Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingsong++Liu">Qingsong Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">High Magnetic Field Laboratory, Chinese Academy of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P. R. China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">CHMFL-HCMTC Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P. R. China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Center for Precision Medicine, CAS (Hefei) Institute of Technology Innovation, Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">University of Science and Technology of China, Hefei, Anhui 230036, P. R. China</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Chemistry, University of Science and Technology of China, Hefei, Anhui 230036, P. R. China</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Hefei Cosource Medicine Technology Co., LTD, 358 Ganquan Road, Hefei, Anhui 230031, P. R. China</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">○</span> <span class="aff-text">SIBS (Institute of Health Sciences)-Changzheng Hospital Joint Center for Translational Medicine, Institute of Health Sciences, Shanghai Changzheng Hospital, Institutes for Translational Medicine (CAS-SMMU), Shanghai 200031, China</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">∇</span> <span class="aff-text">Key Laboratory of Stem Cell Biology, Institute of Health Sciences, SIBS, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai 200031, China</span></div><div class="aff-info" id="aff9"><span class="aff-symbol">◆</span> <span class="aff-text">Collaborative Innovation Center of Systems Biomedicine, Shanghai 200025, China</span></div><div class="corresp-info"><strong>*</strong>Phone: 86-551-65593186. E-mail: <a href="/cdn-cgi/l/email-protection#b7ddded9d0dbdec2f7dfdad1db99d6d499d4d9"><span class="__cf_email__" data-cfemail="771d1e19101b1e02371f1a111b591614591419">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Phone: 86-551-65595161. E-mail: <a href="/cdn-cgi/l/email-protection#08797b64617d313f4860656e6426696b266b66"><span class="__cf_email__" data-cfemail="18696b74716d212f5870757e7436797b367b76">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00200&amp;href=/doi/10.1021%2Facs.jmedchem.6b00200" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3964–3979</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 14, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 February 2016</li><li><span class="item_label"><b>Published</b> online</span>14 April 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00200" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00200</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3964%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DQiang%2BWang%252C%2BFeiyang%2BLiu%252C%2BBeilei%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D8%26contentID%3Dacs.jmedchem.6b00200%26title%3DDiscovery%2Bof%2BN-%25283-%2528%25281-Isonicotinoylpiperidin-4-yl%2529oxy%2529-4-methylphenyl%2529-3-%2528trifluoromethyl%2529benzamide%2B%2528CHMFL-KIT-110%2529%2Bas%2Ba%2BSelective%252C%2BPotent%252C%2Band%2BOrally%2BAvailable%2BType%2BII%2Bc-KIT%2BKinase%2BInhibitor%2Bfor%2BGastrointestinal%2BStromal%2BTumors%2B%2528GISTs%2529%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3979%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00200"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1799</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00200" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (CHMFL-KIT-110) as a Selective, Potent, and Orally Available Type II c-KIT Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Qiang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Feiyang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Beilei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Fengming&quot;,&quot;last_name&quot;:&quot;Zou&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xiaochuan&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Aoli&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Shuang&quot;,&quot;last_name&quot;:&quot;Qi&quot;},{&quot;first_name&quot;:&quot;Wenchao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Ziping&quot;,&quot;last_name&quot;:&quot;Qi&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Zhenquan&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Shanchun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yuexiang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Qingsong&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3964-3979&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00200&quot;},&quot;abstract&quot;:&quot;c-KIT kinase is a validated drug discovery target for gastrointestinal stromal tumors (GISTs). Clinically used c-KIT kinase inhibitors, i.e., Imatinib and Sunitinib, bear other important targets such as ABL or FLT3 kinases. Here we report our discovery of a more selective c-KIT inhibitor, compound 13 (CHMFL-KIT-110), which completely abolished ABL and FLT3 kinase activity. KinomeScan selectivity profiling (468 kinases) of 13 exhibited a high selectivity (S score (1) = 0.01). 13 displayed great antiproliferative efficacy against GISTs cell lines GIST-T1 and GIST-882 (GI50: 0.021 and 0.043 μM, respectively). In the cellular context, it effectively affected c-KIT-mediated signaling pathways and induced apoptosis as well as cell cycle arrest. In addition, 13 possessed acceptable bioavailability (36%) and effectively suppressed the tumor growth in GIST-T1 cell inoculated xenograft model without apparent toxicity. 13 currently is undergoing extensive preclinical evaluation and might be a potential drug candidate fo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00200&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00200" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00200&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00200" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00200&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00200" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00200&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00200&amp;href=/doi/10.1021/acs.jmedchem.6b00200" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00200" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00200" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00200%26sid%3Dliteratum%253Aachs%26pmid%3D27077705%26genre%3Darticle%26aulast%3DWang%26date%3D2016%26atitle%3DDiscovery%2Bof%2BN-%25283-%2528%25281-Isonicotinoylpiperidin-4-yl%2529oxy%2529-4-methylphenyl%2529-3-%2528trifluoromethyl%2529benzamide%2B%2528CHMFL-KIT-110%2529%2Bas%2Ba%2BSelective%252C%2BPotent%252C%2Band%2BOrally%2BAvailable%2BType%2BII%2Bc-KIT%2BKinase%2BInhibitor%2Bfor%2BGastrointestinal%2BStromal%2BTumors%2B%2528GISTs%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D8%26spage%3D3964%26epage%3D3979%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/jmcmar.2016.59.issue-8/20160428/jmcmar.2016.59.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">c-KIT kinase is a validated drug discovery target for gastrointestinal stromal tumors (GISTs). Clinically used c-KIT kinase inhibitors, i.e., Imatinib and Sunitinib, bear other important targets such as ABL or FLT3 kinases. Here we report our discovery of a more selective c-KIT inhibitor, compound <b>13</b> (CHMFL-KIT-110), which completely abolished ABL and FLT3 kinase activity. KinomeScan selectivity profiling (468 kinases) of <b>13</b> exhibited a high selectivity (S score (1) = 0.01). <b>13</b> displayed great antiproliferative efficacy against GISTs cell lines GIST-T1 and GIST-882 (GI<sub>50</sub>: 0.021 and 0.043 μM, respectively). In the cellular context, it effectively affected c-KIT-mediated signaling pathways and induced apoptosis as well as cell cycle arrest. In addition, <b>13</b> possessed acceptable bioavailability (36%) and effectively suppressed the tumor growth in GIST-T1 cell inoculated xenograft model without apparent toxicity. <b>13</b> currently is undergoing extensive preclinical evaluation and might be a potential drug candidate for GISTs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the digestive tract, and they are generally resistant to chemotherapy and radiation therapy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Most GISTs express constitutively activated forms of the c-KIT kinase whose activation is an essential driving force in most of the early development stages of GISTs.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> c-KIT kinase belongs to the type III receptor tyrosine kinase (RTK) family, which also includes platelet-derived growth factor receptor alpha/beta (PDGFRα/β), FMS-related tyrosine kinase 3 (FLT3), and colony stimulating factor-1 receptor (CSF1R).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Structurally, the type III RTKs are characterized by five extracellular immunoglobulin-like repeats and a kinase insert separating the ATP-binding and phospho-transferase regions of the kinase domain. The physiologic activation of wild-type KIT is accomplished by binding to its ligand, stem cell factor (SCF), which promotes KIT dimerization, kinase activation, and tyrosine cross phosphorylation. However, these normal mechanisms of KIT activation can be subverted by oncogenic mutations, which contribute to constitutive activation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> All c-KIT mutations in GISTs appear to be associated with constitutive c-KIT tyrosine phosphorylation,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and this makes c-KIT a validated target for the anti-GIST therapy.</div><div class="NLM_p">Currently two of the kinase inhibitors that bear c-KIT kinase inhibitory activity have been approved for the clinical use of GISTs. Compound <b>1</b> (Imatinib, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> as the first clinically approved type II c-KIT kinase inhibitor for GIST treatment, binds to the inactive conformation (DFG-out) of c-KIT and achieved excellent overall success. However, the potent ABL kinase inhibitory activity of compound <b>1</b> did not contribute to the GISTs treatment and has been arguably reported to link to potential cardiotoxicity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Compound <b>2</b> (Sunitinib, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> the second FDA-approved (type I inhibitor, which binds to the active conformation (DFG-In) of kinases) second line drug for GISTs, was reported to possess FLT3/c-KIT dual inhibition which might be related to potential myelosuppression toxicity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Several other multitarget inhibitors, such as <b>3</b> (Amuvatinib),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a><b>4</b> (Masitinib),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a><b>5</b> (Nilotinib),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a><b>6</b> (Pexidartinib),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><b>7</b> (OSI930),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><b>8</b> (Dovitinib),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> etc. were also reported to bear c-KIT kinase inhibitory activity (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). However, for most of them, c-KIT is not their primary target. In order to trim the off-target profile and increase the therapeutic safety window, herein we report our medicinal chemistry effort starting with the compound <b>1</b> core scaffold which led to the discovery of a selective, potent, and orally available type II c-KIT inhibitor compound <b>13</b> (CHMFL-KIT-110) that abolished both the ABL and FLT3 kinase activities (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the representative c-KIT kinase inhibitors: (A) FDA approved c-KIT inhibitors for GISTs and (B) multitarget inhibitors possess c-KIT inhibitory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic illustration of discovery of compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Structure–Activity Relation (SAR) Exploration</h3><div class="NLM_p">We started with examination of the c-KIT/compound <b>1</b> X-ray crystal complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>) and envisioned that this is a typical type II binding mode (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). The key binding elements include the hinge binding moiety, linker moiety, DFG-out hydrophobic pocket binding moiety, and the well-known “Flag” methyl fragment.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The two key hydrogen bonds formed between Glu640 located in the α-helix and Asp810 located in the DFG motif with the amide group in the linker moiety stabilize the DFG-out conformation of the c-KIT kinase. The hydrogen bond formed between Cys673 and the terminal pyridine in the hinge binding area and the hydrogen bond formed between the gatekeeper residue Thr670 with the −NH of the aminopyrimidine help to improve the binding affinity. Comparison of the three available type II c-KIT kinase inhibitors, compounds <b>1</b>, <b>4</b>, and <b>5</b>, revealed that they all share the same linker moiety and only slightly differ from the hinge binding moiety and the DFG-out hydrophobic pocket binding moiety (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). In addition, further analysis revealed that in the hinge binding area, all of these three drugs bear a terminal pyridine (<b>R1</b>), which presumably can provide the hinge binding hydrogen bond. All of the <b>R2</b> parts share similar aromatic rings that connect the <b>R1</b> and the linker moiety. Since the hinge binding and the typical type II binding hydrogen bonds are required for the type II binding inhibitor, we envisioned that variation of the <b>R2</b> and <b>R3</b> fragments might provide more selectivity space to develop the c-KIT specific inhibitor.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic illustration of SAR exploration rationale. (A) Analysis of c-KIT/compound <b>1</b> binding mode (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>). (B) Comparison of compounds <b>1</b>, <b>4</b>, and <b>5</b> type II key binding moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As the starting point for the SAR exploration, we chose the <i>meta</i>-CF<sub>3</sub>-substituted benzene as <b>R3</b> fragment, which is slightly smaller than the corresponding part of compounds <b>1</b>, <b>4</b>, and <b>5</b> in order to leave space for further exploration (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). We used TEL-c-KIT-BaF3 and parental BaF3 cells to monitor the c-KIT kinase inhibitory activity and K562 cells to monitor the BCR-ABL inhibitory activity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Replacing the <b>R2</b> fragment from amine linked aromatic ring to a more flexible ether linked aliphatic chain (<b>9</b> and <b>10</b>) led to significant activity loss compared to compound <b>1</b> in the TEL-c-KIT-BaF3 growth inhibitory assay. However, when we fixed the conformation of aliphatic chain with the aliphatic piperidine ring (<b>11</b>), it started to gain the c-KIT activity and became even more potent than compound <b>1</b> (GI<sub>50</sub>: 0.11 versus 0.40 μM). Although <b>11</b> bore a good selectivity window between the TEL-c-KIT-BaF3 and the parental BaF3 cells (GI<sub>50</sub>: >10 μM), it also exhibited moderate activity against K562 cell (GI<sub>50</sub>: 2.94 μM), indicating the moderate BCR-ABL inhibitory activity. Shifting the nitrogen atom position in the <b>R1</b> fragment, i.e., the terminal pyridine (<b>12</b> and <b>13</b>), not only retained the c-KIT activity (GI<sub>50</sub>: 0.33 and 0.19 μM, respectively) but also abolished the BCR-ABL activity completely (K562 cell, GI<sub>50</sub>: >10 μM), meanwhile retaining the selectivity over the parental BaF3 cells (GI<sub>50</sub>: >10 μM). However, when the pyridine group was replaced by the isoxazole group (<b>14</b>) in <b>R1</b>, it started to gain back the BCR-ABL activity (GI<sub>50</sub>: 0.16 μM). Changing the <b>R1</b> fragment from the aromatic rings to the aliphatic chains such as ethyl (<b>15</b>) and ethylene (<b>16</b>) both led to the c-KIT activity loss. Switching the ether linkage from the 4-position of the piperidine to the 3-position in <b>R2</b> (<b>17</b> and <b>18</b>) replaced the “flag” methyl to hydrogen atom completely lost the c-KIT activity. In addition, replacing the “flag” methyl group with hydrogen atom (<b>19</b>) led to the slight c-KIT activity loss compared to the most active lead compound <b>11</b> (GI<sub>50</sub>: 0.49 versus 0.11 μM). Substitution of the “flag” methyl with −Cl (<b>20</b>) further decreased the c-KIT activity (GI<sub>50</sub>: 0.96 μM) and −OMe group (<b>21</b>) led to the complete c-KIT activity loss (GI<sub>50</sub>: > 10 μM). These results implied that the piperidine ring in the <b>R2</b> fraction is well tolerated and that the “flag” methyl in the <b>R4</b> fraction is required for the high inhibitory activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Exploration Focused on the <b>R1</b>/<b>R2</b>/<b>R4</b> Positions<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All GI<sub>50</sub> values were obtained by triplet testing.</p></div></div><div></div></div><div class="NLM_p">For the SAR exploration of the <b>R1</b> and <b>R3</b> moieties, we choose to start with fixing the <b>R2</b> as the ether linked piperidine ring (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Introduction of the methyl group at the 4-position of the benzene ring (<b>22</b>) to compound <b>13</b> gained 6-fold c-KIT activity improvement (GI<sub>50</sub>: 0.031 versus 0.19 μM). However, its selectivity window against parental BaF3 (GI<sub>50</sub>: 6.39 μM) and K562 (GI<sub>50</sub>: 2.32 μM) has remarkably narrowed down. Further variation of the <b>R1</b> fragment (<b>23</b>, <b>24</b>, and <b>25</b>) all led to gaining back of BCR-ABL inhibitory activity, although the c-KIT inhibitory activities were better than <b>13</b>. Introducing the −Cl (<b>26, 27</b>) or −F (<b>28</b>) atom at the 5-position of the benzene ring in the <b>R3</b> fragment started to gain back the BCR-ABL activity. Interestingly, changing the benzene ring to pyridine ring in <b>R3</b> (<b>29</b> and <b>30</b>) led to complete loss of activity to both the c-KIT and BCR-ABL. Replacement of −CF<sub>3</sub> group with a larger −OMe group in <b>R3</b> (<b>31</b>) brought about 15-fold activity loss against c-KIT compared to <b>12</b> (GI<sub>50</sub>: 1.48 versus 0.11 μM). A <i>tert</i>-butyl isoxazole moiety at <b>R3</b> position (<b>32</b>) only moderately decreased the c-KIT activity (GI<sub>50</sub>: 0.34 versus 0.11 μM) compared to <b>12</b>. Benzodioxole (<b>33</b>) and quinolone (<b>34</b>) moieties at the <b>R3</b> position both led to around 50-fold activity loss against c-KIT kinase. Changing the amide linkage between the linker moiety and <b>R3</b> fragment to the urea linkage (<b>35</b>) increased the BCR-ABL activity meanwhile lowering the c-KIT activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Exploration Focused on the <b>R1</b>/<b>R3</b> Positions<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0015.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All GI<sub>50</sub> values were obtained by triplet testing.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biochemical and Cellular Property Evaluation</h3><div class="NLM_p">Among all of the compounds tested, <b>13</b> displayed the best potency against c-KIT kinase and selectivity over ABL kinase, therefore we chose it for further characterization. We first examined its kinome wide selectivity profile with DiscoveRx’s KinomeScan technology.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The results demonstrated that <b>13</b> bore a high selectivity (S score (1) = 0.01 at 1 μM) among 468 kinases and mutants tested. Besides high binding affinity to c-KIT, it also displayed strong binding against CSF1R, DDR1, and PDGFRβ kinases (percent activity remaining <1% at 1 μM) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_001.pdf" class="ext-link">Supporting Information</a> Table 1. Given the fact that KinomeScan is a binding assay and may not fully reflect the inhibitory activity, we then used Invitrogen’s Z’lyte and Promega’s ADP-Glo based biochemical activity assay with the purified kinase proteins to confirm <b>13</b>’s inhibition activity against CSF1R, DDR1, c-KIT, and PDGFRβ kinases. The ADP-Glo assay results showed that <b>13</b> inhibited c-KIT kinase with an IC<sub>50</sub> of 99 nM and PDGFRβ with an IC<sub>50</sub> of 120 nM. The results of Z’lyte assay demonstrated that <b>13</b> inhibited DDR1 kinase with an IC<sub>50</sub> of 126 nM and CSF1R with an IC<sub>50</sub> of 133 nM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinome wide selectivity profiling of <b>13</b>. (A) KinomeScan profiling of <b>13</b> at a concentration of 1 μM against 468 kinases. (B) Biochemical assay characterization of <b>13</b>’s inhibitory activity against c-KIT, PDGFRβ (Promega ADP-Glo), DDR1, and CSF1R (Invitrogen Z’lyte).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>13</b>’s inhibitory activity among a variety of c-KIT mutants was examined in the TEL-c-KIT-BaF3 cells. The results showed that <b>13</b> was more sensitive to c-KIT/V559D mutant (GI<sub>50</sub>: 0.04 μM) than others and that it exhibited a similar trend to <b>1</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Compound <b>2</b> was more potent against these mutants, but it also affected the parental BaF3 cells growth (GI<sub>50</sub>: 2.78 μM) which indicated the multiple target features.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antiproliferative Effects of <b>1</b>, <b>2</b>, and <b>13</b> against a Variety of TEL-c-KIT-BaF3 Isogenic Cells<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center"><b>1</b> GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><b>2</b> GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><b>13</b> GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">parental BaF3</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.78</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KIT-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">0.078</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KIT/V559D-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KIT/V559D/V654A-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">1.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KIT/N822K-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">1.29</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KITt/T670I-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">8.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KIT/V654A-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KITt/L567P-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KIT/T670I/V559D-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">6.67</td><td class="colsep0 rowsep0" align="char" char=".">0.053</td><td class="colsep0 rowsep0" align="char" char=".">5.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tel-c-KIT/D816V-BaF3</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.38</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">All GI<sub>50</sub> values were obtained by triplet testing.</p></div></div></div><div class="NLM_p">Compound <b>13</b> was next tested against a variety of intact cancer cell lines. Not surprisingly, it did potently inhibit the growth of c-KIT-dependent GIST cancer cells such as GIST-T1 (GI<sub>50</sub>: 0.021 μM) and GIST-882 (GI<sub>50</sub>: 0.043 μM) but not the c-KIT-independent GIST cell line GIST48B (GI<sub>50</sub>: > 10 μM) (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). In addition, unlike <b>1</b>, <b>13</b> did not exhibit potent antiproliferative activity against BCR-ABL driven CML cell lines such as K562 (GI<sub>50</sub>: > 10 μM), MEG-01 (GI<sub>50</sub>: 7.43 μM), and KU812 (GI<sub>50</sub>: 6.71 μM). Furthermore, <b>13</b> did not show any apparent inhibitory activity against MV4-11 and MOLM13 cells that are FLT3-ITD growth dependent, which further confirmed that it had no FLT3 kinase activity. <b>13</b> did not inhibit the growth of other leukemic cell lines such as U937, HL-60, REC-1, and the normal Chinese hamster ovary cells CHO and CHL cells either, indicating a good safety profile. Comparably, <b>2</b> exhibited weaker antiproliferative effect against c-KIT-dependent cell lines and moderate inhibitory activities against BCR-ABL-dependent CML cell lines. However, it did show potent efficacies against several AML cell lines such as MV4-11, MOLM14, and HL-60, which reflected its multiple target features such as FLT3-ITD and others (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antiproliferation Effects of <b>1</b>, <b>2</b>, and <b>13</b> against a Variety of Intact Cancer Cell Lines<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char="."><b>1</b> GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><b>2</b> GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><b>13</b> GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GIST-T1</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GIST-882</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.043</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GIST48B</td><td class="colsep0 rowsep0" align="center" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.01</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K562</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MEG-01</td><td class="colsep0 rowsep0" align="char" char=".">0.074</td><td class="colsep0 rowsep0" align="char" char=".">1.20</td><td class="colsep0 rowsep0" align="char" char=".">7.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KU812</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">1.10</td><td class="colsep0 rowsep0" align="char" char=".">6.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">U937</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">1.70</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MV-4–11</td><td class="colsep0 rowsep0" align="center" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MOLM-14</td><td class="colsep0 rowsep0" align="center" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL-60</td><td class="colsep0 rowsep0" align="center" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">REC-1</td><td class="colsep0 rowsep0" align="center" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHL</td><td class="colsep0 rowsep0" align="center" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.48</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHO</td><td class="colsep0 rowsep0" align="center" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">2.03</td><td class="colsep0 rowsep0" align="center" char=".">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">All GI<sub>50</sub> values were obtained by triplet testing.</p></div></div></div><div class="NLM_p">In order to understand the structural binding mechanism of <b>13</b> to c-KIT kinase and the selectivity mechanism between the c-KIT and ABL kinase, <b>13</b> was docked into c-KIT kinase and ABL kinase, respectively. The docking results demonstrated that <b>13</b> could adopt the DFG-out conformation of c-KIT kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>) with a typical type II binding mode (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). Surprisingly, instead of using the terminal pyridine as the hinge binding like <b>1</b> does, <b>13</b> forms an O–H–N hydrogen bond by the amide carbonyl connecting the terminal pyridine moiety and piperidine moiety with the Cys673 in the hinge binding area at a distance about 2.9 Å. There are also two typical hydrogen bonds formed between the Glu640 and Asp810 with the amide moiety in the tail part of <b>13</b>. In the ABL kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>), although the docking results showed that <b>13</b> could also adopt the similar type II binding mode, the hydrogen bond formed in the hinge binding area is a little longer than in the c-KIT kinase (3.6 versus 2.9 Å) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). In addition, the spatially adjacent Tyr253 (3.1 Å to the pyridine moiety) in the P-loop introduces a possible steric hindrance which prevents <b>13</b> from stably binding to the ABL kinase. This could be more clearly illustrated when superimposing <b>13</b> and <b>1</b> in the <b>1</b>-ABL kinase X-ray crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). The pyridine moiety in <b>1</b> forms a hydrogen bond in the hinge binding area with a distance of 2.9 Å, and this aromatic moiety moves slightly further from the Tyr253 compared to the pyridine moiety in <b>13</b>, which presumably could avoid the potential steric hindrance. While in the c-KIT kinase, the Tyr253 was replaced by the Gly596, which would provide enough space for this terminal pyridine moiety to be accommodated (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural basis of the binding and selectivity mechanism for <b>13</b> against c-KIT and ABL kinase. Hydrogen bonds are indicated by red-hatched lines to key amino acid residues (highlighted). (A) <b>13</b> (in color by atoms) was docked into c-KIT kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>) (in white). (B) <b>13</b> (in color by atoms) was docked into ABL kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>) (in white). (C) Superimposition of <b>1</b>-ABL kinase X-ray crystal structure (in purple) and docking model of <b>13</b> (in color by atoms) with ABL kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>) (in white). (D) Superimposition of docked model of <b>13</b> with ABL kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>) (in purple) and <b>13</b> with c-KIT kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>) (in white).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>13</b>’s effect on the signaling pathways was evaluated in the intact GIST cancer cell lines (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). As expected, it significantly affected c-KIT pY719, pY703, and pY823 autophosphorylation sites and downstream signaling mediators such as pAKT(S473), pERK(T202/204), pS6K(T389), and pSTAT5(Y694) in the c-KIT growth-dependent GIST cancer cell lines GIST-T1 and GIST-882. However, in the c-KIT-independent GIST cancer cell line GIST-48B, despite the c-KIT (Y719, Y703) autophosphorylation site inhibition, it did not or only weakly affected pc-KIT(Y823) and downstream mediators pAKT, pERK, and pS6K, though it still strongly affected pSTAT5(Y694). In addition, in all of these three cell lines, <b>13</b> greatly inhibited pPDGFR which matched the in vitro biochemical characterizations. It is noteworthy that in all of the signaling pathways tested, <b>13</b> exhibited similar trends to the well-established c-KIT inhibitor <b>1</b>, which further proved its c-KIT kinase inhibitory activity. In accordance with <b>13</b>’s effect on the c-KIT-mediated signaling pathways, it could also induce cell cycle arrest and apoptosis in GIST-T1 and GIST-882 cells but not GIST-48B cells (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>13</b>’s effects on the signaling transduction pathways in the c-KIT-dependent and -independent intact GIST cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>13</b>’s induction of cell cycle arrest and apoptosis in GIST-T1 and GIST-882 cell lines but not in GIST-48B cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vivo PK/PD Evaluation</h3><div class="NLM_p">Compound <b>13</b>’s PK properties were tested in rats following intravenous and oral administration (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The results demonstrated that <b>13</b> bore an acceptable bioavailability (<i>F</i> = 36%) and a suitable half-life (<i>T</i><sub>1/2</sub> = 4.11 h) for the oral administration. It is noteworthy that in the iv injection, <b>13</b> bore a short half-life (<i>T</i><sub>1/2</sub>, 0.45h) and quick clearance (CLz, 4.988 L/h/kg), which indicated that it might not be very metabolically stable, which required further detailed full spectrum of PK characterization.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Characterization of <b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>13</b></th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0-t)</sub> (ng/mL·h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0-∞)</sub> (ng/mL·h)</th><th class="colsep0 rowsep0" align="center" char=".">MRT<sub>(0-t)</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">Vz (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CLz (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv (1 mg/kg) mean</td><td class="colsep0 rowsep0" align="char" char=".">198.069</td><td class="colsep0 rowsep0" align="char" char=".">202.038</td><td class="colsep0 rowsep0" align="char" char=".">0.484</td><td class="colsep0 rowsep0" align="char" char=".">0.451</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">3.219</td><td class="colsep0 rowsep0" align="char" char=".">4.988</td><td class="colsep0 rowsep0" align="char" char=".">510.610</td><td class="colsep0 rowsep0" align="char" char=".">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">22.942</td><td class="colsep0 rowsep0" align="char" char=".">21.202</td><td class="colsep0 rowsep0" align="char" char=".">0.103</td><td class="colsep0 rowsep0" align="char" char=".">0.056</td><td class="colsep0 rowsep0" align="char" char=".">0.000</td><td class="colsep0 rowsep0" align="char" char=".">0.142</td><td class="colsep0 rowsep0" align="char" char=".">0.545</td><td class="colsep0 rowsep0" align="char" char=".">82.438</td><td class="colsep0 rowsep0" align="char" char=".">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po (10 mg/kg) mean</td><td class="colsep0 rowsep0" align="char" char=".">714.588</td><td class="colsep0 rowsep0" align="char" char=".">779.793</td><td class="colsep0 rowsep0" align="char" char=".">4.799</td><td class="colsep0 rowsep0" align="char" char=".">4.114</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">76.407</td><td class="colsep0 rowsep0" align="char" char=".">12.888</td><td class="colsep0 rowsep0" align="char" char=".">125.167</td><td class="colsep0 rowsep0" align="char" char=".">36.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">153.466</td><td class="colsep0 rowsep0" align="char" char=".">65.913</td><td class="colsep0 rowsep0" align="char" char=".">0.941</td><td class="colsep0 rowsep0" align="char" char=".">0.252</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">6.419</td><td class="colsep0 rowsep0" align="char" char=".">1.145</td><td class="colsep0 rowsep0" align="char" char=".">35.483</td><td class="colsep0 rowsep0" align="char" char=".">NA</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>13</b>’s antitumor efficacy was tested in GIST-T1 cell inoculated xenograft mouse model. With oral gavage, none of the 25, 50, and 100 mg/kg/day administrations affected the mice body weight (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A). However, a 50 and 100 mg/kg dosage significantly suppressed tumor progression (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B–D). Immunohistochemistry stain showed that <b>13</b> could strongly suppress the antiproliferation (Ki67 stain) and induce the apoptosis effect (TUNEL stain) in the tumor tissues (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>E). It is worth mentioning that the PK profile obtained from rats may not be directly transformed into mice due to the species difference.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>13</b>’s antitumor efficacy in GIST-T1 xenograft mouse model. Female nu/nu mice bearing established GIST-T1 tumor xenografts were treated with <b>13</b> at 25.0, 50.0, and 100 mg/kg/d or vehicle. Daily oral administration was initiated when GIST-T1 tumors had reached a size of 100 to 200 mm<sup>3</sup>. Each group contained six animals. Data, mean ± SEM (A) body weight and (B) tumor size measurements from GIST-T1 xenograft mice after <b>13</b> administration. Initial body weight and tumor size were set as 100%. (C) Representative photographs of tumors in each group after 25.0, 50.0, or 100 mg/kg/d <b>13</b> or vehicle treatment. (D) Comparison of the final tumor weight in each group after 21-day treatment period of <b>13</b>; ns, <i>p</i> > 0.05, *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Starting from commercially available 2-substituted nitrophenol derivatives <b>36a</b>–<b>d</b>, etherification with various Boc-protected <b>R2</b> groups followed by hydrogenation afforded aniline compound <b>38</b>. Amide formation with carboxylic acid format of <b>R3</b> group followed by Boc-deprotection furnished intermediate <b>40</b>. Finally installment of <b>R1</b> group with amide formation conditions generated compounds <b>9</b>–<b>30</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compounds <b>31</b>–<b>34</b> were obtained with a slightly modified procedure (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Starting from compound <b>37a</b>, Boc-deprotection was followed by amide formation to install the <b>R1</b> group first. Then hydrogenation reduction of nitro group and subsequent introduction of various <b>R3</b> groups were by amide formation conditions affording compounds <b>31</b>–<b>34</b>. The synthesis of urea compound <b>35</b> started from <b>38a</b>, which upon urea formation was first to install the <b>R3</b> group, and then <b>R1</b> group was introduced via <b>42a</b> and <b>42b</b> intermediates (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for <b>37a</b>–<b>d</b>: <i>tert</i>-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate; for <b>37e</b>: <i>tert</i>-butyl 3-hydroxypiperidine-1-carboxylate, DIAD, PPh<sub>3</sub>, THF, 0 °C to rt; for <b>37f</b>: <i>tert</i>-butyl (2-bromoethyl)carbamate, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, overnight; (b) Pd/C, H<sub>2</sub>, EtOAc, rt, 6 h; (c) R3CO<sub>2</sub>H, HATU, DIPEA, DMF, rt, 2 h; (d) 4 N HCl in EtOAc, rt, overnight; (e) R1CO<sub>2</sub>H, HATU, DIPEA, DMF, rt, 2 h.</p></p></figure><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>31</b>–<b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4 N HCl in EtOAc, rt, overnight; (b) nicotinic acid, HATU, DIPEA, DMF, rt, 2 h; (c) Pd/C, H<sub>2</sub>, EtOAc, rt, 6 h; (d) R3CO<sub>2</sub>H, HATU, DIPEA, DMF, rt, 2 h.</p></p></figure><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-chloro-4-isocyanato-2-(trifluoromethyl)benzene, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight; (b) 4 N HCl in EtOAc, rt; (c) nicotinic acid, HATU, DIPEA, DMF, rt, 2 h.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting with the well-known type II BCR-ABL/c-KIT dual inhibitor Imatinib’s core scaffold, with the hybrid type II inhibitor design approach, we have discovered a highly selective c-KIT inhibitor <b>13</b> which almost completely abolished the ABL kinase activity. In addition, <b>13</b> has no FLT3 kinase activity which might avoid the potential myeloid suppression problem of c-KIT/FLT3 dual kinase inhibitors. The extensive biological activity study also revealed that <b>13</b> potently inhibited PDGFRβ, DDR1, and CSF1-R kinase, which might strengthen its antitumor activity since PDGFR plays critical roles in the angiogenesis,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> DDR1 kinase plays a role in the tumor proliferation, migration, and invasion,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and CSF1-R is essential for the cell survival, proliferation, and differentiation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><b>13</b> strongly inhibited the cell proliferation and also induced the cell cycle arrest and apoptosis in the c-KIT-dependent GISTs cancer cells (GIST-T1 and GIST-882) but not in the c-KIT-independent GIST-48B cells. It is worth noting that <b>13</b> is not sensitive to compound <b>1</b>-resistant c-KIT mutants such as V654A, D816V, etc., which are important mutants observed in the clinic. Further detailed SAR study based on this new pharmacophore or combinatorial with other related signaling mediator inhibitors was required for achievement of sensitivity against those drug-resistant mutants. The acceptable selectivity profile, PK profile, and antitumor efficacy suggest that <b>13</b> might be a useful pharmacological tool to further study the pathology of GISTs, and currently it is under extensive preclinical PK/PD evaluation to determine whether it might serve as a good potential drug candidate for further clinical development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p">All reagents and solvents were purchased from commercial sources and used as obtained. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded with a Bruker 400 NMR spectrometer and referenced to deuterium dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>) or deuterium chloroform (CDCl<sub>3</sub>). Chemical shifts are expressed in ppm. In the NMR tabulation, s indicates singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad peak. LC/MS were performed on an Agilent 6224 TOF using an ESI source coupled to an Agilent 1260 Infinity HPLC system operating in reverse mode with an Agilent Eclipse Plus C18 1.8 μm 3.0 × 50 mm column. Flash column chromatography was conducted using silica gel (Silicycle 40–64 μm). The purities of all compounds were determined to be above 95% by HPLC.</div><div class="NLM_p">Compounds <b>9</b>–<b>30</b> and <b>35</b> were prepared following the synthetic <a class="ref internalNav" href="#sec5_1_5" aria-label="procedure of 13">procedure of 13</a>.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(2-(2-Methyl-5-(3-(trifluoromethyl)benzamido)phenoxy)ethyl)nicotinamide (<b>9</b>)</h4><div class="NLM_p last">Yield 68%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 9.05 (s, 1H), 8.95 (s, 1H), 8.72 (s, 1H), 8.26 (m, 3H), 7.98 (d, <i>J</i> = 7.0 Hz, 1H), 7.80 (t, <i>J</i> = 6.8 Hz, 1H), 7.51 (m, 2H), 7.32 (d, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 7.1 Hz, 1H), 4.16 (s, 2H), 3.74 (s, 2H), 2.15 (s, 3H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 444.1466 [M + H<sup>+</sup>].</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-(2-(2-Methyl-5-(3-(trifluoromethyl)benzamido)phenoxy)ethyl)isoxazole-5-carboxamide (<b>10</b>)</h4><div class="NLM_p last">Yield 71%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 9.19 (s, 1H), 8.76 (s, 1H), 8.30 (s, 2H), 7.98 (s, 1H), 7.81 (s, 1H), 7.47 (s, 1H), 7.31 (s, 1H), 7.11 (s, 2H), 4.13 (s, 2H), 3.71 (s, 2H), 2.13 (s, 3H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 434.1933 [M + H<sup>+</sup>].</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-(4-Methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>11</b>)</h4><div class="NLM_p last">Yield 58%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.65 (s, 2H), 8.27 (s, 2H), 7.87–7.78 (m, 3H), 7.48 (s, 2H), 7.30 (s, 1H), 7.14 (s, 1H), 4.61 (s, 1H), 3.86–3.36 (m, 3H), 2.16 (s, 3H), 2.02 (s, 2H), 1.79 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 484.1775 [M + H<sup>+</sup>].</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(4-Methyl-3-((1-picolinoylpiperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>12</b>)</h4><div class="NLM_p last">Yield 62%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.61 (s, 1H), 8.28 (s, 2H), 7.96 (m, 2H), 7.80 (t, <i>J</i> = 7.9 Hz, 1H), 7.61 (d, <i>J</i> = 7.2 Hz, 1H), 7.50 (s, 2H), 7.31 (d, <i>J</i> = 7.7 Hz, 1H), 7.16 (d, <i>J</i> = 8.4 Hz, 1H), 3.96–3.33 (m, 4H), 2.18 (s, 3H), 2.03 (s, 2H), 1.76 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 484.1773 [M + H<sup>+</sup>].</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-(3-(1-Isonicotinoylpiperidin-4-yloxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (<b>13</b>)</h4><div class="NLM_p last">HATU (0.06 mmol, 23 mg), <b>40a</b> (0.05 mmol, 19 mg), and DIPEA (0.075 mmol, 10 mg) were dissolved in 0.5 mL of DMF and cooled to 0 °C. Isonicotinic acid (0.06 mmol, 7.4 mg) was added to the system, and the mixture was stirred at room temperature for 2 h. The system was extracted with EtOAc and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under vacuum, and the residue was purified by silica gel flash chromatography (DCM/MeOH = 10/1) to offer the product <b>13</b> (16.2 mg, 67%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.37 (s, 1H), 8.67 (s, 2H), 8.27 (s, 2H), 7.96 (d, <i>J</i> = 6.8 Hz, 1H), 7.79–7.76 (m, 1H), 7.48 (s, 1H), 7.43 (s, 2H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.14 (d, <i>J</i> = 7.6 Hz, 1H), 4.60 (s, 1H), 3.83–3.28 (m, 4H), 2.16 (s, 3H), 1.95 (brs, 2H), 1.77 (brs, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.02, 164.34, 155.06, 152.22, 143.67, 138.37, 136.22, 132.38, 130.92, 130.14, 128.52, 124.94, 122.94, 113.44, 106.97, 71.90, 44.21, 39.38, 38.94, 30.94, 30.19, 16.15. LC/MS (ESI, <i>m</i>/<i>z</i>) = 484.1781 [M + H<sup>+</sup>].</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-(3-((1-(Isoxazole-5-carbonyl)piperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide (<b>14</b>)</h4><div class="NLM_p last">Yield 57%, <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.76 (s, 1H), 8.27 (s, 2H), 7.96 (s, 1H), 7.79 (s, 1H), 7.49 (s, 1H), 7.29 (d, <i>J</i> = 7.2 Hz, 1H), 7.14 (d, <i>J</i> = 8.0 Hz, 1H), 6.96 (s, 1H), 4.64 (s, 1H), 3.79–3.50 (m, 4H), 2.17 (s, 3H), 2.03 (s, 2H), 1.81 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 474.1568 [M + H<sup>+</sup>].</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(4-Methyl-3-((1-propionylpiperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>15</b>)</h4><div class="NLM_p last">Yield 72%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.29 (s, 2H), 7.99 (d, <i>J</i> = 7.4 Hz, 1H), 7.81 (t, <i>J</i> = 7.0 Hz, 1H), 7.50 (s, 1H), 7.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.15 (d, <i>J</i> = 7.9 Hz, 1H), 4.57 (s, 1H), 3.68 (s, 2H), 3.44 (s, 2H), 2.37 (m, 2H), 2.16 (s, 3H), 1.95 (s, 2H), 1.68 (s, 2H), 1.02 (m, 3H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 435.1816 [M + H<sup>+</sup>].</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(3-((1-Acryloylpiperidin-4-yl)oxy)-4-methylphenyl)-3-(trifluoromethyl)benzamid (<b>16</b>)</h4><div class="NLM_p last">Yield 76%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.27 (s, 2H), 7.97 (s, 1H), 7.79 (d, <i>J</i> = 7.9 Hz, 1H), 7.48 (s, 1H), 7.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.13 (d, <i>J</i> = 8.2 Hz, 1H), 6.84 (dd, <i>J</i> = 16.5, 10.2 Hz, 1H), 6.11 (d, <i>J</i> = 16.1 Hz, 1H), 5.68 (d, <i>J</i> = 10.2 Hz, 1H), 4.58 (s, 1H), 3.77 (s, 2H), 3.56 (s, 2H), 2.14 (s, 3H), 1.97 (s, 2H), 1.70 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 433.1668 [M + H<sup>+</sup>].</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(3-((1-Nicotinoylpiperidin-3-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>17</b>)</h4><div class="NLM_p last">Yield 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.66–8.56(m, 3H), 8.27 (s, 2H), 7.97 (s, 1H), 7.83–7.19 (m, 5H), 6.84 (s, 0.4H), 6.64 (s, 0.6H), 4.51(s, 1H), 4.05–3.30 (m, 4H), 2.07–1.58 (m, 4H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 470.1620 [M + H<sup>+</sup>].</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(3-((1-(Isoxazole-5-carbonyl)piperidin-3-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>18</b>)</h4><div class="NLM_p last">Yield 56%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.46 (s, 0.43H), 10.40 (s, 0.57H), 8.78 (s, 0.43H), 8.63 (s, 0.57H), 8.27 (s, 2H), 7.99 (d, <i>J</i> = 7.4 Hz, 1H), 7.80 (t, <i>J</i> = 7.7 Hz, 1H), 7.35 (m, 3H), 6.96 (s, 0.43H), 6.78 (s, 1H), 6.68 (d, <i>J</i> = 7.9 Hz, 0.57H), 4.55 (s, 1H), 3.99–3.30 (m,4H), 2.06–1.85 (m, 3H), 1.61 (s, 1H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 460.1412 [M + H<sup>+</sup>].</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(3-((1-Nicotinoylpiperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>19</b>)</h4><div class="NLM_p last">Yield 53%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.45 (s, 1H), 8.64 (s, 2H), 8.27 (s, 2H), 8.04–7.69 (m, 3H), 7.50 (s, 1H), 7.48(s, 1H), 7.34(s, 1H), 7.27 (s, 1H), 6.78 (s, 1H), 4.64 (s, 1H), 3.95 (s, 1H), 3.52 (s, 2H), 1.98 (s, 2H), 1.70 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 470.1619 [M + H<sup>+</sup>].</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(4-Chloro-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>20</b>)</h4><div class="NLM_p last">Yield 55%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.57 (s, 1H), 8.67 (s, 2H), 8.27 (s, 2H), 8.00 (d, <i>J</i> = 7.4 Hz, 1H), 7.90 (d, <i>J</i> = 7.1 Hz, 1H), 7.82 (t, <i>J</i> = 7.5 Hz, 1H), 7.72 (s, 1H), 7.58–7.38 (m, 3H), 4.71 (s, 1H), 3.91–3.34 (m, 4H), 2.07 (s, 2H), 1.81 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 504.1229 [M + H<sup>+</sup>].</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(4-Methoxy-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>21</b>)</h4><div class="NLM_p last">Yield 66%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 8.65 (s, 2H), 8.27 (s, 2H), 8.04–7.72 (m, 3H), 7.59–7.44 (m, 2H), 7.38 (d, <i>J</i> = 8.0 Hz, 1H), 7.02 (d, <i>J</i> = 8.6 Hz, 1H), 4.52 (s, 1H), 3.97 (s, 1H), 3.78 (s, 3H), 3.5–3.32 (m, 3H), 2.02 (s, 2H), 1.74 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 500.1726 [M + H<sup>+</sup>].</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(3-((1-Isonicotinoylpiperidin-4-yl)oxy)-4-methylphenyl)-4-methyl-3-(trifluoromethyl)benzamide (<b>22</b>)</h4><div class="NLM_p last">Yield 66%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.33 (s, 1H), 8.68 (d, <i>J</i> = 4.1 Hz, 2H), 8.23 (s, 1H), 8.15 (d, <i>J</i> = 7.2 Hz, 1H), 7.64 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.36 (m, 3H), 7.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.14 (d, <i>J</i> = 8.0 Hz, 1H), 4.61 (s, 1H), 3.84 (s, 1H), 3.68 (s, 1H), 3.48 (s, 1H), 3.30 (s, 1H), 2.17 (s, 3H), 2.00 (s, 2H), 1.78 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 498.1933 [M + H<sup>+</sup>].</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-Methyl-<i>N</i>-(4-methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>23</b>)</h4><div class="NLM_p last">Yield 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.31 (s, 1H), 8.65 (s, 2H), 8.22 (s, 2H), 7.88 (s, 1H), 7.62 (s, 1H), 7.49 (s, 2H), 7.28 (s, 1H), 7.12 (s, 1H), 4.60 (s, 1H), 3.98–3.43 (m, 4H), 2.16 (s, 3H), 2.00 (s, 2H), 1.77 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 498.1923 [M + H<sup>+</sup>].</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Methyl-<i>N</i>-(4-methyl-3-((1-(thiazole-5-carbonyl)piperidin-4-yl)oxy)phenyl)-3-(trifluoromethyl)benzamide (<b>24</b>)</h4><div class="NLM_p last">Yield 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 9.24 (s, 1H), 8.22 (s, 2H), 8.14 (s, 1H), 7.62 (s, 1H), 7.49 (s, 1H), 7.27 (s, 1H), 7.12 (s, 1H), 4.62 (s, 1H), 3.79 (s, 2H), 3.66 (s, 2H), 2.16 (s, 3H), 2.02 (s, 2H), 1.79 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 504.1496 [M + H<sup>+</sup>].</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(3-((1-(Isoxazole-5-carbonyl)piperidin-4-yl)oxy)-4-methylphenyl)-4-methyl-3-(trifluoromethyl)benzamide (<b>25</b>)</h4><div class="NLM_p last">Yield 75%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.33 (s, 1H), 8.76 (s, 1H), 8.22 (s, 1H), 8.15 (d, <i>J</i> = 7.7 Hz, 1H), 7.62 (d, <i>J</i> = 7.6 Hz, 1H), 7.49 (s, 1H), 7.28 (d, <i>J</i> = 7.7 Hz, 1H), 7.13 (d, <i>J</i> = 7.9 Hz, 1H), 6.96 (s, 1H), 4.63 (s, 1H), 3.67 (t, <i>J</i> = 47.8 Hz, 4H), 2.16 (s, 3H), 2.02 (s, 2H), 1.79 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 488.1722 [M + H<sup>+</sup>].</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-Chloro-<i>N</i>-(4-methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)-5-(trifluoromethyl)benzamide (<b>26</b>)</h4><div class="NLM_p last">Yield 72%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44 (s, 1H), 8.65 (s, 2H), 8.31 (s, 1H), 8.23 (s, 1H), 8.13 (s, 1H), 7.87 (s, 1H), 7.46 (s, 2H), 7.27 (s, 1H), 7.15 (d, <i>J</i> = 6.8 Hz, 1H), 4.60 (s, 1H), 3.92–3.34 (m, 4H), 2.17 (s, 3H), 2.01 (s, 2H), 1.77 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 518.1385 [M + H<sup>+</sup>].</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-Chloro-<i>N</i>-(3-((1-(isoxazole-5-carbonyl)piperidin-4-yl)oxy)-4-methylphenyl)-5-(trifluoromethyl)benzamide (<b>27</b>)</h4><div class="NLM_p last">Yield 56%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.45 (s, 1H), 8.76 (s, 1H), 8.32 (s, 1H), 8.24 (s, 1H), 8.13 (s, 1H), 7.47 (s, 1H), 7.28 (s, 1H), 7.15 (d, <i>J</i> = 7.4 Hz, 1H), 6.96 (s, 1H), 4.63 (s, 1H), 3.79–3.54 (m, 4H), 2.17 (s, 3H), 2.03 (s, 3H), 1.81 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 508.1169 [M + H<sup>+</sup>].</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-Fluoro-<i>N</i>-(4-methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)-5-(trifluoromethyl)benzamide (<b>28</b>)</h4><div class="NLM_p last">Yield 66%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 8.65 (s, 2H), 8.15–8.09 (m, 2H), 7.96 (s, 1H), 7.87 (s, 1H), 7.47 (s, 2H), 7.27 (s, 1H), 7.15 (d, <i>J</i> = 7.4 Hz, 1H), 4.60 (s, 1H), 3.82–3.35 (m, 3H), 2.17 (s, 3H), 1.99 (s, 2H), 1.77 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 502.1669 [M + H<sup>+</sup>].</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(4-Methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)-6-(trifluoromethyl)picolinamide (<b>29</b>)</h4><div class="NLM_p last">Yield 58%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (s, 1H), 8.65 (s, 2H), 8.38 (s, 2H), 8.17 (s, 1H), 7.87 (s, 1H), 7.68–7.27 (m, 3H), 7.15 (s, 1H), 4.66 (s, 1H), 3.98–3.34 (m, 4H), 2.17 (s, 3H), 1.97 (s, 2H), 1.77 (s, 2H). HRMS (ESI, <i>m</i>/<i>z</i>) = 485.1729 [M + H<sup>+</sup>].</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(3-((1-(Isoxazole-5-carbonyl)piperidin-4-yl)oxy)-4-methylphenyl)-6-(trifluoromethyl)picolinamide (<b>30</b>)</h4><div class="NLM_p">Yield 61%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.29 (s, 1H), 8.75 (s, 1H), 8.37 (d, <i>J</i> = 8.4 Hz, 2H), 8.18 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (s, 1H), 7.41 (d, <i>J</i> = 7.3 Hz, 1H), 7.16 (d, <i>J</i> = 7.2 Hz, 1H), 7.02–6.86 (m, 1H), 4.69 (s, 1H), 3.79–3.54 (m, 4H), 2.17 (s, 3H), 2.03 (s, 2H), 1.80 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 475.1522 [M + H<sup>+</sup>].</div><div class="NLM_p last">Compounds <b>31</b>–<b>34</b> were prepared following the synthetic <a class="ref internalNav" href="#sec5_1_25" aria-label="procedure of 33">procedure of 33</a>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-Methoxy-<i>N</i>-(4-methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)benzamide (<b>31</b>)</h4><div class="NLM_p last">Yield 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.11 (s, 1H), 8.64 (s, 2H), 7.87 (s, 1H), 7.50–7.46(m, 5H), 7.27 (s, 1H), 7.12 (s, 2H), 4.59 (s, 1H), 3.83–3.55 (m, 7H), 2.15 (s, 3H), 2.00 (s, 2H), 1.76 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 446.2010 [M + H<sup>+</sup>].</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-(<i>tert</i>-Butyl)-<i>N</i>-(4-methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)isoxazole-3-carboxamide (<b>32</b>)</h4><div class="NLM_p last">Yield 59%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.51 (s, 1H), 8.67 (s, 2H), 7.90 (d, <i>J</i> = 7.8 Hz, 1H), 7.49 (m, 2H), 7.36 (d, <i>J</i> = 7.5 Hz, 1H), 7.14 (d, <i>J</i> = 7.8 Hz, 1H), 6.68 (s, 1H), 4.58 (s, 1H), 3.96–3.32 (m, 4H), 2.17 (s, 3H), 2.01 (s, 2H), 1.78 (s, 2H), 1.37 (s, 9H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 463.2273 [M + H<sup>+</sup>].</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(4-Methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)benzo[<i>d</i>][1,3]dioxole-5-carboxamide (<b>33</b>)</h4><div class="NLM_p last">To a solution of benzo[<i>d</i>][1,3]dioxole-5-carboxylic acid (0.05 mmol, 8.3 mg) and <b>41c</b> (0.05 mmol, 16 mg) in 0.5 mL DMF were added HATU (0.06 mmol, 22.8 mg) and DIPEA (0.1 mmol, 13 mg). The mixture was stirred at room temperature for 2 h, and the system was quenched with water, extracted with EtOAc, and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvents were removed under vacuum, and the crude product was purified by silica gel flash chromatography (DCM: MeOH = 10:1) to give the product <b>33</b> (15.3 mg, 67%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.97 (s, 1H), 8.67 (s, 2H), 7.89 (s, 1H), 7.61–7.40 (m, 4H), 7.28 (s, 1H), 7.09 (m, 2H), 6.15 (s, 2H), 4.60 (s, 1H), 3.95–3.37 (m, 4H), 2.17 (s, 3H), 2.04 (s, 2H), 1.78 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 460.1803 [M + H<sup>+</sup>].</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(4-Methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)quinoline-3-carboxamide (<b>34</b>)</h4><div class="NLM_p last">Yield 57%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.55 (s, 1H), 9.38 (s, 1H), 8.97 (s, 1H), 8.68 (s, 2H), 8.18–8.13 (m, 2H), 7.90 (s, 2H), 7.76 (s, 1H), 7.57 (s, 1H), 7.51(s, 1H), 7.35 (s, 1H), 7.18 (d, <i>J</i> = 7.1 Hz, 1H), 4.64 (s, 1H), 3.87–3.55 (m, 4H), 2.20 (s, 3H), 2.03 (s, 2H), 1.81 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 467.2001 [M + H<sup>+</sup>].</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-methyl-3-((1-nicotinoylpiperidin-4-yl)oxy)phenyl)urea (<b>35</b>)</h4><div class="NLM_p last">Yield 53%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (s, 1H), 8.82 (s, 1H), 8.65 (s, 2H), 8.08 (s, 1H), 7.88 (d, <i>J</i> = 7.9 Hz, 1H), 7.70–7.56 (m, 2H), 7.50 (d, <i>J</i> = 4.7 Hz, 1H), 7.25 (s, 1H), 7.06 (d, <i>J</i> = 8.2 Hz, 1H), 6.87 (d, <i>J</i> = 6.9 Hz, 1H), 4.62 (s, 1H), 3.83–3.52 (m, 4H), 2.14 (s, 3H), 2.00 (s, 2H), 1.78 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 533.1486 [M + H<sup>+</sup>].</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>tert</i>-Butyl 4-(5-Amino-2-methylphenoxy) piperidine-1-carboxylate (<b>38a</b>)</h4><div class="NLM_p">2-Methyl-5-nitrophenol (<b>36a</b>) (5 mmol, 0.77g) and <i>tert</i>-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate (10 mmol, 2.79g) were dissolved in 15 mL DMF. Then K<sub>2</sub>CO<sub>3</sub> (10 mmol, 1.38g) was added to the system and heated at 90 °C overnight. The system was extracted with EtOAc and dried with anhydrous Na<sub>2</sub>SO<sub>4.</sub> The solvent was removed under vacuum, and the residue was purified by silica gel flash column chromatography (petroleum ether:EtOAc = 6:1) to give <b>37a</b> as a yellow solid. LC/MS (ESI, <i>m</i>/<i>z</i>) [M + Na<sup>+</sup>] = 359.1693. The obtained <b>37a</b> was directly dissolved in 20 mL EtOAc, and Pd/C (5%) was added. The mixture was stirred under hydrogen balloon at room temperature for 6 h. The system was filtered by diatomaceous earth, and the filtered organic system was concentrated under vacuum. The residue was purified by silica gel flash chromatography (petroleum ether:EtOAc = 8:1) to give <b>38a</b> (1.12g) as a yellow oil with a two-step yield of 73%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.74(d, <i>J</i> = 6.0 Hz, 1H), 6.23 (s, 1H), 6.07 (d, <i>J</i> = 6.0 Hz, 1H), 4.78 (s, 2H), 4.37–4.35 (m, 1H), 3.55 (m, 2H), 3.26 (m, 2H), 1.97 (s, 3H), 1.83 (s, 2H), 1.55 (s, 2H), 1.40 (s, 9H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 329.1949 [M + Na<sup>+</sup>].</div><div class="NLM_p last">Compounds <b>38b</b>–<b>d</b> were prepared following the synthetic <a class="ref internalNav" href="#sec5_1_28" aria-label="procedure of 38a">procedure of 38a</a>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 4-(5-Amino-2-chlorophenoxy)piperidine-1-carboxylate (<b>38b</b>)</h4><div class="NLM_p last">Yield (two-step) 71%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.09 (d, <i>J</i> = 7.6 Hz, 1H), 6.29–6.23 (m, 2H), 4.32–4.28 (m, 1H), 3.64–3.62 (m, 2H), 3.46–3.42 (m, 2H), 1.82 (s, 4H), 1.45 (s, 9H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 349.1403 [M + Na<sup>+</sup>].</div></div><div id="sec5_1_29a" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>tert</i>-Butyl 4-(5-Amino-2-methoxyphenoxy)piperidine-1-carboxylate (<b>38c</b>)</h4><div class="NLM_p last">Yield (two-step) 69%. <sup>1</sup>H NMR(400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.67 (d, <i>J</i> = 7.6 Hz, 1H), 6.30 (s, 1H), 6.13 (d, <i>J</i> = 7.6 Hz, 1H), 4.61 (s, 2H), 4.32–4.28 (m, 1H), 3.63–3.60 (m, 5H), 3.16 (s, 2H), 1.97 (s, 3H), 1.81 (s, 2H), 1.51 (s, 2H), 1.40 (s, 9H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 345.1898 [M + Na<sup>+</sup>].</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>tert</i>-Butyl 4-(3-Aminophenoxy)piperidine-1-carboxylate (<b>38d</b>)</h4><div class="NLM_p last">Yield (two-step) 58%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.87 (d, <i>J</i> = 4.4 Hz, 1H), 6.15–6.08 (m, 3H), 4.98 (s, 2H), 4.38–4.36 (m, 1H), 3.61 (s, 2H), 3.16 (s, 2H), 1.97 (s, 3H), 1.84 (s, 2H), 1.50 (s, 2H), 1.40 (s, 9H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 315.1783 [M + Na<sup>+</sup>].</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>tert</i>-Butyl 3-(3-Aminophenoxy)piperidine-1-carboxylate (<b>38e</b>)</h4><div class="NLM_p last">Diisopropyl azodicarboxylate (DIAD) (6 mmol, 1.21g) and triphenylphosphine (6 mmol, 1.57g) in 20 mL dry THF were stirred at 0 °C for 0.5 h. <i>tert</i>-Butyl 3-hydroxypiperidine-1-carboxylate (6 mmol, 1g) and 3-nitrophenol (5 mmol, 595 mg) were added to the system, which was warmed to room temperature and stirred overnight. The solvent was removed under vacuum, and the crude product was purified by silica gel flash chromatography (petroleum ether:EtOAc = 6:1) to give the intermediate <b>37e</b> as a yellow solid. The obtained <b>37e</b> was dissolved in 20 mL EtOAc, and Pd/C (5%) was added. The mixture was stirred under hydrogen balloon at room temperature for 6 h. Then the system was filtered through diatomaceous earth, and the filtrate was concentrated under vacuum to give <b>38e</b> (1.17g) as yellow oil with a two-step yield 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.90 (t, <i>J</i> = 7.7 Hz, 1H), 6.17–6.10 (m, 3H), 5.04 (s, 2H), 4.20 (s, 1H), 3.79–3.11 (m, 4H), 1.90–1.71 (m, 3H), 1.40–1.31 (m, 10H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 315.1793 [M + Na<sup>+</sup>].</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>tert</i>-Butyl (2-(5-amino-2-methylphenoxy)ethyl)carbamate (<b>38f</b>)</h4><div class="NLM_p last">2-Methyl-5-nitrophenol (5 mmol, 0.77g) and <i>tert</i>-butyl (2-bromoethyl)carbamate (8 mmol, 1.79g) were dissolved in 15 mL DMF. K<sub>2</sub>CO<sub>3</sub> (10 mmol, 1.38g) was added to the system and heated at 90 °C overnight. The system was extracted with EtOAc and dried with anhydrous Na<sub>2</sub>SO<sub>4.</sub> The solvent was removed under vacuum, and the residue was purified by silica gel flash chromatography (petroleum ether:EtOAc = 6:1) to give the intermediate <b>37f</b> as a yellow solid. <b>37f</b> (4 mmol, 1.13 g) was dissolved in 20 mL EtOAc, and Pd/C (5%) was added. The mixture was stirred under hydrogen balloon at room temperature for 6 h. The system was filtered through diatomaceous earth, and the filtrate was concentrated under vacuum to give compound <b>38f</b> (780 mg) as a yellow oil in two-step yield 59%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.95 (s, 1H), 6.74 (d, <i>J</i> = 7.7 Hz, 1H), 6.17 (s, 1H), 6.07 (d, <i>J</i> = 7.6 Hz, 1H), 4.82 (s, 2H), 3.82 (s, 2H), 3.30 (d, <i>J</i> = 5.5 Hz, 2H), 1.98 (s, 3H), 1.40 (s, 9H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 267.1626 [M + H<sup>+</sup>].</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(4-Methyl-3-(piperidin-4-yloxy)phenyl)-3-(trifluoromethyl)benzamide (<b>40a</b>)</h4><div class="NLM_p">To a solution of 3-(trifluoromethyl)benzoic acid (3 mmol 570 mg) and <b>38a</b> (3 mmol, 918 mg) in 15 mL DMF were added HATU (3.6 mmol, 1.37g) and DIPEA (4.5 mmol, 585 mg). The mixture was stirred at room temperature for 2 h, and the system was quenched with water, extracted with EtOAc, and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvents were removed under vacuum and provided the crude product <b>39a</b>. LC/MS (ESI, <i>m</i>/<i>z</i>) [M + H<sup>+</sup>] = 479.2069. Then <b>39a</b> was dissolved in 10 mL 4 N HCl in EtOAc. The mixture was stirred at room temperature overnight and neutralized by NaHCO<sub>3</sub> (aq), then extracted by EtOAc and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The concentrated residue was purified by silica gel flash chromatography (DCM:MeOH = 10:1) to give the product <b>40a</b> (782 mg) as a white solid with two-step yield 69%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (s, 1H), 8.27 (s, 2H), 7.94 (s, 1H), 7.77 (s, 1H), 7.48 (s, 1H), 7.28 (s, 1H), 7.11 (s, 1H), 4.44–4.42 (m, 1H), 3.07 (s, 2H), 2.82 (s, 2H), 2.13 (s, 1H), 1.97 (s, 3H), 2.01 (s 2H), 1.70 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 379.1564 [M + H<sup>+</sup>].</div><div class="NLM_p last">Compounds <b>40b</b>–<b>i</b> were prepared following the synthetic <a class="ref internalNav" href="#sec5_1_33" aria-label="procedure of 40a">procedure of 40a</a>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-Methyl-<i>N</i>-(4-methyl-3-(piperidin-4-yloxy)phenyl)-3-(trifluoromethyl)benzamide Hydrochloride (<b>40b</b>)</h4><div class="NLM_p last">Yield (two-step) 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (s, 1H), 9.31 (s, 2H), 8.24 (s, 2H), 7.59–7.49 (m, 2H), 7.31 (s, 1H), 7.11 (s, 1H), 4.57–4.55 (m, 1H), 3.17 (brs, 2H), 3.08 (s, 2H), 2.5 (s, 1H), 2.14 (s, 5H), 1.96 (s, 3H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 393.1719 [M + H<sup>+</sup>].</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-Fluoro-<i>N</i>-(4-methyl-3-(piperidin-4-yloxy)phenyl)-5-(trifluoromethyl)benzamide (<b>40c</b>)</h4><div class="NLM_p last">Yield (two-step) <b>5</b>8%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.43 (s, 1H), 8.27–8.05 (m, 2H), 7.97 (d, <i>J</i> = 7.1 Hz, 1H), 7.43 (s, 1H), 7.28 (d, <i>J</i> = 7.6 Hz, 1H), 7.14 (d, <i>J</i> = 8.0 Hz, 1H), 4.40 (s, 1H), 3.03 (s, 2H), 2.72 (s, 2H), 2.13 (d, <i>s</i>, 3H), 1.93 (s, 2H), 1.64 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = <i><b>397.1466 [M + H</b></i><sup><i><b>+</b></i></sup><i><b>]</b></i>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-Chloro-<i>N</i>-(4-methyl-3-(piperidin-4-yloxy)phenyl)-5-(trifluoromethyl)benzamide (<b>40d</b>)</h4><div class="NLM_p last">Yield (two-step) 61%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.49 (s, 1H), 8.34 (s, 1H), 8.26 (s, 1H), 8.13 (s, 1H), 7.47 (s, 1H), 7.29 (d, <i>J</i> = 7.9 Hz, 1H), 7.15 (d, <i>J</i> = 7.8 Hz, 1H), 4.43 (s, 1H), 3.07 (s, 2H), 2.77 (s, 2H), 2.16 (s, 3H), 1.95 (s, 2H), 1.70 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 413.1172 [M + H<sup>+</sup>].</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(4-Methyl-3-(piperidin-4-yloxy)phenyl)-6-(trifluoromethyl)picolinamide Hydrochloride (<b>40e</b>)</h4><div class="NLM_p last">Yield (two-step) 53%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.29 (s, 1H), 9.26 (s, 2H), 8.96 (s, 1H), 8.45–8.27 (m, 2H), 8.19 (d, <i>J</i> = 6.8 Hz, 1H), 7.53 (s, 1H), 7.43 (d, <i>J</i> = 8.1 Hz, 1H), 7.18 (d, <i>J</i> = 7.7 Hz, 1H), 4.65 (s, 1H), 3.21 (s, 2H), 3.12 (s, 2H), 2.18 (s, 5H), 1.97 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 416.1280 [M + H<sup>+</sup>].</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(4-Chloro-3-(piperidin-4-yloxy)phenyl)-3-(trifluoromethyl)benzamide (<b>40f</b>)</h4><div class="NLM_p last">Yield (two-step) 56%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.69 (s, 1H), 8.32 (s, 2H), 8.00 (d, <i>J</i> = 6.6 Hz, 1H), 7.81 (d, <i>J</i> = 9.3 Hz, 2H), 7.46 (s, 2H), 4.64 (s, 1H), 3.19 (s, 2H), 3.04 (s, 2H), 2.13 (s, 2H), 1.91 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 399.1006 [M + H<sup>+</sup>].</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(4-Methoxy-3-(piperidin-4-yloxy)phenyl)-3-(trifluoromethyl)benzamide (<b>40g</b>)</h4><div class="NLM_p last">Yield (two-step) 59%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.46 (s, 1H), 9.05 (s, 2H), 8.32 (s, 2H), 7.98 (d, <i>J</i> = 7.6 Hz, 1H), 7.80 (s, 1H), 7.58 (s, 1H), 7.40 (d, <i>J</i> = 9.1 Hz, 1H), 7.04 (d, <i>J</i> = 8.7 Hz, 1H), 4.50 (s, 1H), 3.80 (s, 3H), 3.25 (s, 2H), 3.08 (s, 2H), 2.11 (s, 2H), 1.92 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) [M + H<sup>+</sup>] = 395.1513.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(3-(Piperidin-4-yloxy)phenyl)-3-(trifluoromethyl)benzamide Hydrochloride (<b>40h</b>)</h4><div class="NLM_p last">Yield (two-step) 47%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (s, 1H), 9.18 (s, 2H), 8.28 (s, 2H), 7.98 (d, <i>J</i> = 7.2 Hz, 1H), 7.80 (s, 1H), 7.57 (s, 1H), 7.40 (d, <i>J</i> = 7.7 Hz, 1H), 7.30 (t, <i>J</i> = 8.0 Hz, 1H), 6.81 (d, <i>J</i> = 7.7 Hz, 1H), 4.65 (s, 1H), 3.20 (s, 3H), 3.10 (s, 2H), 2.15 (s, 2H), 1.91 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 365.1396 [M + H<sup>+</sup>].</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(3-(piperidin-3-yloxy)phenyl)-3-(trifluoromethyl)benzamide (<b>40i</b>)</h4><div class="NLM_p last">Yield (two-step) 52%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.47 (s, 1H), 8.29 (s, 2H), 7.98 (d, <i>J</i> = 6.6 Hz, 1H), 7.81 (d, <i>J</i> = 7.2 Hz, 1H), 7.59–7.12 (m, 3H), 6.74 (d, <i>J</i> = 7.4 Hz, 1H), 4.31 (s, 1H), 3.19–2.58 (m, 4H), 2.04 (s, 1H), 1.73 (s, 1H), 1.57–1.50 (m, 2H), 1.23–1.20 (m, 1H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 365.1407 [M + H<sup>+</sup>].</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-(3-(2-aminoethoxy)-4-methylphenyl)-3-(trifluoromethyl)benzamide Hydrochloride (<b>40j</b>)</h4><div class="NLM_p last">Yield (two-step) 56%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (s, 1H), 8.46 (s, 3H), 8.35 (d, <i>J</i> = 7.4 Hz, 2H), 7.97 (d, <i>J</i> = 7.4 Hz, 1H), 7.79 (t, <i>J</i> = 7.4 Hz, 1H), 7.54 (s, 1H), 7.39 (d, <i>J</i> = 7.8 Hz, 1H), 7.14 (d, <i>J</i> = 8.0 Hz, 1H), 4.20 (s, 2H), 3.26 (s, 2H), 2.19 (s, 3H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 339.1249 [M + H<sup>+</sup>].</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-(2-Methyl-5-nitrophenoxy)piperidine Hydrochloride (<b>41a</b>)</h4><div class="NLM_p last">Compound <b>37a</b> (5 mmol, 1.68 g) was added into 20 mL EtOAc (4 N HCl), and the system was stirred at room temperature for 6 h. The solid was collected and dried to give the product <b>41a</b> HCl salt as a yellow solid (1.22g, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.35 (s, 2H), 7.91–7.65 (m, 2H), 7.47 (d, <i>J</i> = 8.1 Hz, 1H), 4.92 (s, 1H), 3.16 (s, 4H), 2.29 (s, 3H), 2.17 (s, 2H), 1.95 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 237.1159 [M + H<sup>+</sup>].</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (4-(5-Amino-2-methylphenoxy)piperidin-1-yl) (pyridin-3-yl)methanone (<b>41c</b>)</h4><div class="NLM_p last">To a solution of nicotinic acid (3 mmol, 369 mg) and <b>41a</b> (3 mmol, 816 mg) in DMF (15 mL) were added HATU (3.6 mmol, 1.37g) and DIPEA (4.5 mmol, 585 mg). The resulting mixture was stirred at room temperature for 2 h, and the system was quenched with water, extracted with EtOAc, and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvents were removed under vacuum to yield the crude product <b>41b</b>, which was dissolved in EtOAc (20 mL), and Pd/C (5%) was added. The mixture was stirred under hydrogen balloon at room temperature for 6 h. The system was filtered through diatomaceous earth, and the filtrate was concentrated under vacuum to give the product <b>41c</b> (727 mg) as yellow oil. Yield (two-step) 78%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (s, 2H), 7.88 (d, <i>J</i> = 7.5 Hz, 1H), 7.49 (dd, <i>J</i> = 7.5, 4.7 Hz, 1H), 6.77 (d, <i>J</i> = 7.8 Hz, 1H), 6.28 (s, 1H), 6.09 (d, <i>J</i> = 7.6 Hz, 1H), 4.87 (s, 2H), 4.49 (s, 1H), 3.96–3.38 (m, 4H), 2.02 (s, 5H), 1.72 (s, 3H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 312.1640 [M + H<sup>+</sup>].</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-methyl-3-(piperidin-4-yloxy)phenyl)urea Hydrochloride (<b>42b</b>)</h4><div class="NLM_p last">Compound <b>38a</b> (5 mmol, 1.53 g) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added to 1-chloro-4-isocyanato-2-(trifluoromethyl)benzene (5 mmol, 1.1 g), and the mixture was stirred overnight at room temperature. The system was extracted with EtOAc and dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvents were removed under vacuum to give the crude product <b>42a</b>, which was added directly into 4 N HCl in EtOAc (30 mL). The mixture was stirred overnight at room temperature. The solid was collected and washed with EtOAc to give the product <b>42b</b> (1.6 g) as a white solid. Yield (two step) 69%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (s, 1H), 9.33 (s, 1H), 8.90 (s, 2H), 8.10 (s, 1H), 7.72–7.52 (m, 2H), 7.30 (s, 1H), 7.06 (d, <i>J</i> = 7.9 Hz, 1H), 6.85 (d, <i>J</i> = 7.8 Hz, 1H), 4.59 (s, 1H), 3.20 (s, 2H), 3.14 (s, 2H), 2.13 (s, 5H), 1.92 (s, 2H). LC/MS (ESI, <i>m</i>/<i>z</i>) = 428.1281 [M + H<sup>+</sup>].</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Cell Lines and Cell Culture</h3><div class="NLM_p last">The human GIST-T1 cell line was purchased from Cosmo Bio Co., Ltd. Tokyo, Japan. GIST-882 and GIST-48B cell lines were kindly provided by the Group of Professor Jonathan A. Fletcher, Brigham and Women’s Hospital in Boston, USA. K562 (CML), KU812 (CML), MEG-01 (CML), MV4-11 (AML), MOLM14 (AML), U937 (AML), REC-1 (human B-cell lymphoma cell), HL-60 (human promyelocytic leukemia cells), MEC-1(CLL), Kasumi-1 (AML), CHL (hamster lung cell), and CHO (hamster ovary cell) were obtained from American Type Culture Collection (Manassas, VA). All the cells were grown in a humidified incubator (Thermo, USA) at 37 °C under 5% CO<sub>2</sub>. GIST-T1, CHO cells were maintained in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. MV4-11 (AML), GIST-882, and GIST-48B were grown in IMDM supplemented with 10% FBS and 1% penicillin/streptomycin. All other cell lines and all the isogenic BaF3 cells were grown in RPMI 1640 medium supported with 10% FBS and 1% penicillin/streptomycin. Kasumi-1 (AML) was grown in RPMI 1640 medium supported with 20% FBS and 1% penicillin/streptomycin. Adherent cells were grown in tissue culture flasks until they were 85–95% confluent prior to use. For suspension cells, cells were collected by spinning down at 700 rpm/min for 4 min before use.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> General Procedure for Antiproliferation Assays</h3><div class="NLM_p last">A density of 1 to 3 × 10<sup>4</sup> cells/mL cells were mixed with various concentrations of compounds, then 100 μL suspension was added to each well and incubated for 72 h. Cell viability was determined using the CellTiter-Glo (Promega, USA) or CCK-8 (Beboy, China). Both assays were performed according to the manufacturer instructions. For CellTiter-Glo assay, luminescence was determined in a multilabel reader (Envision, PerkinElmer, USA). For CCK-8 assay, absorbance was measured in a microplate reader (iMARK, Bio-Rad, USA) at 450 and 655 nm. Data were normalized to control group (DMSO). GI<sub>50</sub> values were calculated using Prism 5.0 (GraphPad Software, San Diego, CA).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> TEL-Isogenic Cell Generation</h3><div class="NLM_p last">Retroviral constructs for BaF3-KIT mutants were made based on the pMSCVpuro (Clontech) backbone. For TEL-KIT vector, the first 1 kb of human TEL gene with an artificial myristoylation sequence (MGCGCSSHPEDD) was cloned into the pMSCVpuro retroviral vector, followed by a 3xFLAG tag sequence and a stop codon. Then, the kinase domain coding sequence of KIT was inserted in-frame between TEL and 3xFLAG sequences. For full-length expression vectors, the coding sequences of KIT variants were directly cloned in pMSCVpuro vector with a 3xFLAG tag at the C-terminal end. All mutagenesis was performed using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) following the manufacturer’s instructions. Retrovirus was packaged in HEK293T cells by transfecting KIT-containing MSCV vectors together with two helper plasmids. Virus supernatants were harvested 48 h after transfection and filtered before infection. Then BaF3 cells were infected with harvested virus supernatants using spinoculation protocol, and stable cell lines were obtained by puromycin selection for 48 h. The IL-3 concentrations in the culture medium were gradually withdrawn until cells were able to grow in the absence of IL-3.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Kinase Biochemical Assay</h3><div class="NLM_p">The fluorescence resonance energy-transfer-based Z′-LYTE kinase assay kit–Tyr 06 peptide (Invitrogen, Carlsbad, CA) was used to evaluate the IC<sub>50</sub> value of compound <b>13</b> for inhibition of c-KIT kinase. The reaction was performed on a 384-well plate with a 10 μL reaction volume per well containing 2 μM Tyr 06 peptide substrate in reaction buffer and 2.5 μL c-KIT kinase with a serial 3-fold dilution of compound <b>13</b> (2.5 μL, 10 μM to 1.5 nM). The final reaction concentration of ATP was 300 μM. After 1 h incubation, a reaction was developed and terminated, and the fluorescence measured with an automated plate reader (SpectraMax I3, MD, USA). A dose–response curve was fitted using Prism 5.0 (GraphPad Software Inc., San Diego, CA). The biochemical tests of CSF1R and DDR1 were provided by Invitrogen (Carlsbad, CA, USA).</div><div class="NLM_p last">The ADP-Glo kinase assay (Promega, Madison, WI) was used to screen compound <b>13</b> for its PDGFRβ inhibition effects. The kinase reaction system contains 9 μL PDGFRβ (10 ng/μL), 1 μL of serially diluted compound <b>13</b>, and 10 μL substrate Poly(4:1 Glu, Tyr) peptide (0.4 μg/μL) (Promega, Madison, WI) with 100 μM ATP (Promega, Madison, WI). The reaction in each tube was started immediately by adding ATP and kept going for 1 h under 37 °C. After the tube was cooled for 5 min at room temperature, 5 μL solvent reactions were carried out in a 384-well plate. Then 5 μL of ADP-Glo reagent was added into each well to stop the reaction and consume the remaining ATP within 40 min. At the end, 10 μL of kinase detection reagent was added into the well and incubated for 30 min to produce a luminescence signal. The luminescence signal was measured with an automated plate reader (Envision, PE, USA), and the dose–response curve was fitted using Prism 5.0 (GraphPad Software Inc., San Diego, CA).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Signaling Pathway Study</h3><div class="NLM_p last">GIST-T1, GIST-882, and GIST-48B cells were treated with DMSO, serially diluted compound <b>13</b>, and 1 μM Imatinib for 2 h. Cells were then washed with cold PBS and lysed in RIPA buffer (Beyotime, China). Western blotting was performed by standard methods, as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The following antibodies were used at a range of antibody concentrations as indicated by the manufacturers to probe for specific proteins: rabbit polyclonal antibodies to total c-KIT (cat. no. 3308) and phospho-KIT Y719 (cat. no. 3308) and Y703 (cat. no. 3308) were from Cell Signaling Technology. Rabbit polyclonal antibodies to phospho-KIT Y823 was from Invitrogen (cat. no. 44–498G). Polyclonal rabbit antibodies to total p42/44 mitogen activated protein kinase (MAPK) (cat. no. 4695), phospho-p44/42 MAPK T202/Y204 (cat. no. 4370), phospho-AKT S473 (cat. no. 4060), total AKT (cat. no. 4691), phospho-Stat5 (cat. no. 9314), total Stat5 (cat. no. 9363), phospho-Stat3 (cat. no. 9145), total Stat3 (cat. no. 12640), phospho-S6K T389 (cat. no. 9206), total S6K (cat. no. 9202), phospho-S6 S235/236 (cat. no. 2211), total S6 (cat. no. 2217), phospho-Src Y416 (cat. no. 6943), total Src (cat. no. 2123), phospho-PDGFRα Y849/PDGFRβ Y857 (cat. no. 3308), and total PDGFRα (cat. no. 3308) were from Cell Signaling Technology. Beta actin antibodies were purchased from Sigma (cat. no. A5316).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Apoptosis Effect Examination</h3><div class="NLM_p last">GIST-T1, GIST-882, and GIST-48B cells were treated with DMSO, serially diluted compound <b>13</b>, 1 μM Imatinib for the indicated periods. Cells were collected and analyzed by Western blotting using the following antibodies: PARP (cat. no. 9532) and Caspase-3 (cat. no. 9665) from Cell Signaling Technology. Beta actin antibodies were purchased from Sigma (cat. no. A5316).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Cell Cycle Analysis</h3><div class="NLM_p last">GIST-T1, GIST-882, and GIST-48B cells were treated with DMSO, serially diluted compound <b>13</b> (0.3, 1, and 3 μM), and 3 μM Imatinib for the indicated periods. The cells were fixed in 70% cold ethanol and incubated at −20 °C overnight then stained with PI/RNase staining buffer (BD Pharmingen). Flow cytometry was performed using a FACS Calibur (BD), and results were analyzed by ModFit software.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> In Vivo Pharmacokinetics Study</h3><div class="NLM_p last">Compound <b>13</b> was dissolved in 55% saline containing 5% DMSO and 40% PEG400 by vortex. The final concentration of the stock solution was 1 mg/mL for administration. Six 8 week old male Sprague–Dawely rats were fasted overnight before starting drug treatment via intravenous and oral administration. Animal blood collection time points were as follows: for groups 1, 3, 5 (intravenous): 1 min, 5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h before and after administration was selected; for groups 2, 4, 6 (oral): 5 min, 15 min, 30 min, 1 h, 2 h, 4 h, 6 h, 8 h, and 24 h before and after dosing. Each time about 0.2 mL of blood was collected through the jugular vein adding heparin for anticoagulation and kept on ice. Then plasma was separated by centrifugation at 8000 rpm for 6 min at 2–8 °C. The obtained plasma was stored at −80 °C before analysis. After finishing the test, all surviving animals were transferred to the repository or euthanasia (CO<sub>2</sub> asphyxiation).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> GIST-T1 Xenograft Model</h3><div class="NLM_p last">Six week old female nu/nu mice were purchased from the Shanghai Experimental Center, Chinese Academy of Sciences (Shanghai, China). All animals were maintained in a specific pathogen-free facility and used according to the animal care regulations of Hefei Institutes of Physical Science, Chinese Academy of Sciences (Hefei, China), and all efforts were made to minimize animal suffering. To obtain orthotopic xenograft of human mammary tumor in the mice, cells were harvested during exponential growth. Five million GIST-T1 cells in PBS were suspended in a 1:1 mixture with Matrigel (BD Biosciences) and injected into the subcutaneous space on the right flank of nu/nu mice. Daily oral administration was initiated when GIST-T1 tumors had reached a size of 100–200 mm<sup>3</sup>. Animals were then randomized into treatment groups of six mice each for efficacy studies. Compound <b>13</b> was delivered daily in a HKI solution (0.5% methocellulose/0.4% Tween80 in ddH<sub>2</sub>O) by orally gavages. A range of doses of <b>13</b> or its vehicle was administered, as indicated in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a> legends. Body weight and tumor growth were measured daily after <b>13</b> treatment. Tumor volumes were calculated as follows: tumor volume (mm<sup>3</sup>) = [(<i>W</i><sup>2</sup> × <i>L</i>)/2], where width (<i>W</i>) is defined as the smaller of the two measurements and length (<i>L</i>) is defined as the larger of the two measurements.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> HE Staining</h3><div class="NLM_p last">HE staining was carried out according to the previous report.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> First the sections were hydrated, and then the slide was dipped into a Coplin jar containing Mayer’s hematoxylin and agitated for 30 s. After rinsing the slide in H<sub>2</sub>O for 1 min, it was stained with 1% eosin Y solution for 10–30 s with agitation. Subsequently, the sections were dehydrated with two changes of 95% alcohol and two changes of 100% alcohol for 30 s each. The alcohol was extracted with two changes of xylene. Finally, one or two drops of mounting medium were added and covered with a coverslip.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>K</i><sub>i</sub>-67 Staining</h3><div class="NLM_p last">For IHC demonstration of <i>K</i><sub>i</sub>-67, tissue sections were quenched for endogenous peroxides and placed in an antigen retrieval solution (0.01 M citrate buffer, pH 6.0) for 15 min in a microwave oven at 100 °C at 600 W. After incubation in the casein block, mouse mAb anti-<i>K</i><sub>i</sub>-67 (ZSGB-BIO, China) was applied to the sections at dilutions of 1:50. Incubations with primary antibodies lasted overnight at 4 °C. The secondary detection system was used to visualize antibody binding. Staining was developed with 3,3′-diaminobenzidine (DAB), and the slides were counterstained with hematoxylin, dehydrated, and mounted.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> TUNEL Staining</h3><div class="NLM_p last">TUNEL staining was performed using the POD in Situ Cell Death Detection kit (Roche, USA). Briefly, sections were deparaffinized in xylene, rehydrated in decreasing concentrations of ethanol, and then treated by nuclease-free Proteinase K for 15 min at room temperature before the endogenous peroxidase was blocked in 3% H<sub>2</sub>O<sub>2</sub> in methanol. Terminal deoxynucleotidyl transferase in reaction buffer was applied to sections for 1 h at 37 °C. Following washes, the slides were covered by converter-POD solution for 30 min at 37 °C. Apoptotic cells were detected after incubation in DAB chromogen (Beyotime Biotechnology, China) for approximately 8 min, and the slides were counterstained with hematoxylin.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Molecular Modeling</h3><div class="NLM_p last">Molecular docking of compound <b>13</b> to the ABL1 kinase and the c-KIT kinase was performed with software Yeti<sup>X</sup> 8.3.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The kinase domain of chain A in the PDB was used for docking (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a> for ABL1 and c-KIT, respectively). Alternative conformations of the side chains were manually confirmed, missing side chains were automatically added using AmberTools,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the protonation and tautomeric state at physiological pH were confirmed by software Reduce,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and the receptor side-chain structure was further optimized using Yeti<sup>X</sup> 8.3. Compound <b>13</b> was constructed using Bio<sup>X</sup> 4.6,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and the atomic partial charges were generated by AmberTools. Template-based induced-fit docking of small molecules to the two kinases: ABL1 and c-Kit were performed using Yeti<sup>X</sup> 8.3. The docked models were optimized by the directional <i>Yeti</i> force field.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00200">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00200" class="ext-link">10.1021/acs.jmedchem.6b00200</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Table S1 listing the DiscoveRx’s KinomeScan selectivity profiling data of <b>13</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Compound data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_001.pdf">jm6b00200_si_001.pdf (518.73 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_002.csv">jm6b00200_si_002.csv (3.61 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00200" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Liu</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#eb8182858c87829eab83868d87c58a88c58885"><span class="__cf_email__" data-cfemail="690300070e05001c2901040f0547080a470a07">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingsong Liu</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Science and Technology of China, Hefei, Anhui 230036, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#83f2f0efeaf6bab4c3ebeee5efade2e0ade0ed"><span class="__cf_email__" data-cfemail="69181a05001c505e2901040f0547080a470a07">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiang Wang</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feiyang Liu</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Science and Technology of China, Hefei, Anhui 230036, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beilei Wang</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fengming Zou</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Chen</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaochuan Liu</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Science and
Technology of China, Hefei, Anhui 230036, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aoli Wang</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Science and Technology of China, Hefei, Anhui 230036, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuang Qi</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenchao Wang</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ziping Qi</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Zhao</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenquan Hu</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Wang</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Wang</span> - <span class="hlFld-Affiliation affiliation">High
Magnetic Field Laboratory, Chinese Academy
of Sciences, Mailbox 1110, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Precision Medicine, CAS (Hefei) Institute of Technology Innovation,
Hefei Institute of Physical Science, Chinese
Academy of Sciences, Hefei, Anhui 230088, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shanchun Zhang</span> - <span class="hlFld-Affiliation affiliation">CHMFL-HCMTC
Target Therapy Joint Laboratory, 350 Shushanhu Road, Hefei, Anhui 230031, P.
R. China</span>; 
    <span class="hlFld-Affiliation affiliation">Hefei Cosource
Medicine Technology Co., LTD, 358 Ganquan Road, Hefei, Anhui 230031, P.
R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuexiang Wang</span> - <span class="hlFld-Affiliation affiliation">SIBS
(Institute of Health Sciences)-Changzheng Hospital Joint Center for
Translational Medicine, Institute of Health Sciences, Shanghai Changzheng
Hospital, Institutes for Translational Medicine
(CAS-SMMU), Shanghai 200031, China</span>; 
    <span class="hlFld-Affiliation affiliation">Key
Laboratory of Stem Cell Biology, Institute of Health Sciences, SIBS, Chinese Academy of Sciences/Shanghai Jiao Tong University
School of Medicine, Shanghai 200031, China</span>; 
    <span class="hlFld-Affiliation affiliation">Collaborative
Innovation Center of Systems Biomedicine, Shanghai 200025, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Q.W., F.L., B.W., F.Z., and C.C. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Dr. Shanchun Zhang is a shareholder of Hefei Cosource Medicine Technology Co., LTD.<br /></br></div></li></ul></div><div class="ack" id="ACK-d164e4136-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Q.L. is supported by the Joint Funds of Research on Major Science Facilities, Key Program of the National NSFC (no. U1432250). W.W., J.L., and Q.L. are supported by the grant of “Cross-disciplinary Collaborative Teams Program for Science, Technology, and Innovation (2014-2016)” from Chinese Academy of Sciences. We are grateful for the China “Thousand Talents Program” support for Q.L. and “Hundred Talents Program” of the Chinese Academy of Sciences support for J.L. and W.W. J.L. is also supported by the National Program for Support of Top-notch Young Professionals. Q.L. is also supported by the CAS/SAFEA international partnership program for creative research teams.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used</h2><tr><td class="NLM_term">CML</td><td class="NLM_def"><p class="first last">chronic myeloid leukemia</p></td></tr><tr><td class="NLM_term">GISTs</td><td class="NLM_def"><p class="first last">gastrointestinal stromal tumors</p></td></tr><tr><td class="NLM_term">ABL kinase</td><td class="NLM_def"><p class="first last">Abelson kinase</p></td></tr><tr><td class="NLM_term">KIT kinase</td><td class="NLM_def"><p class="first last">v-kit Hardy–Zuckerman 4 feline sarcoma viral oncogene homologue</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">FMS-related tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">PDGFR</td><td class="NLM_def"><p class="first last">platelet derived growth factor receptor</p></td></tr><tr><td class="NLM_term">CSF1R</td><td class="NLM_def"><p class="first last">stimulating factor-1 receptor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Rubin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duensing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lux, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbard, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">KIT activation is a ubiquitous feature of gastrointestinal stromal tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8118</span><span class="NLM_x">–</span> <span class="NLM_lpage">8121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8118-8121&author=B.+P.+Rubinauthor=S.+Singerauthor=C.+Tsaoauthor=A.+Duensingauthor=M.+L.+Luxauthor=R.+Ruizauthor=M.+K.+Hibbardauthor=C.+J.+Chenauthor=S.+Xiaoauthor=D.+A.+Tuvesonauthor=G.+D.+Demetriauthor=C.+D.+Fletcherauthor=J.+A.+Fletcher&title=KIT+activation+is+a+ubiquitous+feature+of+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DB.%2BP.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DC.%26aulast%3DDuensing%26aufirst%3DA.%26aulast%3DLux%26aufirst%3DM.%2BL.%26aulast%3DRuiz%26aufirst%3DR.%26aulast%3DHibbard%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BJ.%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DKIT%2520activation%2520is%2520a%2520ubiquitous%2520feature%2520of%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8118%26epage%3D8121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarlomo-Rikala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tervahartiala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siberman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span> </span><span class="NLM_article-title">Effect of the tyrosine inhibitor STI571 in a patient with a metastatis gastrointestinal stromal tumor</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span><span class="refDoi"> DOI: 10.1056/NEJM200104053441404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1056%2FNEJM200104053441404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=11287975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gvVekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1052-1056&author=H.+Joensuuauthor=P.+J.+Robertsauthor=M.+Sarlomo-Rikalaauthor=L.+C.+Andersonauthor=P.+Tervahartialaauthor=D.+Tuvesonauthor=S.+L.+Sibermanauthor=R.+Capdevilleauthor=S.+Dimitrijevicauthor=B.+Drukerauthor=G.+D.+Demetri&title=Effect+of+the+tyrosine+inhibitor+STI571+in+a+patient+with+a+metastatis+gastrointestinal+stromal+tumor&doi=10.1056%2FNEJM200104053441404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor</span></div><div class="casAuthors">Joensuu H; Roberts P J; Sarlomo-Rikala M; Andersson L C; Tervahartiala P; Tuveson D; Silberman S; Capdeville R; Dimitrijevic S; Druker B; Demetri G D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1052-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYZ86Vmj15i5otVjB3IRIyfW6udTcc2eb2HqrB_ZXiKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gvVekuw%253D%253D&md5=d361debf544b136b28889449118225e3</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1056%2FNEJM200104053441404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200104053441404%26sid%3Dliteratum%253Aachs%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DSarlomo-Rikala%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DL.%2BC.%26aulast%3DTervahartiala%26aufirst%3DP.%26aulast%3DTuveson%26aufirst%3DD.%26aulast%3DSiberman%26aufirst%3DS.%2BL.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DDruker%26aufirst%3DB.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26atitle%3DEffect%2520of%2520the%2520tyrosine%2520inhibitor%2520STI571%2520in%2520a%2520patient%2520with%2520a%2520metastatis%2520gastrointestinal%2520stromal%2520tumor%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1052%26epage%3D1056%26doi%3D10.1056%2FNEJM200104053441404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanke, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Abbeele, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span> </span><span class="NLM_article-title">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span><span class="refDoi"> DOI: 10.1056/NEJMoa020461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1056%2FNEJMoa020461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=12181401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=472-480&author=G.+D.+Demetriauthor=M.+von+Mehrenauthor=C.+D.+Blankeauthor=A.+D.+Van+den+Abbeeleauthor=B.+Eisenbergauthor=P.+J.+Robertsauthor=M.+C.+Heinrichauthor=D.+A.+Tuvesonauthor=S.+Singerauthor=M.+Janicekauthor=J.+A.+Fletcherauthor=S.+G.+Silvermanauthor=S.+L.+Silbermanauthor=R.+Capdevilleauthor=B.+Kieseauthor=B.+Pengauthor=S.+Dimitrijevicauthor=B.+J.+Drukerauthor=C.+Corlessauthor=C.+D.+Fletcherauthor=H.+Joensuu&title=Efficacy+and+safety+of+imatinib+mesylate+in+advanced+gastrointestinal+stromal+tumors&doi=10.1056%2FNEJMoa020461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span></div><div class="casAuthors">Demetri, George D.; von Mehren, Margaret; Blanke, Charles D.; Van den Abbeele, Annick D.; Eisenberg, Burton; Roberts, Peter J.; Heinrich, Michael C.; Tuveson, David A.; Singer, Samuel; Janicek, Milos; Fletcher, Jonathan A.; Silverman, Stuart G.; Silberman, Sandra L.; Capdeville, Renaud; Kiese, Beate; Peng, Bin; Dimitrijevic, Sasa; Druker, Brian J.; Corless, Christopher; Fletcher, Christopher D. M.; Joensuu, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">472-480</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Constitutive activation of KIT receptor tyrosine kinase is crit. in the pathogenesis of gastrointestinal stromal tumors.  Imatinib mesylate, a selective tyrosine kinase inhibitor, has been shown in preclin. models and preliminary clin. studies to have activity against such tumors.  We conducted an open-label, randomized, multicenter trial to evaluate the activity of imatinib in patients with advanced gastrointestinal stromal tumor.  We assessed antitumor response and the safety and tolerability of the drug.  Pharmacokinetics were assessed in a subgroup of patients.  A total of 147 patients were randomly assigned to receive 400 mg or 600 mg of imatinib daily.  Overall, 79 patients (53.7 percent) had a partial response, 41 patients (27.9 percent) had stable disease, and for tech. reasons, response could not be evaluated in 7 patients (4.8 percent).  No patient had a complete response to the treatment.  The median duration of response had not been reached after a median follow-up of 24 wk after the onset of response.  Early resistance to imatinib was noted in 20 patients (13.6 percent).  Therapy was well tolerated, although mild-to-moderate edema, diarrhea, and fatigue were common.  Gastrointestinal or intraabdominal hemorrhage occurred in approx. 5 percent of patients.  There were no significant differences in toxic effects or response between the two doses.  Imatinib was well absorbed, with pharmacokinetics similar to those reported in patients with chronic myeloid leukemia.  Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor.  Inhibition of the KIT signal-transduction pathway is a promising treatment for advanced gastrointestinal stromal tumors, which resist conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVE0HpuuKXXrVg90H21EOLACvtfcHk0ljxjocSzcwnqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D&md5=95c9ea076dd2b0e053ae2061cb3f5d24</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020461%26sid%3Dliteratum%253Aachs%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26aulast%3DBlanke%26aufirst%3DC.%2BD.%26aulast%3DVan%2Bden%2BAbbeele%26aufirst%3DA.%2BD.%26aulast%3DEisenberg%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DJanicek%26aufirst%3DM.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DSilverman%26aufirst%3DS.%2BG.%26aulast%3DSilberman%26aufirst%3DS.%2BL.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DCorless%26aufirst%3DC.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DJoensuu%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520imatinib%2520mesylate%2520in%2520advanced%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D472%26epage%3D480%26doi%3D10.1056%2FNEJMoa020461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yarden, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang-Feng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coussens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munemitsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dull, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">Human proto-oncogene kit: a new cell surface receptor tyrosine kinase for an unidentified ligand</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">–</span> <span class="NLM_lpage">3351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1987&pages=3341-3351&author=Y.+Yardenauthor=W.+J.+Kuangauthor=T.+Yang-Fengauthor=L.+Coussensauthor=S.+Munemitsuauthor=T.+J.+Dullauthor=E.+Chenauthor=J.+Schlessingerauthor=U.+Franckeauthor=A.+Ullrich&title=Human+proto-oncogene+kit%3A+a+new+cell+surface+receptor+tyrosine+kinase+for+an+unidentified+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DKuang%26aufirst%3DW.%2BJ.%26aulast%3DYang-Feng%26aufirst%3DT.%26aulast%3DCoussens%26aufirst%3DL.%26aulast%3DMunemitsu%26aufirst%3DS.%26aulast%3DDull%26aufirst%3DT.%2BJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DHuman%2520proto-oncogene%2520kit%253A%2520a%2520new%2520cell%2520surface%2520receptor%2520tyrosine%2520kinase%2520for%2520an%2520unidentified%2520ligand%26jtitle%3DEMBO%2520J.%26date%3D1987%26volume%3D6%26spage%3D3341%26epage%3D3351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isozaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunio, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span> </span><span class="NLM_article-title">Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1126/science.279.5350.577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1126%2Fscience.279.5350.577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=9438854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK1cXotVyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=577-580&author=S.+Hirotaauthor=K.+Isozakiauthor=Y.+Moriyamaauthor=K.+Hashimotoauthor=T.+Nishidaauthor=S.+Ishiguroauthor=K.+Kawanoauthor=M.+Hanadaauthor=A.+Kurataauthor=M.+Takedaauthor=G.+M.+Tunioauthor=Y.+Matsuzawaauthor=Y.+Kanakuraauthor=Y.+Shinomuraauthor=Y.+Kitamura&title=Gain-of-function+mutations+of+c-kit+in+human+gastrointestinal+stromal+tumors&doi=10.1126%2Fscience.279.5350.577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</span></div><div class="casAuthors">Hirota, Seiichi; Isozaki, Koji; Moriyama, Yasuhiro; Hashimoto, Koji; Nishida, Toshirou; Ishiguro, Shingo; Kawano, Kiyoshi; Hanada, Masato; Kurata, Akihiko; Takeda, Masashi; Muhammad Tunio, Ghulam; Matsuzawa, Yuji; Kanakura, Yuzuru; Shinomura, Yasuhisa; Kitamura, Yukihiko</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">5350</span>),
    <span class="NLM_cas:pages">577-580</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the human digestive tract, but their mol. etiol. and cellular origin are unknown.  Sequencing of c-kit complementary DNA, which encodes a proto-oncogenic receptor tyrosine kinase (KIT), from five GISTs revealed mutations in the region between the transmembrane and tyrosine kinase domains.  All of the corresponding mutant KIT proteins were constitutively activated without the KIT ligand, stem cell factor (SCF).  Stable transfection of the mutant c-kit complementary DNAs induced malignant transformation of Ba/F3 murine lymphoid cells, suggesting that the mutations contribute to tumor development.  GISTs may originate from the interstitial cells of Cajal (ICCs) because the development of ICCs is dependent on the SCF-KIT interaction and because, like GISTs, these cells express both KIT and CD34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlGnWQ79KELVg90H21EOLACvtfcHk0lgNAbcPkIvKpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVyhsw%253D%253D&md5=b66b6b8a389b064f73fba13ca84e8650</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.279.5350.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.279.5350.577%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DIsozaki%26aufirst%3DK.%26aulast%3DMoriyama%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DHanada%26aufirst%3DM.%26aulast%3DKurata%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DTunio%26aufirst%3DG.%2BM.%26aulast%3DMatsuzawa%26aufirst%3DY.%26aulast%3DKanakura%26aufirst%3DY.%26aulast%3DShinomura%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DY.%26atitle%3DGain-of-function%2520mutations%2520of%2520c-kit%2520in%2520human%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D577%26epage%3D580%26doi%3D10.1126%2Fscience.279.5350.577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanke, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGreevey, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Abbeele, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4342</span><span class="NLM_x">–</span> <span class="NLM_lpage">4349</span><span class="refDoi"> DOI: 10.1200/JCO.2003.04.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1200%2FJCO.2003.04.190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=14645423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=4342-4349&author=M.+C.+Heinrichauthor=C.+L.+Corlessauthor=G.+D.+Demetriauthor=C.+D.+Blankeauthor=M.+von+Mehrenauthor=H.+Joensuuauthor=L.+S.+McGreeveyauthor=C.+J.+Chenauthor=A.+D.+Van+den+Abbeeleauthor=B.+J.+Drukerauthor=B.+Kieseauthor=B.+Eisenbergauthor=P.+J.+Robertsauthor=S.+Singerauthor=C.+D.+Fletcherauthor=S.+Silbermanauthor=S.+Dimitrijevicauthor=J.+A.+Fletcher&title=Kinase+mutations+and+imatinib+response+in+patients+with+metastatic+gastrointestinal+stromal+tumor&doi=10.1200%2FJCO.2003.04.190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor</span></div><div class="casAuthors">Heinrich, Michael C.; Corless, Christopher L.; Demetri, George D.; Blanke, Charles D.; von Mehren, Margaret; Joensuu, Heikki; McGreevey, Laura S.; Chen, Chang-Jie; Van den Abbeele, Annick D.; Druker, Brian J.; Kiese, Beate; Eisenberg, Burton; Roberts, Peter J.; Singer, Samuel; Fletcher, Christopher D. M.; Silberman, Sandra; Dimitrijevic, Sasa; Fletcher, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4342-4349</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Most gastrointestinal stromal tumors (GISTs) express constitutively activated mutant isoforms of KIT or kinase platelet-derived growth factor receptor alpha (PDGFRA) that are potential therapeutic targets for imatinib mesylate.  The relationship between mutations in these kinases and clin. response to imatinib was examd. in a group of patients with advanced GIST.  Patients and Methods: GISTs from 127 patients enrolled onto a phase II clin. study of imatinib were examd. for mutations of KIT or PDGFRA.  Mutation types were correlated with clin. outcome.  Results: Activating mutations of KIT or PDGFRA were found in 112 (88.2%) and six (4.7%) GISTs, resp.  Most KIT mutations involved exon 9 (n = 23) or exon 11 (n = 85).  All KIT mutant isoforms, but only a subset of PDGFRA mutant isoforms, were sensitive to imatinib, in vitro.  In patients with GISTs harboring exon 11 KIT mutations, the partial response rate (PR) was 83.5%, whereas patients with tumors contg. an exon 9 KIT mutation or no detectable mutation of KIT or PDGFRA had PR rates of 47.8% (P = .0006) and 0.0% (P < .0001), resp.  Patients whose tumors contained exon 11 KIT mutations had a longer event-free and overall survival than those whose tumors expressed either exon 9 KIT mutations or had no detectable kinase mutation.  Conclusion: Activating mutations of KIT or PDGFRA are found in the vast majority of GISTs, and the mutational status of these oncoproteins is predictive of clin. response to imatinib.  PDGFRA mutations can explain response and sensitivity to imatinib in some GISTs lacking KIT mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquHal4hZZoc7Vg90H21EOLACvtfcHk0lgNAbcPkIvKpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7Y%253D&md5=cbfd753460bdf0005c3bd93f12df98dc</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2003.04.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2003.04.190%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DCorless%26aufirst%3DC.%2BL.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3DBlanke%26aufirst%3DC.%2BD.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DMcGreevey%26aufirst%3DL.%2BS.%26aulast%3DChen%26aufirst%3DC.%2BJ.%26aulast%3DVan%2Bden%2BAbbeele%26aufirst%3DA.%2BD.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DEisenberg%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DSilberman%26aufirst%3DS.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DKinase%2520mutations%2520and%2520imatinib%2520response%2520in%2520patients%2520with%2520metastatic%2520gastrointestinal%2520stromal%2520tumor%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26spage%3D4342%26epage%3D4349%26doi%3D10.1200%2FJCO.2003.04.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sommer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agosti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbacioglu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besmer, P.</span><span> </span><span class="NLM_article-title">Gastrointestinal stromal tumors in a mouse model by target mutation of the kit receptor tyrosine kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">6706</span><span class="NLM_x">–</span> <span class="NLM_lpage">6711</span><span class="refDoi"> DOI: 10.1073/pnas.1037763100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1073%2Fpnas.1037763100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=6706-6711&author=G.+Sommerauthor=V.+Agostiauthor=I.+Ehlersauthor=F.+Rossiauthor=S.+Corbaciogluauthor=J.+Farkasauthor=M.+Mooreauthor=K.+Manovaauthor=C.+R.+Antonescuauthor=P.+Besmer&title=Gastrointestinal+stromal+tumors+in+a+mouse+model+by+target+mutation+of+the+kit+receptor+tyrosine+kinase&doi=10.1073%2Fpnas.1037763100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1037763100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1037763100%26sid%3Dliteratum%253Aachs%26aulast%3DSommer%26aufirst%3DG.%26aulast%3DAgosti%26aufirst%3DV.%26aulast%3DEhlers%26aufirst%3DI.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DCorbacioglu%26aufirst%3DS.%26aulast%3DFarkas%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DManova%26aufirst%3DK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DBesmer%26aufirst%3DP.%26atitle%3DGastrointestinal%2520stromal%2520tumors%2520in%2520a%2520mouse%2520model%2520by%2520target%2520mutation%2520of%2520the%2520kit%2520receptor%2520tyrosine%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D6706%26epage%3D6711%26doi%3D10.1073%2Fpnas.1037763100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ernst, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przygodzki, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emory, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobin, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, T. J.</span><span> </span><span class="NLM_article-title">Kit mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors</span> <span class="citation_source-journal">Lab Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1633</span><span class="NLM_x">–</span> <span class="NLM_lpage">1636</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=1633-1636&author=S.+I.+Ernstauthor=A.+E.+Hubbsauthor=R.+M.+Przygodzkiauthor=T.+S.+Emoryauthor=L.+H.+Sobinauthor=T.+J.+O%E2%80%99Leary&title=Kit+mutation+portends+poor+prognosis+in+gastrointestinal+stromal%2Fsmooth+muscle+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DS.%2BI.%26aulast%3DHubbs%26aufirst%3DA.%2BE.%26aulast%3DPrzygodzki%26aufirst%3DR.%2BM.%26aulast%3DEmory%26aufirst%3DT.%2BS.%26aulast%3DSobin%26aufirst%3DL.%2BH.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DT.%2BJ.%26atitle%3DKit%2520mutation%2520portends%2520poor%2520prognosis%2520in%2520gastrointestinal%2520stromal%252Fsmooth%2520muscle%2520tumors%26jtitle%3DLab%2520Invest.%26date%3D1998%26volume%3D78%26spage%3D1633%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lasota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasinski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarlomo-Rikala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miettinen, M.</span><span> </span><span class="NLM_article-title">Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)65250-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1016%2FS0002-9440%2810%2965250-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=9916918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK1MXnsFCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1999&pages=53-60&author=J.+Lasotaauthor=M.+Jasinskiauthor=M.+Sarlomo-Rikalaauthor=M.+Miettinen&title=Mutations+in+exon+11+of+c-kit+occur+preferentially+in+malignant+versus+benign+gastrointestinal+stromal+tumors+and+do+not+occur+in+leiomyomas+or+leiomyosarcomas&doi=10.1016%2FS0002-9440%2810%2965250-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas</span></div><div class="casAuthors">Lasota, Jerzy; Jasinski, Marek; Sarlomo-Rikala, Maarit; Miettinen, Markku</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Gastrointestinal stromal tumors (GISTs) comprise the largest subset of mesenchymal tumors of the gastrointestinal tract.  These neoplasms differ histol. and immunohistochem. from typical leiomyomas and leiomyosarcomas.  Most GISTs express CD34 and CD117 (c-kit protein) but not desmin.  Recently, gain-of-function mutations of c-kit proto-oncogene have been shown in five solitary GISTs and in tumors and leukocytes from a family with multiple GISTs.  An in-frame deletion or a point mutation in exon 11 of c-kit was detected in these cases.  Stable transfection of the mutant c-kit complementary DNA was also shown to induce malignant transformation of murine lymphoid cells, suggesting that the c-kit mutations contribute to tumor development.  In this study, the authors evaluated 43 GISTs and 14 smooth muscle tumors for mutations in the exon 11 of c-kit by a PCR-assay.  Half of the malignant GISTs (12/24) and only one benign GIST (1/19) revealed mutant bands.  No mutant bands were found in 3 leiomyomas and 11 leiomyosarcomas.  Sequence anal. confirmed the presence of an in-frame deletion of 3-21 bp in all 13 GISTs with mutant bands.  Wild-type bands from 8 malignant and 11 benign GISTs and 7 smooth muscle tumors without mutant bands were cloned and sequenced.  Addnl. mutations were found in 3 malignant and 2 benign GISTs.  There were no mutations in 3 leiomyomas and 4 leiomyosarcomas.  The mutation status of exon 11 did not correlate with immunohistochem. detectable expression of the CD117, as virtually all GISTs with or without such mutations showed CD117 immunoreactivity.  The c-kit mutations occur preferentially in malignant GISTs and might be a clin. useful adjunct marker in the evaluation of GISTs.  The conservation of the c-kit mutation pattern, obsd. in consecutive lesions from the same patients, suggests that these mutations might be useful tumor markers in monitoring recurrence or minimal residual disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ST-g3MIsA7Vg90H21EOLACvtfcHk0ljZtqI5wRqW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsFCqtg%253D%253D&md5=b23dabddc48ceb307935c169d91eb9e0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965250-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965250-9%26sid%3Dliteratum%253Aachs%26aulast%3DLasota%26aufirst%3DJ.%26aulast%3DJasinski%26aufirst%3DM.%26aulast%3DSarlomo-Rikala%26aufirst%3DM.%26aulast%3DMiettinen%26aufirst%3DM.%26atitle%3DMutations%2520in%2520exon%252011%2520of%2520c-kit%2520occur%2520preferentially%2520in%2520malignant%2520versus%2520benign%2520gastrointestinal%2520stromal%2520tumors%2520and%2520do%2520not%2520occur%2520in%2520leiomyomas%2520or%2520leiomyosarcomas%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D154%26spage%3D53%26epage%3D60%26doi%3D10.1016%2FS0002-9440%2810%2965250-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kerkelä, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacobi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beahm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span><span class="refDoi"> DOI: 10.1038/nm1446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnm1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=16862153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=908-916&author=R.+Kerkel%C3%A4author=L.+Grazetteauthor=R.+Yacobiauthor=C.+Iliescuauthor=R.+Pattenauthor=C.+Beahmauthor=B.+Waltersauthor=S.+Shevtsovauthor=S.+Pesantauthor=F.+J.+Clubbauthor=A.+Rosenzweigauthor=R.+N.+Salomonauthor=R.+A.+Van+Ettenauthor=J.+Alroyauthor=J.+B.+Durandauthor=T.+Force&title=Cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate&doi=10.1038%2Fnm1446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span></div><div class="casAuthors">Kerkela Risto; Grazette Luanda; Yacobi Rinat; Iliescu Cezar; Patten Richard; Beahm Cara; Walters Brian; Shevtsov Sergei; Pesant Stephanie; Clubb Fred J; Rosenzweig Anthony; Salomon Robert N; Van Etten Richard A; Alroy Joseph; Durand Jean-Bernard; Force Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">908-16</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.  Here we report ten individuals who developed severe congestive heart failure while on imatinib and we show that imatinib-treated mice develop left ventricular contractile dysfunction.  Transmission electron micrographs from humans and mice treated with imatinib show mitochondrial abnormalities and accumulation of membrane whorls in both vacuoles and the sarco- (endo-) plasmic reticulum, findings suggestive of a toxic myopathy.  With imatinib treatment, cardiomyocytes in culture show activation of the endoplasmic reticulum (ER) stress response, collapse of the mitochondrial membrane potential, release of cytochrome c into the cytosol, reduction in cellular ATP content and cell death.  Retroviral gene transfer of an imatinib-resistant mutant of c-Abl, alleviation of ER stress or inhibition of Jun amino-terminal kinases, which are activated as a consequence of ER stress, largely rescues cardiomyocytes from imatinib-induced death.  Thus, cardiotoxicity is an unanticipated side effect of inhibition of c-Abl by imatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGHOTag-dpJhjv2lLSLOxFfW6udTcc2eZ469y_Jhp9I7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D&md5=4012ddd42a942f1441abb54df1894db8</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnm1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1446%26sid%3Dliteratum%253Aachs%26aulast%3DKerkel%25C3%25A4%26aufirst%3DR.%26aulast%3DGrazette%26aufirst%3DL.%26aulast%3DYacobi%26aufirst%3DR.%26aulast%3DIliescu%26aufirst%3DC.%26aulast%3DPatten%26aufirst%3DR.%26aulast%3DBeahm%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DB.%26aulast%3DShevtsov%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DS.%26aulast%3DClubb%26aufirst%3DF.%2BJ.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3DSalomon%26aufirst%3DR.%2BN.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DAlroy%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DJ.%2BB.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DCardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D908%26epage%3D916%26doi%3D10.1038%2Fnm1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perik, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rikhof, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gietema, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Graaf, W. T.</span><span> </span><span class="NLM_article-title">Results of plasma n-terminal pro b-type natriuretic peptide and cardiac troponin monitoring in gist patients do not support the existence of imatinib-induced cardiotoxicity</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1093/annonc/mdm468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1093%2Fannonc%2Fmdm468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=17962203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FotlemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=359-361&author=P.+J.+Perikauthor=B.+Rikhofauthor=F.+A.+de+Jongauthor=J.+Verweijauthor=J.+A.+Gietemaauthor=W.+T.+van+der+Graaf&title=Results+of+plasma+n-terminal+pro+b-type+natriuretic+peptide+and+cardiac+troponin+monitoring+in+gist+patients+do+not+support+the+existence+of+imatinib-induced+cardiotoxicity&doi=10.1093%2Fannonc%2Fmdm468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity</span></div><div class="casAuthors">Perik P J; Rikhof B; de Jong F A; Verweij J; Gietema J A; van der Graaf W T A</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Recently, case reports of patients treated with imatinib (imatinib mesylate; Gleevec; Glivec) indicated that this tyrosine kinase inhibitor may induce cardiomyopathy.  Consequently, careful cardiac monitoring was advocated for clinical studies.  The purpose of this study was to prospectively evaluate whether imatinib (Gleevec) induces early, subclinical, cardiac toxicity.  PATIENTS AND METHODS:  History and physical examination were carried out with special attention for symptoms of heart failure.  Additionally, assessments of serial plasma N-terminal pro B-type natriuretic peptide (NT-proBNP) and serum cardiac troponin T (cTnT) measurement before and 1 and 3 months after the start of imatinib treatment (400-800 mg daily) were done in patients with advanced and/or metastatic gastrointestinal stromal tumours (GIST).  RESULTS:  A total of 55 GIST patients were enrolled.  Only one patient, with a normal pretreatment NT-proBNP, showed an increase in NT-proBNP to above age-specific normal values during imatinib treatment and developed symptomatic heart failure due to pre-existent cardiac valvular disease. cTnT levels remained stable.  CONCLUSIONS:  In our study population, imatinib treatment for GIST was not associated with an increase in plasma NT-proBNP levels, indicating that the risk of subclinical cardiac toxicity is limited with the use of this agent.  These results do not support the current strategy to standard cardiac monitoring in all patients.  This may be restricted to GIST patients with a history of cardiac disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKUu-458lfnekdrW1FkXG-fW6udTcc2eYlfLkhc341OLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FotlemtA%253D%253D&md5=77337a332892670dd84e8e2e4f3a2a1d</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdm468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdm468%26sid%3Dliteratum%253Aachs%26aulast%3DPerik%26aufirst%3DP.%2BJ.%26aulast%3DRikhof%26aufirst%3DB.%26aulast%3Dde%2BJong%26aufirst%3DF.%2BA.%26aulast%3DVerweij%26aufirst%3DJ.%26aulast%3DGietema%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2Bder%2BGraaf%26aufirst%3DW.%2BT.%26atitle%3DResults%2520of%2520plasma%2520n-terminal%2520pro%2520b-type%2520natriuretic%2520peptide%2520and%2520cardiac%2520troponin%2520monitoring%2520in%2520gist%2520patients%2520do%2520not%2520support%2520the%2520existence%2520of%2520imatinib-induced%2520cardiotoxicity%26jtitle%3DAnn.%2520Oncol.%26date%3D2008%26volume%3D19%26spage%3D359%26epage%3D361%26doi%3D10.1093%2Fannonc%2Fmdm468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccarani, M.</span><span> </span><span class="NLM_article-title">In reply to ’cardiotoxicity of the cancer therapeutic agent imatinib mesylate’</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1038/nm0107-15a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnm0107-15a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=13-14&author=G.+Rostiauthor=G.+Martinelliauthor=M.+Baccarani&title=In+reply+to+%E2%80%99cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate%E2%80%99&doi=10.1038%2Fnm0107-15a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1038%2Fnm0107-15a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0107-15a%26sid%3Dliteratum%253Aachs%26aulast%3DRosti%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DBaccarani%26aufirst%3DM.%26atitle%3DIn%2520reply%2520to%2520%25E2%2580%2599cardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%25E2%2580%2599%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D13%26epage%3D14%26doi%3D10.1038%2Fnm0107-15a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-Diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1021/jm0204183</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cuiauthor=J.+Y.+Fukudaauthor=J.+Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-Fluoro-2-oxo-1%2C2-dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+acid+%282-Diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase&doi=10.1021%2Fjm0204183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-Fluoro-2-oxo-1%252C2-dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-Diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119%26doi%3D10.1021%2Fjm0204183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Warkentin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasater, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, A. Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Overcoming myelosuppression due to synthetic lethal toxicity in FLT3-targeted acute myeloid leukemia therapy</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e03445</span><span class="refDoi"> DOI: 10.7554/eLife.03445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.7554%2FeLife.03445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=e03445&author=A.+A.+Warkentinauthor=M.+S.+Lopezauthor=E.+A.+Lasaterauthor=K.+Linauthor=B.+L.+Heauthor=A.+Y.+H.+Leungauthor=C.+C.+Smithauthor=N.+P.+Shahauthor=K.+M.+Shokat&title=Overcoming+myelosuppression+due+to+synthetic+lethal+toxicity+in+FLT3-targeted+acute+myeloid+leukemia+therapy&doi=10.7554%2FeLife.03445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.7554%2FeLife.03445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.03445%26sid%3Dliteratum%253Aachs%26aulast%3DWarkentin%26aufirst%3DA.%2BA.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DLasater%26aufirst%3DE.%2BA.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DB.%2BL.%26aulast%3DLeung%26aufirst%3DA.%2BY.%2BH.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DOvercoming%2520myelosuppression%2520due%2520to%2520synthetic%2520lethal%2520toxicity%2520in%2520FLT3-targeted%2520acute%2520myeloid%2520leukemia%2520therapy%26jtitle%3DeLife%26date%3D2014%26volume%3D3%26spage%3De03445%26doi%3D10.7554%2FeLife.03445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bearss, D. J.; Joshi-hangal, R.; Liu, X.-H.; Phiasivongsa, P.; Redkar, S. G.; Vankayalapati, H.</span><span> </span><span class="NLM_article-title">Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same</span>. U.S. Patent US 20080226747, September 18,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+J.+Bearss&author=R.+Joshi-hangal&author=X.-H.+Liu&author=P.+Phiasivongsa&author=S.+G.+Redkar&author=H.+Vankayalapati&title=Pharmaceutical+formulations+comprising+salts+of+a+protein+kinase+inhibitor+and+methods+of+using+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26atitle%3DPharmaceutical%2520formulations%2520comprising%2520salts%2520of%2520a%2520protein%2520kinase%2520inhibitor%2520and%2520methods%2520of%2520using%2520same%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Dubreuil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciufolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castéran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermine, O.</span><span> </span><span class="NLM_article-title">Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7258</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1371%2Fjournal.pone.0007258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=19789626" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7258&author=P.+Dubreuilauthor=S.+Letardauthor=M.+Ciufoliniauthor=L.+Grosauthor=M.+Humbertauthor=N.+Cast%C3%A9ranauthor=O.+Hermine&title=Masitinib+%28AB1010%29%2C+a+potent+and+selective+tyrosine+kinase+inhibitor+targeting+KIT&doi=10.1371%2Fjournal.pone.0007258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007258%26sid%3Dliteratum%253Aachs%26aulast%3DDubreuil%26aufirst%3DP.%26aulast%3DLetard%26aufirst%3DS.%26aulast%3DCiufolini%26aufirst%3DM.%26aulast%3DGros%26aufirst%3DL.%26aulast%3DHumbert%26aufirst%3DM.%26aulast%3DCast%25C3%25A9ran%26aufirst%3DN.%26aulast%3DHermine%26aufirst%3DO.%26atitle%3DMasitinib%2520%2528AB1010%2529%252C%2520a%2520potent%2520and%2520selective%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520KIT%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7258%26doi%3D10.1371%2Fjournal.pone.0007258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Blay, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span> </span><span class="NLM_article-title">Nilotinib: a novel, selective tyrosine kinase inhibitor</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">S9</span><span class="refDoi"> DOI: 10.1053/j.seminoncol.2011.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1053%2Fj.seminoncol.2011.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=21419934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1yqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=S3-S9&author=J.-Y.+Blayauthor=M.+von+Mehren&title=Nilotinib%3A+a+novel%2C+selective+tyrosine+kinase+inhibitor&doi=10.1053%2Fj.seminoncol.2011.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor</span></div><div class="casAuthors">Blay, Jean-Yves; von Mehren, Margaret</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2, Suppl. 1</span>),
    <span class="NLM_cas:pages">S3-S9</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The development of tyrosine kinase inhibitors (TKIs) for the treatment of chronic myelogenous leukemia (CML) was based on the discovery that CML stem and progenitor cells overexpress the abnormal fusion protein kinase BCR-ABL.  The prototype TKI, imatinib, selectively inhibits BCR-ABL, as well as several other kinases, including stem cell factor receptor (KIT), discoidin domain receptor (DDR), platelet-derived growth factor receptor (PDGFR), and colony-stimulating factor receptor-1 (CSF-1R).  Although the management of CML improved dramatically with the introduction of imatinib, not all patients benefit from treatment because of resistance or intolerance.  Consequently, research efforts have focused on developing more potent TKIs with the ability to circumvent imatinib resistance.  Nilotinib, a second-generation oral TKI, was rationally designed based on the crystal structure of imatinib to be highly active against a wide range of imatinib-resistant BCR-ABL mutants and is approved for the treatment of newly diagnosed or imatinib-resistant or -intolerant CML, and has shown superiority over imatinib in first-line treatment for newly diagnosed CML.  Furthermore, the activity of nilotinib against KIT and PDGFRα has led to its evaluation in advanced gastrointestinal stromal tumors (GIST).  The purpose of this review is to describe the development of nilotinib, providing a structural explanation for the differential activity of nilotinib and imatinib in GIST.  Activity of nilotinib against KIT and PDGFR and emerging evidence of differences in cellular uptake between nilotinib and imatinib are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpA1cOx61-ZbVg90H21EOLACvtfcHk0lhNWyBhlMNfTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1yqtrk%253D&md5=dc9c1ed5d36f09ad93be258a81d486e2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2011.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2011.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DBlay%26aufirst%3DJ.-Y.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26atitle%3DNilotinib%253A%2520a%2520novel%252C%2520selective%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DSemin.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3DS3%26epage%3DS9%26doi%3D10.1053%2Fj.seminoncol.2011.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">DeNardo, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rexhepaj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junaid, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coussens, L. M.</span><span> </span><span class="NLM_article-title">Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1158/2159-8274.CD-10-0028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1158%2F2159-8274.CD-10-0028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=22039576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsVylsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=54-67&author=D.+G.+DeNardoauthor=D.+J.+Brennanauthor=E.+Rexhepajauthor=B.+Ruffellauthor=S.+L.+Shiaoauthor=S.+F.+Maddenauthor=W.+M.+Gallagherauthor=N.+Wadhwaniauthor=S.+D.+Keilauthor=S.+A.+Junaidauthor=H.+S.+Rugoauthor=E.+S.+Hwangauthor=K.+Jirstr%C3%B6mauthor=B.+L.+Westauthor=L.+M.+Coussens&title=Leukocyte+complexity+predicts+breast+cancer+survival+and+functionally+regulates+response+to+chemotherapy&doi=10.1158%2F2159-8274.CD-10-0028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy</span></div><div class="casAuthors">DeNardo, David G.; Brennan, Donal J.; Rexhepaj, Elton; Ruffell, Brian; Shiao, Stephen L.; Madden, Stephen F.; Gallagher, William M.; Wadhwani, Nikhil; Keil, Scott D.; Junaid, Sharfaa A.; Rugo, Hope S.; Hwang, E. Shelley; Jirstroem, Karin; West, Brian L.; Coussens, Lisa M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-67</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research, Inc.</span>)
        </div><div class="casAbstract">Immune-regulated pathways influence multiple aspects of cancer development.  In this article we demonstrate that both macrophage abundance and T-cell abundance in breast cancer represent prognostic indicators for recurrence-free and overall survival.  We provide evidence that response to chemotherapy is in part regulated by these leukocytes; cytotoxic therapies induce mammary epithelial cells to produce monocyte/macrophage recruitment factors, including colony stimulating factor 1 (CSF1) and interleukin-34, which together enhance CSF1 receptor (CSF1R)-dependent macrophage infiltration.  Blockade of macrophage recruitment with CSF1R-signaling antagonists, in combination with paclitaxel, improved survival of mammary tumor-bearing mice by slowing primary tumor development and reducing pulmonary metastasis.  These improved aspects of mammary carcinogenesis were accompanied by decreased vessel d. and appearance of antitumor immune programs fostering tumor suppression in a CD8+ T-cell-dependent manner.  These data provide a rationale for targeting macrophage recruitment/response pathways, notably C5F1R, in combination with cytotoxic therapy, and identification of a breast cancer population likely to benefit from this novel therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGFqFZ3CvAgbVg90H21EOLACvtfcHk0lhNWyBhlMNfTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsVylsbo%253D&md5=098edea4f3ec31f1e31d2e9fc5569ac6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F2159-8274.CD-10-0028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8274.CD-10-0028%26sid%3Dliteratum%253Aachs%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26aulast%3DBrennan%26aufirst%3DD.%2BJ.%26aulast%3DRexhepaj%26aufirst%3DE.%26aulast%3DRuffell%26aufirst%3DB.%26aulast%3DShiao%26aufirst%3DS.%2BL.%26aulast%3DMadden%26aufirst%3DS.%2BF.%26aulast%3DGallagher%26aufirst%3DW.%2BM.%26aulast%3DWadhwani%26aufirst%3DN.%26aulast%3DKeil%26aufirst%3DS.%2BD.%26aulast%3DJunaid%26aufirst%3DS.%2BA.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DHwang%26aufirst%3DE.%2BS.%26aulast%3DJirstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DLeukocyte%2520complexity%2520predicts%2520breast%2520cancer%2520survival%2520and%2520functionally%2520regulates%2520response%2520to%2520chemotherapy%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D54%26epage%3D67%26doi%3D10.1158%2F2159-8274.CD-10-0028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Garton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynne, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keily, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srebernak, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulevic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henninger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelhano, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span> </span><span class="NLM_article-title">Osi-930: a novel selective inhibitor of kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1158%2F0008-5472.CAN-05-2873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=16424037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1015-1024&author=A.+J.+Gartonauthor=A.+P.+Crewauthor=M.+Franklinauthor=A.+R.+Cookeauthor=G.+M.+Wynneauthor=L.+Castaldoauthor=J.+Kahlerauthor=S.+L.+Winskiauthor=A.+Franksauthor=E.+N.+Brownauthor=M.+A.+Bittnerauthor=J.+F.+Keilyauthor=P.+Brinerauthor=C.+Hiddenauthor=M.+C.+Srebernakauthor=C.+Pirritauthor=M.+O%E2%80%99Connorauthor=A.+Chanauthor=B.+Vulevicauthor=D.+Henningerauthor=K.+Hartauthor=R.+Sennelloauthor=A.+H.+Liauthor=T.+Zhangauthor=F.+Richardsonauthor=D.+L.+Emersonauthor=A.+L.+Castelhanoauthor=L.+D.+Arnoldauthor=N.+W.+Gibson&title=Osi-930%3A+a+novel+selective+inhibitor+of+kit+and+kinase+insert+domain+receptor+tyrosine+kinases+with+antitumor+activity+in+mouse+xenograft+models&doi=10.1158%2F0008-5472.CAN-05-2873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">OSI-930: A novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models</span></div><div class="casAuthors">Garton, Andrew J.; Crew, Andrew P. A.; Franklin, Maryland; Cooke, Andrew R.; Wynne, Graham M.; Castaldo, Linda; Kahler, Jennifer; Winski, Shannon L.; Franks, April; Brown, Eric N.; Bittner, Mark A.; Keily, John F.; Briner, Paul; Hidden, Chris; Srebernak, Mary C.; Pirrit, Carrie; O'Connor, Matthew; Chan, Anna; Vulevic, Bojana; Henninger, Dwight; Hart, Karen; Sennello, Regina; Li, An-Hu; Zhang, Tao; Richardson, Frank; Emerson, David L.; Castelhano, Arlindo L.; Arnold, Lee D.; Gibson, Neil W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1015-1024</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">OSI-930 is a novel inhibitor of the receptor tyrosine kinases Kit and kinase insert domain receptor (KDR), which is currently being evaluated in clin. studies.  OSI-930 selectively inhibits Kit and KDR with similar potency in intact cells and also inhibits these targets in vivo following oral dosing.  We have investigated the relationships between the potency obsd. in cell-based assays in vitro, the plasma exposure levels achieved following oral dosing, the time course of target inhibition in vivo, and antitumor activity of OSI-930 in tumor xenograft models.  In the mutant Kit-expressing HMC-1 xenograft model, prolonged inhibition of Kit was achieved at oral doses between 10 and 50 mg/kg and this dose range was assocd. with antitumor activity.  Similarly, prolonged inhibition of wild-type Kit in the NCI-H526 xenograft model was obsd. at oral doses of 100 to 200 mg/kg, which was the dose level assocd. with significant antitumor activity in this model as well as in the majority of other xenograft models tested.  The data suggest that antitumor activity of OSI-930 in mouse xenograft models is obsd. at dose levels that maintain a significant level of inhibition of the mol. targets of OSI-930 for a prolonged period.  Furthermore, pharmacokinetic evaluation of the plasma exposure levels of OSI-930 at these ED levels provides an est. of the target plasma concns. that may be required to achieve prolonged inhibition of Kit and KDR in humans and which would therefore be expected to yield a therapeutic benefit in future clin. evaluations of OSI-930.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZVGkBTVXW-LVg90H21EOLACvtfcHk0lizgWEBFTfHzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFOhtA%253D%253D&md5=32ca7af9e9de04507cd35d2d462a2fe8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2873%26sid%3Dliteratum%253Aachs%26aulast%3DGarton%26aufirst%3DA.%2BJ.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DFranklin%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%2BR.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DCastaldo%26aufirst%3DL.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DFranks%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DE.%2BN.%26aulast%3DBittner%26aufirst%3DM.%2BA.%26aulast%3DKeily%26aufirst%3DJ.%2BF.%26aulast%3DBriner%26aufirst%3DP.%26aulast%3DHidden%26aufirst%3DC.%26aulast%3DSrebernak%26aufirst%3DM.%2BC.%26aulast%3DPirrit%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DVulevic%26aufirst%3DB.%26aulast%3DHenninger%26aufirst%3DD.%26aulast%3DHart%26aufirst%3DK.%26aulast%3DSennello%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DRichardson%26aufirst%3DF.%26aulast%3DEmerson%26aufirst%3DD.%2BL.%26aulast%3DCastelhano%26aufirst%3DA.%2BL.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26atitle%3DOsi-930%253A%2520a%2520novel%2520selective%2520inhibitor%2520of%2520kit%2520and%2520kinase%2520insert%2520domain%2520receptor%2520tyrosine%2520kinases%2520with%2520antitumor%2520activity%2520in%2520mouse%2520xenograft%2520models%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1015%26epage%3D1024%26doi%3D10.1158%2F0008-5472.CAN-05-2873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reece, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">Chir-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2941</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span><span class="refDoi"> DOI: 10.1182/blood-2004-10-3913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1182%2Fblood-2004-10-3913" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2941-2948&author=S.+Trudelauthor=Z.-H.+Liauthor=E.+Weiauthor=M.+Wiesmannauthor=H.+Changauthor=C.+Chenauthor=D.+Reeceauthor=C.+Heiseauthor=A.+K.+Stewart&title=Chir-258%2C+a+novel%2C+multitargeted+tyrosine+kinase+inhibitor+for+the+potential+treatment+of+t%284%3B14%29+multiple+myeloma&doi=10.1182%2Fblood-2004-10-3913"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-10-3913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-10-3913%26sid%3Dliteratum%253Aachs%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.-H.%26aulast%3DWei%26aufirst%3DE.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DReece%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DChir-258%252C%2520a%2520novel%252C%2520multitargeted%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520potential%2520treatment%2520of%2520t%25284%253B14%2529%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D2941%26epage%3D2948%26doi%3D10.1182%2Fblood-2004-10-3913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1038/nchembio799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations&doi=10.1038%2Fnchembio799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lizgWEBFTfHzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364%26doi%3D10.1038%2Fnchembio799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sipes, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarnes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harig, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asatryan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. S.</span><span> </span><span class="NLM_article-title">An efficient rapid system for profiling the cellular activities of molecular libraries</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3158</span><span class="refDoi"> DOI: 10.1073/pnas.0511292103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1073%2Fpnas.0511292103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3153-3158&author=J.+S.+Melnickauthor=J.+Janesauthor=S.+Kimauthor=J.+Y.+Changauthor=D.+G.+Sipesauthor=D.+Gundersonauthor=L.+Jarnesauthor=J.+T.+Matzenauthor=M.+E.+Garciaauthor=T.+L.+Hoodauthor=R.+Beigiauthor=G.+Xiaauthor=R.+A.+Harigauthor=H.+Asatryanauthor=S.+F.+Yanauthor=Y.+Zhouauthor=X.+J.+Guauthor=A.+Saadatauthor=V.+Zhouauthor=F.+J.+Kingauthor=C.+M.+Shawauthor=A.+I.+Suauthor=R.+Downsauthor=N.+S.+Grayauthor=P.+G.+Schultzauthor=M.+Warmuthauthor=J.+S.+Caldwell&title=An+efficient+rapid+system+for+profiling+the+cellular+activities+of+molecular+libraries&doi=10.1073%2Fpnas.0511292103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0511292103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0511292103%26sid%3Dliteratum%253Aachs%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DJ.%2BY.%26aulast%3DSipes%26aufirst%3DD.%2BG.%26aulast%3DGunderson%26aufirst%3DD.%26aulast%3DJarnes%26aufirst%3DL.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DGarcia%26aufirst%3DM.%2BE.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DBeigi%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DHarig%26aufirst%3DR.%2BA.%26aulast%3DAsatryan%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DX.%2BJ.%26aulast%3DSaadat%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DF.%2BJ.%26aulast%3DShaw%26aufirst%3DC.%2BM.%26aulast%3DSu%26aufirst%3DA.%2BI.%26aulast%3DDowns%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520efficient%2520rapid%2520system%2520for%2520profiling%2520the%2520cellular%2520activities%2520of%2520molecular%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3153%26epage%3D3158%26doi%3D10.1073%2Fpnas.0511292103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0ljJvSon5iYcqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Williams, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobedo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Signal transduction by the platelet-derived growth factor receptor</span> <span class="citation_source-journal">Cold Spring Harbor Symp. Quant. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1101/SQB.1988.053.01.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1101%2FSQB.1988.053.01.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=2855486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK3MXmtFw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=455-465&author=L.+T.+Williamsauthor=J.+A.+Escobedoauthor=M.+T.+Keatingauthor=S.+R.+Coughlin&title=Signal+transduction+by+the+platelet-derived+growth+factor+receptor&doi=10.1101%2FSQB.1988.053.01.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by the platelet-derived growth factor receptor</span></div><div class="casAuthors">Williams, L. T.; Escobedo, J. A.; Keating, M. T.; Coughlin, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Mol. Biol. Signal Transduction, Pt. 1</span>),
    <span class="NLM_cas:pages">455-65</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review, with 22 refs., discussing platelet-derived growth factor receptor structure and domains with respect to signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRoIaTC9VfbrVg90H21EOLACvtfcHk0ljJvSon5iYcqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtFw%253D&md5=2bb073de11315e298362ef04d8c068a3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1101%2FSQB.1988.053.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252FSQB.1988.053.01.053%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DL.%2BT.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DSignal%2520transduction%2520by%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1988%26volume%3D53%26spage%3D455%26epage%3D465%26doi%3D10.1101%2FSQB.1988.053.01.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Valiathan, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitinger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span> </span><span class="NLM_article-title">Discoidin domain receptor tyrosine kinases: new players in cancer progression</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1007/s10555-012-9346-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1007%2Fs10555-012-9346-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=22366781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFajs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=295-321&author=R.+R.+Valiathanauthor=M.+Marcoauthor=B.+Leitingerauthor=C.+G.+Kleerauthor=R.+Fridman&title=Discoidin+domain+receptor+tyrosine+kinases%3A+new+players+in+cancer+progression&doi=10.1007%2Fs10555-012-9346-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discoidin domain receptor tyrosine kinases: new players in cancer progression</span></div><div class="casAuthors">Valiathan, Rajeshwari R.; Marco, Marta; Leitinger, Birgit; Kleer, Celina G.; Fridman, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">295-321</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Almost all human cancers display dysregulated expression and/or function of one or more receptor tyrosine kinases (RTKs).  The strong causative assocn. between altered RTK function and cancer progression has been translated into novel therapeutic strategies that target these cell surface receptors in cancer.  Yet, the full spectrum of RTKs that may alter the oncogenic process is not completely understood.  Accumulating evidence suggests that a unique set of RTKs known as the discoidin domain receptors (DDRs) play a key role in cancer progression by regulating the interactions of tumor cells with their surrounding collagen matrix.  The DDRs are the only RTKs that specifically bind to and are activated by collagen.  DDRs control cell and tissue homeostasis by acting as collagen sensors, transducing signals that regulate cell polarity, tissue morphogenesis, and cell differentiation.  In cancer, DDRs are hijacked by tumor cells to disrupt normal cell-matrix communication and initiate pro-migratory and pro-invasive programs.  Importantly, several cancer types exhibit DDR mutations, which are thought to alter receptor function and contribute to cancer progression.  Other evidence suggests that the actions of DDRs in cancer are complex, either promoting or suppressing tumor cell behavior in a DDR type/isoform specific- and context-dependent manner.  Thus, there is still a considerable gap in our knowledge of DDR actions in cancer tissues.  This review summarizes and discusses the current knowledge on DDR expression and function in cancer.  It is hoped that this effort will encourage more research into these poorly understood but unique RTKs, which have the potential of becoming novel therapeutic targets in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6IvVtcaWbw7Vg90H21EOLACvtfcHk0lhLB48ii3xwqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFajs7c%253D&md5=da63c7783212d348b80aeaef7d90094c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs10555-012-9346-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-012-9346-z%26sid%3Dliteratum%253Aachs%26aulast%3DValiathan%26aufirst%3DR.%2BR.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DLeitinger%26aufirst%3DB.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DFridman%26aufirst%3DR.%26atitle%3DDiscoidin%2520domain%2520receptor%2520tyrosine%2520kinases%253A%2520new%2520players%2520in%2520cancer%2520progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2012%26volume%3D31%26spage%3D295%26epage%3D321%26doi%3D10.1007%2Fs10555-012-9346-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pollard, J. W.</span><span> </span><span class="NLM_article-title">Trophic macrophages in development and disease</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1038/nri2528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnri2528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=19282852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFCisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=259-270&author=J.+W.+Pollard&title=Trophic+macrophages+in+development+and+disease&doi=10.1038%2Fnri2528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Trophic macrophages in development and disease</span></div><div class="casAuthors">Pollard, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-270</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Specialized phagocytes are found in the most primitive multicellular organisms.  Their roles in homeostasis and in distinguishing self from non-self have evolved with the complexity of organisms and their immune systems.  Equally important, but often overlooked, are the roles of macrophages in tissue development.  As discussed in this Review, these include functions in branching morphogenesis, neuronal patterning, angiogenesis, bone morphogenesis and the generation of adipose tissue.  In each case, macrophage depletion impairs the formation of the tissue and compromises its function.  I argue that in several diseases, the unrestrained acquisition of these developmental macrophage functions exacerbates pathol.  For example, macrophages enhance tumor progression and metastasis by affecting tumor-cell migration and invasion, as well as angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR03M07hzbU7Vg90H21EOLACvtfcHk0lhLB48ii3xwqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFCisbc%253D&md5=d29685d4cbb8d8bdd296f8b8ff869d36</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnri2528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2528%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DJ.%2BW.%26atitle%3DTrophic%2520macrophages%2520in%2520development%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D259%26epage%3D270%26doi%3D10.1038%2Fnri2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Duensing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConarty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panigrahy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3999</span><span class="NLM_x">–</span> <span class="NLM_lpage">4006</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fsj.onc.1207525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=3999-4006&author=A.+Duensingauthor=F.+Medeirosauthor=B.+McConartyauthor=N.+E.+Josephauthor=D.+Panigrahyauthor=S.+Singerauthor=C.+D.+Fletcherauthor=G.+D.+Demetriauthor=J.+A.+Fletcher&title=Mechanisms+of+oncogenic+KIT+signal+transduction+in+primary+gastrointestinal+stromal+tumors+%28GISTs%29&doi=10.1038%2Fsj.onc.1207525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207525%26sid%3Dliteratum%253Aachs%26aulast%3DDuensing%26aufirst%3DA.%26aulast%3DMedeiros%26aufirst%3DF.%26aulast%3DMcConarty%26aufirst%3DB.%26aulast%3DJoseph%26aufirst%3DN.%2BE.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DMechanisms%2520of%2520oncogenic%2520KIT%2520signal%2520transduction%2520in%2520primary%2520gastrointestinal%2520stromal%2520tumors%2520%2528GISTs%2529%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D3999%26epage%3D4006%26doi%3D10.1038%2Fsj.onc.1207525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rossato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smieško, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreafico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedani, A.</span><span> </span><span class="NLM_article-title">Probing small-molecule binding to cytochrome P450 2D6 and 2C9: An in silico protocol for generating toxicity alerts</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2101</span><span class="refDoi"> DOI: 10.1002/cmdc.201000358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1002%2Fcmdc.201000358" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=2088-2101&author=G.+Rossatoauthor=B.+Ernstauthor=M.+Smie%C5%A1koauthor=M.+Spreaficoauthor=A.+Vedani&title=Probing+small-molecule+binding+to+cytochrome+P450+2D6+and+2C9%3A+An+in+silico+protocol+for+generating+toxicity+alerts&doi=10.1002%2Fcmdc.201000358"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000358%26sid%3Dliteratum%253Aachs%26aulast%3DRossato%26aufirst%3DG.%26aulast%3DErnst%26aufirst%3DB.%26aulast%3DSmie%25C5%25A1ko%26aufirst%3DM.%26aulast%3DSpreafico%26aufirst%3DM.%26aulast%3DVedani%26aufirst%3DA.%26atitle%3DProbing%2520small-molecule%2520binding%2520to%2520cytochrome%2520P450%25202D6%2520and%25202C9%253A%2520An%2520in%2520silico%2520protocol%2520for%2520generating%2520toxicity%2520alerts%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D2088%26epage%3D2101%26doi%3D10.1002%2Fcmdc.201000358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Case, D. A.; Babin, V.; Berryman, J. T.; Betz, R. M.; Cai, Q.; Cerutti, D. S.; Cheatham, T. A.,  III; Darden, T. A.; Duke, R. E.; Gohlke, H.; Gietz, A. W.; Gusarov, S.; Homeyer, N.; Jonowski, P.; Kaus, J.; Kolossváry, I.; Kovalenko, A.; Lee, T. S.; LeGrand, S.; Luchko, T.; Luo, R.; Madei, B.; Merz, K. M.; Paesani, F.; Roe, D. R.; Roitberg, A.; Sagui, C.; Salomon-Ferrer, R.; Seabra, G.; Simmerling, C. L.; Smith, W.; Swails, J.; Walker, R. C.; Wang, J.; Wolf, R. M.; Wu, X.; Kollman, P. A.</span>AMBER 14; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+A.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Gietz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Jonowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madei&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Word, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1747</span><span class="refDoi"> DOI: 10.1006/jmbi.1998.2401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1006%2Fjmbi.1998.2401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=9917408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=1735-1747&author=J.+M.+Wordauthor=S.+C.+Lovellauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=Asparagine+and+glutamine%3A+using+hydrogen+atom+contacts+in+the+choice+of+side-chain+amide+orientation&doi=10.1006%2Fjmbi.1998.2401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine and Glutamine: Using Hydrogen Atom Contacts in the Choice of Side-chain Amide Orientation</span></div><div class="casAuthors">Word, J. Michael; Lovell, Simon C.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1735-1747</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Small-probe contact dot surface anal., with all explicit hydrogen atoms added and their van der Waals contacts included, was used to choose between the two possible orientations for each of 1554 asparagine (Asn) and glutamine (Gln) side-chain amide groups in a dataset of 100 unrelated, high-quality protein crystal structures at 0.9 to 1.7 Å resoln.  For the movable-H groups, each connected, closed set of local H-bonds was optimized for both H-bonds and van der Waals overlaps.  In addn. to the Asn/Gln "flips", this process included rotation of OH, SH, NH3+, and methionine Me H atoms, flip and protonation state of histidine rings, interaction with bound ligands, and a simple model of water interactions.  However, except for switching N and O identity for amide flips (or N and C identity for His flips), no non-H atoms were shifted.  Even in these very high-quality structures, about 20 % of the Asn/Gln side-chains required a 180° flip to optimize H-bonding and/or to avoid NH2 clashes with neighboring atoms (incorporating a conservative score penalty which, for marginal cases, favors the assignment in the original coordinate file).  The programs Reduce, Probe, and Mage provide not only a suggested amide orientation, but also a numerical score comparison, a categorization of the marginal cases, and a direct visualization of all relevant interactions in both orientations.  Visual examn. allowed confirmation of the raw score assignment for about 40 % of those Asn/Gln flips placed within the "marginal" penalty range by the automated algorithm, while uncovering only a small no. of cases whose automated assignment was incorrect because of special circumstances not yet handled by the algorithm.  It seems that the H-bond and the at.-clash criteria independently look at the same structural realities: when both criteria gave a clear answer, they agreed every time.  But consideration of van der Waals clashes settled many addnl. cases for which H-bonding was either absent or approx. equiv. for the two main alternatives.  With this extra information, 86 % of all side-chain amide groups could be oriented quite unambiguously.  In the absence of further exptl. data, it would probably be inappropriate to assign many more than this.  Some of the remaining 14 % are ambiguous because of coordinate error or inadequacy of the theor. model, but the great majority of ambiguous cases probably occur as a dynamic mix of both flip states in the actual protein mol.  The software and the 100 coordinate files with all H atoms added and optimized and with amide flips cor. are publicly available.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6MEkiSKy07Vg90H21EOLACvtfcHk0lhtKOfslLNKVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D&md5=a3bd044a8652a5ac03e2eb7b9414c2e0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2401%26sid%3Dliteratum%253Aachs%26aulast%3DWord%26aufirst%3DJ.%2BM.%26aulast%3DLovell%26aufirst%3DS.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DAsparagine%2520and%2520glutamine%253A%2520using%2520hydrogen%2520atom%2520contacts%2520in%2520the%2520choice%2520of%2520side-chain%2520amide%2520orientation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D285%26spage%3D1735%26epage%3D1747%26doi%3D10.1006%2Fjmbi.1998.2401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Dobler, M.</span> <span class="citation_source-book">Bio<sup>X</sup></span>, a versatile molecular-modeling software; <span class="NLM_publisher-name">Biographics Laboratory 3R</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span><a href="http://www.biograf.ch/index.php?id=software" class="extLink">http://www.biograf.ch/index.php?id=software</a> (Updated Nov 8, 2014).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Dobler&title=BioX"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDobler%26aufirst%3DM.%26btitle%3DBioX%26pub%3DBiographics%2520Laboratory%25203R%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Vedani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huhta, D. W.</span><span> </span><span class="NLM_article-title">A new force field for modeling metalloproteins</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">4759</span><span class="NLM_x">–</span> <span class="NLM_lpage">4767</span><span class="refDoi"> DOI: 10.1021/ja00168a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00168a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK3cXktVaqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1990&pages=4759-4767&author=A.+Vedaniauthor=D.+W.+Huhta&title=A+new+force+field+for+modeling+metalloproteins&doi=10.1021%2Fja00168a021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A new force field for modeling metalloproteins</span></div><div class="casAuthors">Vedani, Angelo; Huhta, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4759-67</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A force field for the simulation of metalloproteins features a new potential function for modeling metal-ligand interactions.  This function includes s variables the metal-ligand sepns., the symmetry at the metal center, directionality of the metal-ligand bonds, ligand-metal charge transfer, and (for transition-metal ions) ligand-field stabilization.  The function was developed based on the anal. of accurate small-mol. crystal structures retrieved from the Cambridge Structural Database and incorporated into the mol. mechanics program Yeti which also includes directional terms for H-bonds and salt linkages in its force field energy expression.  The program then was used to model details of metal-coordination, H-bond network formation and protein-solvent interactions in native, complexed, and Co(II)-substituted human carbonic anhydrase I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMppUxyYGE4rVg90H21EOLACvtfcHk0lhtKOfslLNKVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVaqsLs%253D&md5=107e319b852d73f13359ea3f40f99f14</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja00168a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00168a021%26sid%3Dliteratum%253Aachs%26aulast%3DVedani%26aufirst%3DA.%26aulast%3DHuhta%26aufirst%3DD.%2BW.%26atitle%3DA%2520new%2520force%2520field%2520for%2520modeling%2520metalloproteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1990%26volume%3D112%26spage%3D4759%26epage%3D4767%26doi%3D10.1021%2Fja00168a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Lu</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Aoli  Wang</span>, <span class="hlFld-ContribAuthor ">Zongru  Jiang</span>, <span class="hlFld-ContribAuthor ">Ziping  Qi</span>, <span class="hlFld-ContribAuthor ">Zhenquan  Hu</span>, <span class="hlFld-ContribAuthor ">Chen  Hu</span>, <span class="hlFld-ContribAuthor ">Feiyang  Liu</span>, <span class="hlFld-ContribAuthor ">Wenliang  Wang</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Beilei  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Shuang  Qi</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Wu</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Tang</span>, <span class="hlFld-ContribAuthor ">Hezhong  Yan</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Bai</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing cabozantinib to GISTs: Overcoming multiple imatinib-resistant cKIT mutations including gatekeeper and activation loop mutants in GISTs preclinical models. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2019,</strong> <em>447 </em>, 105-114. <a href="https://doi.org/10.1016/j.canlet.2019.01.024" title="DOI URL">https://doi.org/10.1016/j.canlet.2019.01.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2019.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2019.01.024%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DRepurposing%252Bcabozantinib%252Bto%252BGISTs%25253A%252BOvercoming%252Bmultiple%252Bimatinib-resistant%252BcKIT%252Bmutations%252Bincluding%252Bgatekeeper%252Band%252Bactivation%252Bloop%252Bmutants%252Bin%252BGISTs%252Bpreclinical%252Bmodels%26aulast%3DLu%26aufirst%3DTingting%26date%3D2019%26volume%3D447%26spage%3D105%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuesong  Liu</span>, <span class="hlFld-ContribAuthor ">Beilei  Wang</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Zongru  Jiang</span>, <span class="hlFld-ContribAuthor ">Chen  Hu</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Yicong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaochuan  Liu</span>, <span class="hlFld-ContribAuthor ">Wenliang  Wang</span>, <span class="hlFld-ContribAuthor ">Junjie  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenquan  Hu</span>, <span class="hlFld-ContribAuthor ">Aoli  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Huang</span>, <span class="hlFld-ContribAuthor ">Qingwang  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Ren</span>, <span class="hlFld-ContribAuthor ">Lili  Li</span>, <span class="hlFld-ContribAuthor ">Ruixiang  Xia</span>, <span class="hlFld-ContribAuthor ">Jian  Ge</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>160 </em>, 61-81. <a href="https://doi.org/10.1016/j.ejmech.2018.10.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528E%252529-N-%2525284-%252528%2525284-methylpiperazin-1-yl%252529methyl%252529-3-%252528trifluoromethyl%252529phenyl%252529-3-%252528%2525283-%2525282-%252528pyridin-2-yl%252529vinyl%252529-1H-indazol-6-yl%252529thio%252529propanamide%252B%252528CHMFL-ABL-121%252529%252Bas%252Ba%252Bhighly%252Bpotent%252BABL%252Bkinase%252Binhibitor%252Bcapable%252Bof%252Bovercoming%252Ba%252Bvariety%252Bof%252BABL%252Bmutants%252Bincluding%252BT315I%252Bfor%252Bchronic%252Bmyeloid%252Bleukemia%26aulast%3DLiu%26aufirst%3DXuesong%26date%3D2018%26volume%3D160%26spage%3D61%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kailin  Yu</span>, <span class="hlFld-ContribAuthor ">Xuesong  Liu</span>, <span class="hlFld-ContribAuthor ">Zongru  Jiang</span>, <span class="hlFld-ContribAuthor ">Chen  Hu</span>, <span class="hlFld-ContribAuthor ">Fengming  Zou</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Juan  Ge</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaochuan  Liu</span>, <span class="hlFld-ContribAuthor ">Aoli  Wang</span>, <span class="hlFld-ContribAuthor ">Wenliang  Wang</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Ziping  Qi</span>, <span class="hlFld-ContribAuthor ">Beilei  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Hezhong  Yan</span>, <span class="hlFld-ContribAuthor ">Jiaoxue  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Ren</span>, <span class="hlFld-ContribAuthor ">Jun  Tang</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs). </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (67)
                                     , 111110-111118. <a href="https://doi.org/10.18632/oncotarget.22624" title="DOI URL">https://doi.org/10.18632/oncotarget.22624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22624%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DDiscovery%252Bof%252Ba%252Bhighly%252Bselective%252BKIT%252Bkinase%252Bprimary%252BV559D%252Bmutant%252Binhibitor%252Bfor%252Bgastrointestinal%252Bstromal%252Btumors%252B%252528GISTs%252529%26aulast%3DYu%26aufirst%3DKailin%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D67%26spage%3D111110%26epage%3D111118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of the representative c-KIT kinase inhibitors: (A) FDA approved c-KIT inhibitors for GISTs and (B) multitarget inhibitors possess c-KIT inhibitory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic illustration of discovery of compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic illustration of SAR exploration rationale. (A) Analysis of c-KIT/compound <b>1</b> binding mode (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>). (B) Comparison of compounds <b>1</b>, <b>4</b>, and <b>5</b> type II key binding moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinome wide selectivity profiling of <b>13</b>. (A) KinomeScan profiling of <b>13</b> at a concentration of 1 μM against 468 kinases. (B) Biochemical assay characterization of <b>13</b>’s inhibitory activity against c-KIT, PDGFRβ (Promega ADP-Glo), DDR1, and CSF1R (Invitrogen Z’lyte).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural basis of the binding and selectivity mechanism for <b>13</b> against c-KIT and ABL kinase. Hydrogen bonds are indicated by red-hatched lines to key amino acid residues (highlighted). (A) <b>13</b> (in color by atoms) was docked into c-KIT kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>) (in white). (B) <b>13</b> (in color by atoms) was docked into ABL kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>) (in white). (C) Superimposition of <b>1</b>-ABL kinase X-ray crystal structure (in purple) and docking model of <b>13</b> (in color by atoms) with ABL kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>) (in white). (D) Superimposition of docked model of <b>13</b> with ABL kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY">2HYY</a>) (in purple) and <b>13</b> with c-KIT kinase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a>) (in white).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>13</b>’s effects on the signaling transduction pathways in the c-KIT-dependent and -independent intact GIST cancer cell lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>13</b>’s induction of cell cycle arrest and apoptosis in GIST-T1 and GIST-882 cell lines but not in GIST-48B cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>13</b>’s antitumor efficacy in GIST-T1 xenograft mouse model. Female nu/nu mice bearing established GIST-T1 tumor xenografts were treated with <b>13</b> at 25.0, 50.0, and 100 mg/kg/d or vehicle. Daily oral administration was initiated when GIST-T1 tumors had reached a size of 100 to 200 mm<sup>3</sup>. Each group contained six animals. Data, mean ± SEM (A) body weight and (B) tumor size measurements from GIST-T1 xenograft mice after <b>13</b> administration. Initial body weight and tumor size were set as 100%. (C) Representative photographs of tumors in each group after 25.0, 50.0, or 100 mg/kg/d <b>13</b> or vehicle treatment. (D) Comparison of the final tumor weight in each group after 21-day treatment period of <b>13</b>; ns, <i>p</i> > 0.05, *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for <b>37a</b>–<b>d</b>: <i>tert</i>-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate; for <b>37e</b>: <i>tert</i>-butyl 3-hydroxypiperidine-1-carboxylate, DIAD, PPh<sub>3</sub>, THF, 0 °C to rt; for <b>37f</b>: <i>tert</i>-butyl (2-bromoethyl)carbamate, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, overnight; (b) Pd/C, H<sub>2</sub>, EtOAc, rt, 6 h; (c) R3CO<sub>2</sub>H, HATU, DIPEA, DMF, rt, 2 h; (d) 4 N HCl in EtOAc, rt, overnight; (e) R1CO<sub>2</sub>H, HATU, DIPEA, DMF, rt, 2 h.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>31</b>–<b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4 N HCl in EtOAc, rt, overnight; (b) nicotinic acid, HATU, DIPEA, DMF, rt, 2 h; (c) Pd/C, H<sub>2</sub>, EtOAc, rt, 6 h; (d) R3CO<sub>2</sub>H, HATU, DIPEA, DMF, rt, 2 h.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/medium/jm-2016-00200d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-8/acs.jmedchem.6b00200/20160422/images/large/jm-2016-00200d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00200&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-chloro-4-isocyanato-2-(trifluoromethyl)benzene, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight; (b) 4 N HCl in EtOAc, rt; (c) nicotinic acid, HATU, DIPEA, DMF, rt, 2 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Rubin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duensing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lux, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbard, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">KIT activation is a ubiquitous feature of gastrointestinal stromal tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8118</span><span class="NLM_x">–</span> <span class="NLM_lpage">8121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8118-8121&author=B.+P.+Rubinauthor=S.+Singerauthor=C.+Tsaoauthor=A.+Duensingauthor=M.+L.+Luxauthor=R.+Ruizauthor=M.+K.+Hibbardauthor=C.+J.+Chenauthor=S.+Xiaoauthor=D.+A.+Tuvesonauthor=G.+D.+Demetriauthor=C.+D.+Fletcherauthor=J.+A.+Fletcher&title=KIT+activation+is+a+ubiquitous+feature+of+gastrointestinal+stromal+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DB.%2BP.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DC.%26aulast%3DDuensing%26aufirst%3DA.%26aulast%3DLux%26aufirst%3DM.%2BL.%26aulast%3DRuiz%26aufirst%3DR.%26aulast%3DHibbard%26aufirst%3DM.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BJ.%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DKIT%2520activation%2520is%2520a%2520ubiquitous%2520feature%2520of%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8118%26epage%3D8121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarlomo-Rikala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tervahartiala, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siberman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span> </span><span class="NLM_article-title">Effect of the tyrosine inhibitor STI571 in a patient with a metastatis gastrointestinal stromal tumor</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span><span class="refDoi"> DOI: 10.1056/NEJM200104053441404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1056%2FNEJM200104053441404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=11287975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gvVekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1052-1056&author=H.+Joensuuauthor=P.+J.+Robertsauthor=M.+Sarlomo-Rikalaauthor=L.+C.+Andersonauthor=P.+Tervahartialaauthor=D.+Tuvesonauthor=S.+L.+Sibermanauthor=R.+Capdevilleauthor=S.+Dimitrijevicauthor=B.+Drukerauthor=G.+D.+Demetri&title=Effect+of+the+tyrosine+inhibitor+STI571+in+a+patient+with+a+metastatis+gastrointestinal+stromal+tumor&doi=10.1056%2FNEJM200104053441404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor</span></div><div class="casAuthors">Joensuu H; Roberts P J; Sarlomo-Rikala M; Andersson L C; Tervahartiala P; Tuveson D; Silberman S; Capdeville R; Dimitrijevic S; Druker B; Demetri G D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1052-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRYZ86Vmj15i5otVjB3IRIyfW6udTcc2eYyFhLJoWZWCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gvVekuw%253D%253D&md5=d361debf544b136b28889449118225e3</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1056%2FNEJM200104053441404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200104053441404%26sid%3Dliteratum%253Aachs%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DSarlomo-Rikala%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DL.%2BC.%26aulast%3DTervahartiala%26aufirst%3DP.%26aulast%3DTuveson%26aufirst%3DD.%26aulast%3DSiberman%26aufirst%3DS.%2BL.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DDruker%26aufirst%3DB.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26atitle%3DEffect%2520of%2520the%2520tyrosine%2520inhibitor%2520STI571%2520in%2520a%2520patient%2520with%2520a%2520metastatis%2520gastrointestinal%2520stromal%2520tumor%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1052%26epage%3D1056%26doi%3D10.1056%2FNEJM200104053441404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanke, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Abbeele, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuveson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capdeville, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span> </span><span class="NLM_article-title">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span><span class="refDoi"> DOI: 10.1056/NEJMoa020461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1056%2FNEJMoa020461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=12181401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=472-480&author=G.+D.+Demetriauthor=M.+von+Mehrenauthor=C.+D.+Blankeauthor=A.+D.+Van+den+Abbeeleauthor=B.+Eisenbergauthor=P.+J.+Robertsauthor=M.+C.+Heinrichauthor=D.+A.+Tuvesonauthor=S.+Singerauthor=M.+Janicekauthor=J.+A.+Fletcherauthor=S.+G.+Silvermanauthor=S.+L.+Silbermanauthor=R.+Capdevilleauthor=B.+Kieseauthor=B.+Pengauthor=S.+Dimitrijevicauthor=B.+J.+Drukerauthor=C.+Corlessauthor=C.+D.+Fletcherauthor=H.+Joensuu&title=Efficacy+and+safety+of+imatinib+mesylate+in+advanced+gastrointestinal+stromal+tumors&doi=10.1056%2FNEJMoa020461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors</span></div><div class="casAuthors">Demetri, George D.; von Mehren, Margaret; Blanke, Charles D.; Van den Abbeele, Annick D.; Eisenberg, Burton; Roberts, Peter J.; Heinrich, Michael C.; Tuveson, David A.; Singer, Samuel; Janicek, Milos; Fletcher, Jonathan A.; Silverman, Stuart G.; Silberman, Sandra L.; Capdeville, Renaud; Kiese, Beate; Peng, Bin; Dimitrijevic, Sasa; Druker, Brian J.; Corless, Christopher; Fletcher, Christopher D. M.; Joensuu, Heikki</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">472-480</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Constitutive activation of KIT receptor tyrosine kinase is crit. in the pathogenesis of gastrointestinal stromal tumors.  Imatinib mesylate, a selective tyrosine kinase inhibitor, has been shown in preclin. models and preliminary clin. studies to have activity against such tumors.  We conducted an open-label, randomized, multicenter trial to evaluate the activity of imatinib in patients with advanced gastrointestinal stromal tumor.  We assessed antitumor response and the safety and tolerability of the drug.  Pharmacokinetics were assessed in a subgroup of patients.  A total of 147 patients were randomly assigned to receive 400 mg or 600 mg of imatinib daily.  Overall, 79 patients (53.7 percent) had a partial response, 41 patients (27.9 percent) had stable disease, and for tech. reasons, response could not be evaluated in 7 patients (4.8 percent).  No patient had a complete response to the treatment.  The median duration of response had not been reached after a median follow-up of 24 wk after the onset of response.  Early resistance to imatinib was noted in 20 patients (13.6 percent).  Therapy was well tolerated, although mild-to-moderate edema, diarrhea, and fatigue were common.  Gastrointestinal or intraabdominal hemorrhage occurred in approx. 5 percent of patients.  There were no significant differences in toxic effects or response between the two doses.  Imatinib was well absorbed, with pharmacokinetics similar to those reported in patients with chronic myeloid leukemia.  Imatinib induced a sustained objective response in more than half of patients with an advanced unresectable or metastatic gastrointestinal stromal tumor.  Inhibition of the KIT signal-transduction pathway is a promising treatment for advanced gastrointestinal stromal tumors, which resist conventional chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVE0HpuuKXXrVg90H21EOLACvtfcHk0lgwzElXTB6IQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtV2nt7s%253D&md5=95c9ea076dd2b0e053ae2061cb3f5d24</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020461%26sid%3Dliteratum%253Aachs%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26aulast%3DBlanke%26aufirst%3DC.%2BD.%26aulast%3DVan%2Bden%2BAbbeele%26aufirst%3DA.%2BD.%26aulast%3DEisenberg%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DJanicek%26aufirst%3DM.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DSilverman%26aufirst%3DS.%2BG.%26aulast%3DSilberman%26aufirst%3DS.%2BL.%26aulast%3DCapdeville%26aufirst%3DR.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DCorless%26aufirst%3DC.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DJoensuu%26aufirst%3DH.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520imatinib%2520mesylate%2520in%2520advanced%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D472%26epage%3D480%26doi%3D10.1056%2FNEJMoa020461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yarden, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang-Feng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coussens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munemitsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dull, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francke, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">Human proto-oncogene kit: a new cell surface receptor tyrosine kinase for an unidentified ligand</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3341</span><span class="NLM_x">–</span> <span class="NLM_lpage">3351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1987&pages=3341-3351&author=Y.+Yardenauthor=W.+J.+Kuangauthor=T.+Yang-Fengauthor=L.+Coussensauthor=S.+Munemitsuauthor=T.+J.+Dullauthor=E.+Chenauthor=J.+Schlessingerauthor=U.+Franckeauthor=A.+Ullrich&title=Human+proto-oncogene+kit%3A+a+new+cell+surface+receptor+tyrosine+kinase+for+an+unidentified+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DKuang%26aufirst%3DW.%2BJ.%26aulast%3DYang-Feng%26aufirst%3DT.%26aulast%3DCoussens%26aufirst%3DL.%26aulast%3DMunemitsu%26aufirst%3DS.%26aulast%3DDull%26aufirst%3DT.%2BJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DFrancke%26aufirst%3DU.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DHuman%2520proto-oncogene%2520kit%253A%2520a%2520new%2520cell%2520surface%2520receptor%2520tyrosine%2520kinase%2520for%2520an%2520unidentified%2520ligand%26jtitle%3DEMBO%2520J.%26date%3D1987%26volume%3D6%26spage%3D3341%26epage%3D3351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isozaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunio, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span> </span><span class="NLM_article-title">Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1126/science.279.5350.577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1126%2Fscience.279.5350.577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=9438854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK1cXotVyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=577-580&author=S.+Hirotaauthor=K.+Isozakiauthor=Y.+Moriyamaauthor=K.+Hashimotoauthor=T.+Nishidaauthor=S.+Ishiguroauthor=K.+Kawanoauthor=M.+Hanadaauthor=A.+Kurataauthor=M.+Takedaauthor=G.+M.+Tunioauthor=Y.+Matsuzawaauthor=Y.+Kanakuraauthor=Y.+Shinomuraauthor=Y.+Kitamura&title=Gain-of-function+mutations+of+c-kit+in+human+gastrointestinal+stromal+tumors&doi=10.1126%2Fscience.279.5350.577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors</span></div><div class="casAuthors">Hirota, Seiichi; Isozaki, Koji; Moriyama, Yasuhiro; Hashimoto, Koji; Nishida, Toshirou; Ishiguro, Shingo; Kawano, Kiyoshi; Hanada, Masato; Kurata, Akihiko; Takeda, Masashi; Muhammad Tunio, Ghulam; Matsuzawa, Yuji; Kanakura, Yuzuru; Shinomura, Yasuhisa; Kitamura, Yukihiko</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">5350</span>),
    <span class="NLM_cas:pages">577-580</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the human digestive tract, but their mol. etiol. and cellular origin are unknown.  Sequencing of c-kit complementary DNA, which encodes a proto-oncogenic receptor tyrosine kinase (KIT), from five GISTs revealed mutations in the region between the transmembrane and tyrosine kinase domains.  All of the corresponding mutant KIT proteins were constitutively activated without the KIT ligand, stem cell factor (SCF).  Stable transfection of the mutant c-kit complementary DNAs induced malignant transformation of Ba/F3 murine lymphoid cells, suggesting that the mutations contribute to tumor development.  GISTs may originate from the interstitial cells of Cajal (ICCs) because the development of ICCs is dependent on the SCF-KIT interaction and because, like GISTs, these cells express both KIT and CD34.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlGnWQ79KELVg90H21EOLACvtfcHk0lg1SEl9FV3VIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVyhsw%253D%253D&md5=b66b6b8a389b064f73fba13ca84e8650</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1126%2Fscience.279.5350.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.279.5350.577%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DIsozaki%26aufirst%3DK.%26aulast%3DMoriyama%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DT.%26aulast%3DIshiguro%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DK.%26aulast%3DHanada%26aufirst%3DM.%26aulast%3DKurata%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DTunio%26aufirst%3DG.%2BM.%26aulast%3DMatsuzawa%26aufirst%3DY.%26aulast%3DKanakura%26aufirst%3DY.%26aulast%3DShinomura%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DY.%26atitle%3DGain-of-function%2520mutations%2520of%2520c-kit%2520in%2520human%2520gastrointestinal%2520stromal%2520tumors%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D577%26epage%3D580%26doi%3D10.1126%2Fscience.279.5350.577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corless, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanke, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensuu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGreevey, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Abbeele, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrijevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4342</span><span class="NLM_x">–</span> <span class="NLM_lpage">4349</span><span class="refDoi"> DOI: 10.1200/JCO.2003.04.190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1200%2FJCO.2003.04.190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=14645423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=4342-4349&author=M.+C.+Heinrichauthor=C.+L.+Corlessauthor=G.+D.+Demetriauthor=C.+D.+Blankeauthor=M.+von+Mehrenauthor=H.+Joensuuauthor=L.+S.+McGreeveyauthor=C.+J.+Chenauthor=A.+D.+Van+den+Abbeeleauthor=B.+J.+Drukerauthor=B.+Kieseauthor=B.+Eisenbergauthor=P.+J.+Robertsauthor=S.+Singerauthor=C.+D.+Fletcherauthor=S.+Silbermanauthor=S.+Dimitrijevicauthor=J.+A.+Fletcher&title=Kinase+mutations+and+imatinib+response+in+patients+with+metastatic+gastrointestinal+stromal+tumor&doi=10.1200%2FJCO.2003.04.190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor</span></div><div class="casAuthors">Heinrich, Michael C.; Corless, Christopher L.; Demetri, George D.; Blanke, Charles D.; von Mehren, Margaret; Joensuu, Heikki; McGreevey, Laura S.; Chen, Chang-Jie; Van den Abbeele, Annick D.; Druker, Brian J.; Kiese, Beate; Eisenberg, Burton; Roberts, Peter J.; Singer, Samuel; Fletcher, Christopher D. M.; Silberman, Sandra; Dimitrijevic, Sasa; Fletcher, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4342-4349</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Most gastrointestinal stromal tumors (GISTs) express constitutively activated mutant isoforms of KIT or kinase platelet-derived growth factor receptor alpha (PDGFRA) that are potential therapeutic targets for imatinib mesylate.  The relationship between mutations in these kinases and clin. response to imatinib was examd. in a group of patients with advanced GIST.  Patients and Methods: GISTs from 127 patients enrolled onto a phase II clin. study of imatinib were examd. for mutations of KIT or PDGFRA.  Mutation types were correlated with clin. outcome.  Results: Activating mutations of KIT or PDGFRA were found in 112 (88.2%) and six (4.7%) GISTs, resp.  Most KIT mutations involved exon 9 (n = 23) or exon 11 (n = 85).  All KIT mutant isoforms, but only a subset of PDGFRA mutant isoforms, were sensitive to imatinib, in vitro.  In patients with GISTs harboring exon 11 KIT mutations, the partial response rate (PR) was 83.5%, whereas patients with tumors contg. an exon 9 KIT mutation or no detectable mutation of KIT or PDGFRA had PR rates of 47.8% (P = .0006) and 0.0% (P < .0001), resp.  Patients whose tumors contained exon 11 KIT mutations had a longer event-free and overall survival than those whose tumors expressed either exon 9 KIT mutations or had no detectable kinase mutation.  Conclusion: Activating mutations of KIT or PDGFRA are found in the vast majority of GISTs, and the mutational status of these oncoproteins is predictive of clin. response to imatinib.  PDGFRA mutations can explain response and sensitivity to imatinib in some GISTs lacking KIT mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquHal4hZZoc7Vg90H21EOLACvtfcHk0ljFdI9lJPnzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVWqu7Y%253D&md5=cbfd753460bdf0005c3bd93f12df98dc</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2003.04.190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2003.04.190%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DCorless%26aufirst%3DC.%2BL.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3DBlanke%26aufirst%3DC.%2BD.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26aulast%3DJoensuu%26aufirst%3DH.%26aulast%3DMcGreevey%26aufirst%3DL.%2BS.%26aulast%3DChen%26aufirst%3DC.%2BJ.%26aulast%3DVan%2Bden%2BAbbeele%26aufirst%3DA.%2BD.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DKiese%26aufirst%3DB.%26aulast%3DEisenberg%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DP.%2BJ.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DSilberman%26aufirst%3DS.%26aulast%3DDimitrijevic%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DKinase%2520mutations%2520and%2520imatinib%2520response%2520in%2520patients%2520with%2520metastatic%2520gastrointestinal%2520stromal%2520tumor%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2003%26volume%3D21%26spage%3D4342%26epage%3D4349%26doi%3D10.1200%2FJCO.2003.04.190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sommer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agosti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbacioglu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besmer, P.</span><span> </span><span class="NLM_article-title">Gastrointestinal stromal tumors in a mouse model by target mutation of the kit receptor tyrosine kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">6706</span><span class="NLM_x">–</span> <span class="NLM_lpage">6711</span><span class="refDoi"> DOI: 10.1073/pnas.1037763100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1073%2Fpnas.1037763100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=6706-6711&author=G.+Sommerauthor=V.+Agostiauthor=I.+Ehlersauthor=F.+Rossiauthor=S.+Corbaciogluauthor=J.+Farkasauthor=M.+Mooreauthor=K.+Manovaauthor=C.+R.+Antonescuauthor=P.+Besmer&title=Gastrointestinal+stromal+tumors+in+a+mouse+model+by+target+mutation+of+the+kit+receptor+tyrosine+kinase&doi=10.1073%2Fpnas.1037763100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1037763100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1037763100%26sid%3Dliteratum%253Aachs%26aulast%3DSommer%26aufirst%3DG.%26aulast%3DAgosti%26aufirst%3DV.%26aulast%3DEhlers%26aufirst%3DI.%26aulast%3DRossi%26aufirst%3DF.%26aulast%3DCorbacioglu%26aufirst%3DS.%26aulast%3DFarkas%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3DManova%26aufirst%3DK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DBesmer%26aufirst%3DP.%26atitle%3DGastrointestinal%2520stromal%2520tumors%2520in%2520a%2520mouse%2520model%2520by%2520target%2520mutation%2520of%2520the%2520kit%2520receptor%2520tyrosine%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D6706%26epage%3D6711%26doi%3D10.1073%2Fpnas.1037763100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ernst, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbs, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przygodzki, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emory, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobin, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, T. J.</span><span> </span><span class="NLM_article-title">Kit mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors</span> <span class="citation_source-journal">Lab Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">1633</span><span class="NLM_x">–</span> <span class="NLM_lpage">1636</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=1633-1636&author=S.+I.+Ernstauthor=A.+E.+Hubbsauthor=R.+M.+Przygodzkiauthor=T.+S.+Emoryauthor=L.+H.+Sobinauthor=T.+J.+O%E2%80%99Leary&title=Kit+mutation+portends+poor+prognosis+in+gastrointestinal+stromal%2Fsmooth+muscle+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DS.%2BI.%26aulast%3DHubbs%26aufirst%3DA.%2BE.%26aulast%3DPrzygodzki%26aufirst%3DR.%2BM.%26aulast%3DEmory%26aufirst%3DT.%2BS.%26aulast%3DSobin%26aufirst%3DL.%2BH.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DT.%2BJ.%26atitle%3DKit%2520mutation%2520portends%2520poor%2520prognosis%2520in%2520gastrointestinal%2520stromal%252Fsmooth%2520muscle%2520tumors%26jtitle%3DLab%2520Invest.%26date%3D1998%26volume%3D78%26spage%3D1633%26epage%3D1636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lasota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasinski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarlomo-Rikala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miettinen, M.</span><span> </span><span class="NLM_article-title">Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1016/S0002-9440(10)65250-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1016%2FS0002-9440%2810%2965250-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=9916918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK1MXnsFCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1999&pages=53-60&author=J.+Lasotaauthor=M.+Jasinskiauthor=M.+Sarlomo-Rikalaauthor=M.+Miettinen&title=Mutations+in+exon+11+of+c-kit+occur+preferentially+in+malignant+versus+benign+gastrointestinal+stromal+tumors+and+do+not+occur+in+leiomyomas+or+leiomyosarcomas&doi=10.1016%2FS0002-9440%2810%2965250-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas</span></div><div class="casAuthors">Lasota, Jerzy; Jasinski, Marek; Sarlomo-Rikala, Maarit; Miettinen, Markku</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Gastrointestinal stromal tumors (GISTs) comprise the largest subset of mesenchymal tumors of the gastrointestinal tract.  These neoplasms differ histol. and immunohistochem. from typical leiomyomas and leiomyosarcomas.  Most GISTs express CD34 and CD117 (c-kit protein) but not desmin.  Recently, gain-of-function mutations of c-kit proto-oncogene have been shown in five solitary GISTs and in tumors and leukocytes from a family with multiple GISTs.  An in-frame deletion or a point mutation in exon 11 of c-kit was detected in these cases.  Stable transfection of the mutant c-kit complementary DNA was also shown to induce malignant transformation of murine lymphoid cells, suggesting that the c-kit mutations contribute to tumor development.  In this study, the authors evaluated 43 GISTs and 14 smooth muscle tumors for mutations in the exon 11 of c-kit by a PCR-assay.  Half of the malignant GISTs (12/24) and only one benign GIST (1/19) revealed mutant bands.  No mutant bands were found in 3 leiomyomas and 11 leiomyosarcomas.  Sequence anal. confirmed the presence of an in-frame deletion of 3-21 bp in all 13 GISTs with mutant bands.  Wild-type bands from 8 malignant and 11 benign GISTs and 7 smooth muscle tumors without mutant bands were cloned and sequenced.  Addnl. mutations were found in 3 malignant and 2 benign GISTs.  There were no mutations in 3 leiomyomas and 4 leiomyosarcomas.  The mutation status of exon 11 did not correlate with immunohistochem. detectable expression of the CD117, as virtually all GISTs with or without such mutations showed CD117 immunoreactivity.  The c-kit mutations occur preferentially in malignant GISTs and might be a clin. useful adjunct marker in the evaluation of GISTs.  The conservation of the c-kit mutation pattern, obsd. in consecutive lesions from the same patients, suggests that these mutations might be useful tumor markers in monitoring recurrence or minimal residual disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ST-g3MIsA7Vg90H21EOLACvtfcHk0lgR0Hp5QjTrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsFCqtg%253D%253D&md5=b23dabddc48ceb307935c169d91eb9e0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2965250-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252965250-9%26sid%3Dliteratum%253Aachs%26aulast%3DLasota%26aufirst%3DJ.%26aulast%3DJasinski%26aufirst%3DM.%26aulast%3DSarlomo-Rikala%26aufirst%3DM.%26aulast%3DMiettinen%26aufirst%3DM.%26atitle%3DMutations%2520in%2520exon%252011%2520of%2520c-kit%2520occur%2520preferentially%2520in%2520malignant%2520versus%2520benign%2520gastrointestinal%2520stromal%2520tumors%2520and%2520do%2520not%2520occur%2520in%2520leiomyomas%2520or%2520leiomyosarcomas%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D1999%26volume%3D154%26spage%3D53%26epage%3D60%26doi%3D10.1016%2FS0002-9440%2810%2965250-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kerkelä, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacobi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beahm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span><span class="refDoi"> DOI: 10.1038/nm1446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnm1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=16862153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=908-916&author=R.+Kerkel%C3%A4author=L.+Grazetteauthor=R.+Yacobiauthor=C.+Iliescuauthor=R.+Pattenauthor=C.+Beahmauthor=B.+Waltersauthor=S.+Shevtsovauthor=S.+Pesantauthor=F.+J.+Clubbauthor=A.+Rosenzweigauthor=R.+N.+Salomonauthor=R.+A.+Van+Ettenauthor=J.+Alroyauthor=J.+B.+Durandauthor=T.+Force&title=Cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate&doi=10.1038%2Fnm1446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span></div><div class="casAuthors">Kerkela Risto; Grazette Luanda; Yacobi Rinat; Iliescu Cezar; Patten Richard; Beahm Cara; Walters Brian; Shevtsov Sergei; Pesant Stephanie; Clubb Fred J; Rosenzweig Anthony; Salomon Robert N; Van Etten Richard A; Alroy Joseph; Durand Jean-Bernard; Force Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">908-16</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.  Here we report ten individuals who developed severe congestive heart failure while on imatinib and we show that imatinib-treated mice develop left ventricular contractile dysfunction.  Transmission electron micrographs from humans and mice treated with imatinib show mitochondrial abnormalities and accumulation of membrane whorls in both vacuoles and the sarco- (endo-) plasmic reticulum, findings suggestive of a toxic myopathy.  With imatinib treatment, cardiomyocytes in culture show activation of the endoplasmic reticulum (ER) stress response, collapse of the mitochondrial membrane potential, release of cytochrome c into the cytosol, reduction in cellular ATP content and cell death.  Retroviral gene transfer of an imatinib-resistant mutant of c-Abl, alleviation of ER stress or inhibition of Jun amino-terminal kinases, which are activated as a consequence of ER stress, largely rescues cardiomyocytes from imatinib-induced death.  Thus, cardiotoxicity is an unanticipated side effect of inhibition of c-Abl by imatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGHOTag-dpJhjv2lLSLOxFfW6udTcc2ebug3qspUHpVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D&md5=4012ddd42a942f1441abb54df1894db8</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnm1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1446%26sid%3Dliteratum%253Aachs%26aulast%3DKerkel%25C3%25A4%26aufirst%3DR.%26aulast%3DGrazette%26aufirst%3DL.%26aulast%3DYacobi%26aufirst%3DR.%26aulast%3DIliescu%26aufirst%3DC.%26aulast%3DPatten%26aufirst%3DR.%26aulast%3DBeahm%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DB.%26aulast%3DShevtsov%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DS.%26aulast%3DClubb%26aufirst%3DF.%2BJ.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3DSalomon%26aufirst%3DR.%2BN.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DAlroy%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DJ.%2BB.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DCardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D908%26epage%3D916%26doi%3D10.1038%2Fnm1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perik, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rikhof, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gietema, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Graaf, W. T.</span><span> </span><span class="NLM_article-title">Results of plasma n-terminal pro b-type natriuretic peptide and cardiac troponin monitoring in gist patients do not support the existence of imatinib-induced cardiotoxicity</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span><span class="refDoi"> DOI: 10.1093/annonc/mdm468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1093%2Fannonc%2Fmdm468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=17962203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FotlemtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=359-361&author=P.+J.+Perikauthor=B.+Rikhofauthor=F.+A.+de+Jongauthor=J.+Verweijauthor=J.+A.+Gietemaauthor=W.+T.+van+der+Graaf&title=Results+of+plasma+n-terminal+pro+b-type+natriuretic+peptide+and+cardiac+troponin+monitoring+in+gist+patients+do+not+support+the+existence+of+imatinib-induced+cardiotoxicity&doi=10.1093%2Fannonc%2Fmdm468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity</span></div><div class="casAuthors">Perik P J; Rikhof B; de Jong F A; Verweij J; Gietema J A; van der Graaf W T A</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Recently, case reports of patients treated with imatinib (imatinib mesylate; Gleevec; Glivec) indicated that this tyrosine kinase inhibitor may induce cardiomyopathy.  Consequently, careful cardiac monitoring was advocated for clinical studies.  The purpose of this study was to prospectively evaluate whether imatinib (Gleevec) induces early, subclinical, cardiac toxicity.  PATIENTS AND METHODS:  History and physical examination were carried out with special attention for symptoms of heart failure.  Additionally, assessments of serial plasma N-terminal pro B-type natriuretic peptide (NT-proBNP) and serum cardiac troponin T (cTnT) measurement before and 1 and 3 months after the start of imatinib treatment (400-800 mg daily) were done in patients with advanced and/or metastatic gastrointestinal stromal tumours (GIST).  RESULTS:  A total of 55 GIST patients were enrolled.  Only one patient, with a normal pretreatment NT-proBNP, showed an increase in NT-proBNP to above age-specific normal values during imatinib treatment and developed symptomatic heart failure due to pre-existent cardiac valvular disease. cTnT levels remained stable.  CONCLUSIONS:  In our study population, imatinib treatment for GIST was not associated with an increase in plasma NT-proBNP levels, indicating that the risk of subclinical cardiac toxicity is limited with the use of this agent.  These results do not support the current strategy to standard cardiac monitoring in all patients.  This may be restricted to GIST patients with a history of cardiac disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKUu-458lfnekdrW1FkXG-fW6udTcc2eZd98WchNK8Orntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FotlemtA%253D%253D&md5=77337a332892670dd84e8e2e4f3a2a1d</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdm468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdm468%26sid%3Dliteratum%253Aachs%26aulast%3DPerik%26aufirst%3DP.%2BJ.%26aulast%3DRikhof%26aufirst%3DB.%26aulast%3Dde%2BJong%26aufirst%3DF.%2BA.%26aulast%3DVerweij%26aufirst%3DJ.%26aulast%3DGietema%26aufirst%3DJ.%2BA.%26aulast%3Dvan%2Bder%2BGraaf%26aufirst%3DW.%2BT.%26atitle%3DResults%2520of%2520plasma%2520n-terminal%2520pro%2520b-type%2520natriuretic%2520peptide%2520and%2520cardiac%2520troponin%2520monitoring%2520in%2520gist%2520patients%2520do%2520not%2520support%2520the%2520existence%2520of%2520imatinib-induced%2520cardiotoxicity%26jtitle%3DAnn.%2520Oncol.%26date%3D2008%26volume%3D19%26spage%3D359%26epage%3D361%26doi%3D10.1093%2Fannonc%2Fmdm468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccarani, M.</span><span> </span><span class="NLM_article-title">In reply to ’cardiotoxicity of the cancer therapeutic agent imatinib mesylate’</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1038/nm0107-15a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnm0107-15a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=13-14&author=G.+Rostiauthor=G.+Martinelliauthor=M.+Baccarani&title=In+reply+to+%E2%80%99cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate%E2%80%99&doi=10.1038%2Fnm0107-15a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1038%2Fnm0107-15a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0107-15a%26sid%3Dliteratum%253Aachs%26aulast%3DRosti%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DG.%26aulast%3DBaccarani%26aufirst%3DM.%26atitle%3DIn%2520reply%2520to%2520%25E2%2580%2599cardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%25E2%2580%2599%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D13%26epage%3D14%26doi%3D10.1038%2Fnm0107-15a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-Diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1021/jm0204183</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cuiauthor=J.+Y.+Fukudaauthor=J.+Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-Fluoro-2-oxo-1%2C2-dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+acid+%282-Diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase&doi=10.1021%2Fjm0204183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-Fluoro-2-oxo-1%252C2-dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-Diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119%26doi%3D10.1021%2Fjm0204183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Warkentin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasater, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, A. Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Overcoming myelosuppression due to synthetic lethal toxicity in FLT3-targeted acute myeloid leukemia therapy</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e03445</span><span class="refDoi"> DOI: 10.7554/eLife.03445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.7554%2FeLife.03445" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=e03445&author=A.+A.+Warkentinauthor=M.+S.+Lopezauthor=E.+A.+Lasaterauthor=K.+Linauthor=B.+L.+Heauthor=A.+Y.+H.+Leungauthor=C.+C.+Smithauthor=N.+P.+Shahauthor=K.+M.+Shokat&title=Overcoming+myelosuppression+due+to+synthetic+lethal+toxicity+in+FLT3-targeted+acute+myeloid+leukemia+therapy&doi=10.7554%2FeLife.03445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.7554%2FeLife.03445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.03445%26sid%3Dliteratum%253Aachs%26aulast%3DWarkentin%26aufirst%3DA.%2BA.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DLasater%26aufirst%3DE.%2BA.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DB.%2BL.%26aulast%3DLeung%26aufirst%3DA.%2BY.%2BH.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DOvercoming%2520myelosuppression%2520due%2520to%2520synthetic%2520lethal%2520toxicity%2520in%2520FLT3-targeted%2520acute%2520myeloid%2520leukemia%2520therapy%26jtitle%3DeLife%26date%3D2014%26volume%3D3%26spage%3De03445%26doi%3D10.7554%2FeLife.03445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bearss, D. J.; Joshi-hangal, R.; Liu, X.-H.; Phiasivongsa, P.; Redkar, S. G.; Vankayalapati, H.</span><span> </span><span class="NLM_article-title">Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same</span>. U.S. Patent US 20080226747, September 18,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+J.+Bearss&author=R.+Joshi-hangal&author=X.-H.+Liu&author=P.+Phiasivongsa&author=S.+G.+Redkar&author=H.+Vankayalapati&title=Pharmaceutical+formulations+comprising+salts+of+a+protein+kinase+inhibitor+and+methods+of+using+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26atitle%3DPharmaceutical%2520formulations%2520comprising%2520salts%2520of%2520a%2520protein%2520kinase%2520inhibitor%2520and%2520methods%2520of%2520using%2520same%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Dubreuil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciufolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castéran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermine, O.</span><span> </span><span class="NLM_article-title">Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7258</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1371%2Fjournal.pone.0007258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=19789626" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7258&author=P.+Dubreuilauthor=S.+Letardauthor=M.+Ciufoliniauthor=L.+Grosauthor=M.+Humbertauthor=N.+Cast%C3%A9ranauthor=O.+Hermine&title=Masitinib+%28AB1010%29%2C+a+potent+and+selective+tyrosine+kinase+inhibitor+targeting+KIT&doi=10.1371%2Fjournal.pone.0007258"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007258%26sid%3Dliteratum%253Aachs%26aulast%3DDubreuil%26aufirst%3DP.%26aulast%3DLetard%26aufirst%3DS.%26aulast%3DCiufolini%26aufirst%3DM.%26aulast%3DGros%26aufirst%3DL.%26aulast%3DHumbert%26aufirst%3DM.%26aulast%3DCast%25C3%25A9ran%26aufirst%3DN.%26aulast%3DHermine%26aufirst%3DO.%26atitle%3DMasitinib%2520%2528AB1010%2529%252C%2520a%2520potent%2520and%2520selective%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520KIT%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7258%26doi%3D10.1371%2Fjournal.pone.0007258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Blay, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Mehren, M.</span><span> </span><span class="NLM_article-title">Nilotinib: a novel, selective tyrosine kinase inhibitor</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">S3</span><span class="NLM_x">–</span> <span class="NLM_lpage">S9</span><span class="refDoi"> DOI: 10.1053/j.seminoncol.2011.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1053%2Fj.seminoncol.2011.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=21419934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1yqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=S3-S9&author=J.-Y.+Blayauthor=M.+von+Mehren&title=Nilotinib%3A+a+novel%2C+selective+tyrosine+kinase+inhibitor&doi=10.1053%2Fj.seminoncol.2011.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor</span></div><div class="casAuthors">Blay, Jean-Yves; von Mehren, Margaret</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2, Suppl. 1</span>),
    <span class="NLM_cas:pages">S3-S9</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The development of tyrosine kinase inhibitors (TKIs) for the treatment of chronic myelogenous leukemia (CML) was based on the discovery that CML stem and progenitor cells overexpress the abnormal fusion protein kinase BCR-ABL.  The prototype TKI, imatinib, selectively inhibits BCR-ABL, as well as several other kinases, including stem cell factor receptor (KIT), discoidin domain receptor (DDR), platelet-derived growth factor receptor (PDGFR), and colony-stimulating factor receptor-1 (CSF-1R).  Although the management of CML improved dramatically with the introduction of imatinib, not all patients benefit from treatment because of resistance or intolerance.  Consequently, research efforts have focused on developing more potent TKIs with the ability to circumvent imatinib resistance.  Nilotinib, a second-generation oral TKI, was rationally designed based on the crystal structure of imatinib to be highly active against a wide range of imatinib-resistant BCR-ABL mutants and is approved for the treatment of newly diagnosed or imatinib-resistant or -intolerant CML, and has shown superiority over imatinib in first-line treatment for newly diagnosed CML.  Furthermore, the activity of nilotinib against KIT and PDGFRα has led to its evaluation in advanced gastrointestinal stromal tumors (GIST).  The purpose of this review is to describe the development of nilotinib, providing a structural explanation for the differential activity of nilotinib and imatinib in GIST.  Activity of nilotinib against KIT and PDGFR and emerging evidence of differences in cellular uptake between nilotinib and imatinib are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpA1cOx61-ZbVg90H21EOLACvtfcHk0liPg15UpIJPvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1yqtrk%253D&md5=dc9c1ed5d36f09ad93be258a81d486e2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2011.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2011.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DBlay%26aufirst%3DJ.-Y.%26aulast%3Dvon%2BMehren%26aufirst%3DM.%26atitle%3DNilotinib%253A%2520a%2520novel%252C%2520selective%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DSemin.%2520Oncol.%26date%3D2011%26volume%3D38%26spage%3DS3%26epage%3DS9%26doi%3D10.1053%2Fj.seminoncol.2011.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">DeNardo, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rexhepaj, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keil, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junaid, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coussens, L. M.</span><span> </span><span class="NLM_article-title">Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span><span class="refDoi"> DOI: 10.1158/2159-8274.CD-10-0028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1158%2F2159-8274.CD-10-0028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=22039576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsVylsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=54-67&author=D.+G.+DeNardoauthor=D.+J.+Brennanauthor=E.+Rexhepajauthor=B.+Ruffellauthor=S.+L.+Shiaoauthor=S.+F.+Maddenauthor=W.+M.+Gallagherauthor=N.+Wadhwaniauthor=S.+D.+Keilauthor=S.+A.+Junaidauthor=H.+S.+Rugoauthor=E.+S.+Hwangauthor=K.+Jirstr%C3%B6mauthor=B.+L.+Westauthor=L.+M.+Coussens&title=Leukocyte+complexity+predicts+breast+cancer+survival+and+functionally+regulates+response+to+chemotherapy&doi=10.1158%2F2159-8274.CD-10-0028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy</span></div><div class="casAuthors">DeNardo, David G.; Brennan, Donal J.; Rexhepaj, Elton; Ruffell, Brian; Shiao, Stephen L.; Madden, Stephen F.; Gallagher, William M.; Wadhwani, Nikhil; Keil, Scott D.; Junaid, Sharfaa A.; Rugo, Hope S.; Hwang, E. Shelley; Jirstroem, Karin; West, Brian L.; Coussens, Lisa M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-67</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research, Inc.</span>)
        </div><div class="casAbstract">Immune-regulated pathways influence multiple aspects of cancer development.  In this article we demonstrate that both macrophage abundance and T-cell abundance in breast cancer represent prognostic indicators for recurrence-free and overall survival.  We provide evidence that response to chemotherapy is in part regulated by these leukocytes; cytotoxic therapies induce mammary epithelial cells to produce monocyte/macrophage recruitment factors, including colony stimulating factor 1 (CSF1) and interleukin-34, which together enhance CSF1 receptor (CSF1R)-dependent macrophage infiltration.  Blockade of macrophage recruitment with CSF1R-signaling antagonists, in combination with paclitaxel, improved survival of mammary tumor-bearing mice by slowing primary tumor development and reducing pulmonary metastasis.  These improved aspects of mammary carcinogenesis were accompanied by decreased vessel d. and appearance of antitumor immune programs fostering tumor suppression in a CD8+ T-cell-dependent manner.  These data provide a rationale for targeting macrophage recruitment/response pathways, notably C5F1R, in combination with cytotoxic therapy, and identification of a breast cancer population likely to benefit from this novel therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGFqFZ3CvAgbVg90H21EOLACvtfcHk0liPg15UpIJPvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsVylsbo%253D&md5=098edea4f3ec31f1e31d2e9fc5569ac6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F2159-8274.CD-10-0028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8274.CD-10-0028%26sid%3Dliteratum%253Aachs%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26aulast%3DBrennan%26aufirst%3DD.%2BJ.%26aulast%3DRexhepaj%26aufirst%3DE.%26aulast%3DRuffell%26aufirst%3DB.%26aulast%3DShiao%26aufirst%3DS.%2BL.%26aulast%3DMadden%26aufirst%3DS.%2BF.%26aulast%3DGallagher%26aufirst%3DW.%2BM.%26aulast%3DWadhwani%26aufirst%3DN.%26aulast%3DKeil%26aufirst%3DS.%2BD.%26aulast%3DJunaid%26aufirst%3DS.%2BA.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DHwang%26aufirst%3DE.%2BS.%26aulast%3DJirstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DLeukocyte%2520complexity%2520predicts%2520breast%2520cancer%2520survival%2520and%2520functionally%2520regulates%2520response%2520to%2520chemotherapy%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D54%26epage%3D67%26doi%3D10.1158%2F2159-8274.CD-10-0028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Garton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynne, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaldo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keily, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srebernak, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vulevic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henninger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelhano, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span> </span><span class="NLM_article-title">Osi-930: a novel selective inhibitor of kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1158%2F0008-5472.CAN-05-2873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=16424037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1015-1024&author=A.+J.+Gartonauthor=A.+P.+Crewauthor=M.+Franklinauthor=A.+R.+Cookeauthor=G.+M.+Wynneauthor=L.+Castaldoauthor=J.+Kahlerauthor=S.+L.+Winskiauthor=A.+Franksauthor=E.+N.+Brownauthor=M.+A.+Bittnerauthor=J.+F.+Keilyauthor=P.+Brinerauthor=C.+Hiddenauthor=M.+C.+Srebernakauthor=C.+Pirritauthor=M.+O%E2%80%99Connorauthor=A.+Chanauthor=B.+Vulevicauthor=D.+Henningerauthor=K.+Hartauthor=R.+Sennelloauthor=A.+H.+Liauthor=T.+Zhangauthor=F.+Richardsonauthor=D.+L.+Emersonauthor=A.+L.+Castelhanoauthor=L.+D.+Arnoldauthor=N.+W.+Gibson&title=Osi-930%3A+a+novel+selective+inhibitor+of+kit+and+kinase+insert+domain+receptor+tyrosine+kinases+with+antitumor+activity+in+mouse+xenograft+models&doi=10.1158%2F0008-5472.CAN-05-2873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">OSI-930: A novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models</span></div><div class="casAuthors">Garton, Andrew J.; Crew, Andrew P. A.; Franklin, Maryland; Cooke, Andrew R.; Wynne, Graham M.; Castaldo, Linda; Kahler, Jennifer; Winski, Shannon L.; Franks, April; Brown, Eric N.; Bittner, Mark A.; Keily, John F.; Briner, Paul; Hidden, Chris; Srebernak, Mary C.; Pirrit, Carrie; O'Connor, Matthew; Chan, Anna; Vulevic, Bojana; Henninger, Dwight; Hart, Karen; Sennello, Regina; Li, An-Hu; Zhang, Tao; Richardson, Frank; Emerson, David L.; Castelhano, Arlindo L.; Arnold, Lee D.; Gibson, Neil W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1015-1024</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">OSI-930 is a novel inhibitor of the receptor tyrosine kinases Kit and kinase insert domain receptor (KDR), which is currently being evaluated in clin. studies.  OSI-930 selectively inhibits Kit and KDR with similar potency in intact cells and also inhibits these targets in vivo following oral dosing.  We have investigated the relationships between the potency obsd. in cell-based assays in vitro, the plasma exposure levels achieved following oral dosing, the time course of target inhibition in vivo, and antitumor activity of OSI-930 in tumor xenograft models.  In the mutant Kit-expressing HMC-1 xenograft model, prolonged inhibition of Kit was achieved at oral doses between 10 and 50 mg/kg and this dose range was assocd. with antitumor activity.  Similarly, prolonged inhibition of wild-type Kit in the NCI-H526 xenograft model was obsd. at oral doses of 100 to 200 mg/kg, which was the dose level assocd. with significant antitumor activity in this model as well as in the majority of other xenograft models tested.  The data suggest that antitumor activity of OSI-930 in mouse xenograft models is obsd. at dose levels that maintain a significant level of inhibition of the mol. targets of OSI-930 for a prolonged period.  Furthermore, pharmacokinetic evaluation of the plasma exposure levels of OSI-930 at these ED levels provides an est. of the target plasma concns. that may be required to achieve prolonged inhibition of Kit and KDR in humans and which would therefore be expected to yield a therapeutic benefit in future clin. evaluations of OSI-930.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZVGkBTVXW-LVg90H21EOLACvtfcHk0lhIjxmCrsiJ4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFOhtA%253D%253D&md5=32ca7af9e9de04507cd35d2d462a2fe8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2873%26sid%3Dliteratum%253Aachs%26aulast%3DGarton%26aufirst%3DA.%2BJ.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DFranklin%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%2BR.%26aulast%3DWynne%26aufirst%3DG.%2BM.%26aulast%3DCastaldo%26aufirst%3DL.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DFranks%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DE.%2BN.%26aulast%3DBittner%26aufirst%3DM.%2BA.%26aulast%3DKeily%26aufirst%3DJ.%2BF.%26aulast%3DBriner%26aufirst%3DP.%26aulast%3DHidden%26aufirst%3DC.%26aulast%3DSrebernak%26aufirst%3DM.%2BC.%26aulast%3DPirrit%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DVulevic%26aufirst%3DB.%26aulast%3DHenninger%26aufirst%3DD.%26aulast%3DHart%26aufirst%3DK.%26aulast%3DSennello%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DRichardson%26aufirst%3DF.%26aulast%3DEmerson%26aufirst%3DD.%2BL.%26aulast%3DCastelhano%26aufirst%3DA.%2BL.%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26atitle%3DOsi-930%253A%2520a%2520novel%2520selective%2520inhibitor%2520of%2520kit%2520and%2520kinase%2520insert%2520domain%2520receptor%2520tyrosine%2520kinases%2520with%2520antitumor%2520activity%2520in%2520mouse%2520xenograft%2520models%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D1015%26epage%3D1024%26doi%3D10.1158%2F0008-5472.CAN-05-2873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Trudel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reece, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. K.</span><span> </span><span class="NLM_article-title">Chir-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">2941</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span><span class="refDoi"> DOI: 10.1182/blood-2004-10-3913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1182%2Fblood-2004-10-3913" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2941-2948&author=S.+Trudelauthor=Z.-H.+Liauthor=E.+Weiauthor=M.+Wiesmannauthor=H.+Changauthor=C.+Chenauthor=D.+Reeceauthor=C.+Heiseauthor=A.+K.+Stewart&title=Chir-258%2C+a+novel%2C+multitargeted+tyrosine+kinase+inhibitor+for+the+potential+treatment+of+t%284%3B14%29+multiple+myeloma&doi=10.1182%2Fblood-2004-10-3913"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2004-10-3913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2004-10-3913%26sid%3Dliteratum%253Aachs%26aulast%3DTrudel%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.-H.%26aulast%3DWei%26aufirst%3DE.%26aulast%3DWiesmann%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DReece%26aufirst%3DD.%26aulast%3DHeise%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DA.%2BK.%26atitle%3DChir-258%252C%2520a%2520novel%252C%2520multitargeted%2520tyrosine%2520kinase%2520inhibitor%2520for%2520the%2520potential%2520treatment%2520of%2520t%25284%253B14%2529%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26spage%3D2941%26epage%3D2948%26doi%3D10.1182%2Fblood-2004-10-3913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1038/nchembio799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations&doi=10.1038%2Fnchembio799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lhIjxmCrsiJ4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364%26doi%3D10.1038%2Fnchembio799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sipes, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarnes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harig, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asatryan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. S.</span><span> </span><span class="NLM_article-title">An efficient rapid system for profiling the cellular activities of molecular libraries</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3158</span><span class="refDoi"> DOI: 10.1073/pnas.0511292103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1073%2Fpnas.0511292103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3153-3158&author=J.+S.+Melnickauthor=J.+Janesauthor=S.+Kimauthor=J.+Y.+Changauthor=D.+G.+Sipesauthor=D.+Gundersonauthor=L.+Jarnesauthor=J.+T.+Matzenauthor=M.+E.+Garciaauthor=T.+L.+Hoodauthor=R.+Beigiauthor=G.+Xiaauthor=R.+A.+Harigauthor=H.+Asatryanauthor=S.+F.+Yanauthor=Y.+Zhouauthor=X.+J.+Guauthor=A.+Saadatauthor=V.+Zhouauthor=F.+J.+Kingauthor=C.+M.+Shawauthor=A.+I.+Suauthor=R.+Downsauthor=N.+S.+Grayauthor=P.+G.+Schultzauthor=M.+Warmuthauthor=J.+S.+Caldwell&title=An+efficient+rapid+system+for+profiling+the+cellular+activities+of+molecular+libraries&doi=10.1073%2Fpnas.0511292103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0511292103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0511292103%26sid%3Dliteratum%253Aachs%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DJ.%2BY.%26aulast%3DSipes%26aufirst%3DD.%2BG.%26aulast%3DGunderson%26aufirst%3DD.%26aulast%3DJarnes%26aufirst%3DL.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DGarcia%26aufirst%3DM.%2BE.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DBeigi%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DHarig%26aufirst%3DR.%2BA.%26aulast%3DAsatryan%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DX.%2BJ.%26aulast%3DSaadat%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DF.%2BJ.%26aulast%3DShaw%26aufirst%3DC.%2BM.%26aulast%3DSu%26aufirst%3DA.%2BI.%26aulast%3DDowns%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520efficient%2520rapid%2520system%2520for%2520profiling%2520the%2520cellular%2520activities%2520of%2520molecular%2520libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3153%26epage%3D3158%26doi%3D10.1073%2Fpnas.0511292103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lgVmx330JW5TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Williams, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escobedo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Signal transduction by the platelet-derived growth factor receptor</span> <span class="citation_source-journal">Cold Spring Harbor Symp. Quant. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1101/SQB.1988.053.01.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1101%2FSQB.1988.053.01.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=2855486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK3MXmtFw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=455-465&author=L.+T.+Williamsauthor=J.+A.+Escobedoauthor=M.+T.+Keatingauthor=S.+R.+Coughlin&title=Signal+transduction+by+the+platelet-derived+growth+factor+receptor&doi=10.1101%2FSQB.1988.053.01.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transduction by the platelet-derived growth factor receptor</span></div><div class="casAuthors">Williams, L. T.; Escobedo, J. A.; Keating, M. T.; Coughlin, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Mol. Biol. Signal Transduction, Pt. 1</span>),
    <span class="NLM_cas:pages">455-65</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review, with 22 refs., discussing platelet-derived growth factor receptor structure and domains with respect to signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRoIaTC9VfbrVg90H21EOLACvtfcHk0lgVmx330JW5TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtFw%253D&md5=2bb073de11315e298362ef04d8c068a3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1101%2FSQB.1988.053.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252FSQB.1988.053.01.053%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DL.%2BT.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DKeating%26aufirst%3DM.%2BT.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DSignal%2520transduction%2520by%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1988%26volume%3D53%26spage%3D455%26epage%3D465%26doi%3D10.1101%2FSQB.1988.053.01.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Valiathan, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitinger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleer, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, R.</span><span> </span><span class="NLM_article-title">Discoidin domain receptor tyrosine kinases: new players in cancer progression</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1007/s10555-012-9346-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1007%2Fs10555-012-9346-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=22366781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFajs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=295-321&author=R.+R.+Valiathanauthor=M.+Marcoauthor=B.+Leitingerauthor=C.+G.+Kleerauthor=R.+Fridman&title=Discoidin+domain+receptor+tyrosine+kinases%3A+new+players+in+cancer+progression&doi=10.1007%2Fs10555-012-9346-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discoidin domain receptor tyrosine kinases: new players in cancer progression</span></div><div class="casAuthors">Valiathan, Rajeshwari R.; Marco, Marta; Leitinger, Birgit; Kleer, Celina G.; Fridman, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">295-321</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Almost all human cancers display dysregulated expression and/or function of one or more receptor tyrosine kinases (RTKs).  The strong causative assocn. between altered RTK function and cancer progression has been translated into novel therapeutic strategies that target these cell surface receptors in cancer.  Yet, the full spectrum of RTKs that may alter the oncogenic process is not completely understood.  Accumulating evidence suggests that a unique set of RTKs known as the discoidin domain receptors (DDRs) play a key role in cancer progression by regulating the interactions of tumor cells with their surrounding collagen matrix.  The DDRs are the only RTKs that specifically bind to and are activated by collagen.  DDRs control cell and tissue homeostasis by acting as collagen sensors, transducing signals that regulate cell polarity, tissue morphogenesis, and cell differentiation.  In cancer, DDRs are hijacked by tumor cells to disrupt normal cell-matrix communication and initiate pro-migratory and pro-invasive programs.  Importantly, several cancer types exhibit DDR mutations, which are thought to alter receptor function and contribute to cancer progression.  Other evidence suggests that the actions of DDRs in cancer are complex, either promoting or suppressing tumor cell behavior in a DDR type/isoform specific- and context-dependent manner.  Thus, there is still a considerable gap in our knowledge of DDR actions in cancer tissues.  This review summarizes and discusses the current knowledge on DDR expression and function in cancer.  It is hoped that this effort will encourage more research into these poorly understood but unique RTKs, which have the potential of becoming novel therapeutic targets in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6IvVtcaWbw7Vg90H21EOLACvtfcHk0ljXUrd9xEaSMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFajs7c%253D&md5=da63c7783212d348b80aeaef7d90094c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs10555-012-9346-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-012-9346-z%26sid%3Dliteratum%253Aachs%26aulast%3DValiathan%26aufirst%3DR.%2BR.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DLeitinger%26aufirst%3DB.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DFridman%26aufirst%3DR.%26atitle%3DDiscoidin%2520domain%2520receptor%2520tyrosine%2520kinases%253A%2520new%2520players%2520in%2520cancer%2520progression%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2012%26volume%3D31%26spage%3D295%26epage%3D321%26doi%3D10.1007%2Fs10555-012-9346-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pollard, J. W.</span><span> </span><span class="NLM_article-title">Trophic macrophages in development and disease</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1038/nri2528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fnri2528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=19282852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFCisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=259-270&author=J.+W.+Pollard&title=Trophic+macrophages+in+development+and+disease&doi=10.1038%2Fnri2528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Trophic macrophages in development and disease</span></div><div class="casAuthors">Pollard, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-270</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Specialized phagocytes are found in the most primitive multicellular organisms.  Their roles in homeostasis and in distinguishing self from non-self have evolved with the complexity of organisms and their immune systems.  Equally important, but often overlooked, are the roles of macrophages in tissue development.  As discussed in this Review, these include functions in branching morphogenesis, neuronal patterning, angiogenesis, bone morphogenesis and the generation of adipose tissue.  In each case, macrophage depletion impairs the formation of the tissue and compromises its function.  I argue that in several diseases, the unrestrained acquisition of these developmental macrophage functions exacerbates pathol.  For example, macrophages enhance tumor progression and metastasis by affecting tumor-cell migration and invasion, as well as angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR03M07hzbU7Vg90H21EOLACvtfcHk0ljXUrd9xEaSMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFCisbc%253D&md5=d29685d4cbb8d8bdd296f8b8ff869d36</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnri2528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2528%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DJ.%2BW.%26atitle%3DTrophic%2520macrophages%2520in%2520development%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D259%26epage%3D270%26doi%3D10.1038%2Fnri2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Duensing, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConarty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panigrahy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span> </span><span class="NLM_article-title">Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3999</span><span class="NLM_x">–</span> <span class="NLM_lpage">4006</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1038%2Fsj.onc.1207525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=3999-4006&author=A.+Duensingauthor=F.+Medeirosauthor=B.+McConartyauthor=N.+E.+Josephauthor=D.+Panigrahyauthor=S.+Singerauthor=C.+D.+Fletcherauthor=G.+D.+Demetriauthor=J.+A.+Fletcher&title=Mechanisms+of+oncogenic+KIT+signal+transduction+in+primary+gastrointestinal+stromal+tumors+%28GISTs%29&doi=10.1038%2Fsj.onc.1207525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207525%26sid%3Dliteratum%253Aachs%26aulast%3DDuensing%26aufirst%3DA.%26aulast%3DMedeiros%26aufirst%3DF.%26aulast%3DMcConarty%26aufirst%3DB.%26aulast%3DJoseph%26aufirst%3DN.%2BE.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DFletcher%26aufirst%3DC.%2BD.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26atitle%3DMechanisms%2520of%2520oncogenic%2520KIT%2520signal%2520transduction%2520in%2520primary%2520gastrointestinal%2520stromal%2520tumors%2520%2528GISTs%2529%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D3999%26epage%3D4006%26doi%3D10.1038%2Fsj.onc.1207525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rossato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smieško, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreafico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedani, A.</span><span> </span><span class="NLM_article-title">Probing small-molecule binding to cytochrome P450 2D6 and 2C9: An in silico protocol for generating toxicity alerts</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2101</span><span class="refDoi"> DOI: 10.1002/cmdc.201000358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1002%2Fcmdc.201000358" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=2088-2101&author=G.+Rossatoauthor=B.+Ernstauthor=M.+Smie%C5%A1koauthor=M.+Spreaficoauthor=A.+Vedani&title=Probing+small-molecule+binding+to+cytochrome+P450+2D6+and+2C9%3A+An+in+silico+protocol+for+generating+toxicity+alerts&doi=10.1002%2Fcmdc.201000358"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000358%26sid%3Dliteratum%253Aachs%26aulast%3DRossato%26aufirst%3DG.%26aulast%3DErnst%26aufirst%3DB.%26aulast%3DSmie%25C5%25A1ko%26aufirst%3DM.%26aulast%3DSpreafico%26aufirst%3DM.%26aulast%3DVedani%26aufirst%3DA.%26atitle%3DProbing%2520small-molecule%2520binding%2520to%2520cytochrome%2520P450%25202D6%2520and%25202C9%253A%2520An%2520in%2520silico%2520protocol%2520for%2520generating%2520toxicity%2520alerts%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D2088%26epage%3D2101%26doi%3D10.1002%2Fcmdc.201000358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Case, D. A.; Babin, V.; Berryman, J. T.; Betz, R. M.; Cai, Q.; Cerutti, D. S.; Cheatham, T. A.,  III; Darden, T. A.; Duke, R. E.; Gohlke, H.; Gietz, A. W.; Gusarov, S.; Homeyer, N.; Jonowski, P.; Kaus, J.; Kolossváry, I.; Kovalenko, A.; Lee, T. S.; LeGrand, S.; Luchko, T.; Luo, R.; Madei, B.; Merz, K. M.; Paesani, F.; Roe, D. R.; Roitberg, A.; Sagui, C.; Salomon-Ferrer, R.; Seabra, G.; Simmerling, C. L.; Smith, W.; Swails, J.; Walker, R. C.; Wang, J.; Wolf, R. M.; Wu, X.; Kollman, P. A.</span>AMBER 14; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+A.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Gietz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Jonowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madei&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Word, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1747</span><span class="refDoi"> DOI: 10.1006/jmbi.1998.2401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=10.1006%2Fjmbi.1998.2401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=9917408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=1735-1747&author=J.+M.+Wordauthor=S.+C.+Lovellauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=Asparagine+and+glutamine%3A+using+hydrogen+atom+contacts+in+the+choice+of+side-chain+amide+orientation&doi=10.1006%2Fjmbi.1998.2401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine and Glutamine: Using Hydrogen Atom Contacts in the Choice of Side-chain Amide Orientation</span></div><div class="casAuthors">Word, J. Michael; Lovell, Simon C.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1735-1747</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Small-probe contact dot surface anal., with all explicit hydrogen atoms added and their van der Waals contacts included, was used to choose between the two possible orientations for each of 1554 asparagine (Asn) and glutamine (Gln) side-chain amide groups in a dataset of 100 unrelated, high-quality protein crystal structures at 0.9 to 1.7 Å resoln.  For the movable-H groups, each connected, closed set of local H-bonds was optimized for both H-bonds and van der Waals overlaps.  In addn. to the Asn/Gln "flips", this process included rotation of OH, SH, NH3+, and methionine Me H atoms, flip and protonation state of histidine rings, interaction with bound ligands, and a simple model of water interactions.  However, except for switching N and O identity for amide flips (or N and C identity for His flips), no non-H atoms were shifted.  Even in these very high-quality structures, about 20 % of the Asn/Gln side-chains required a 180° flip to optimize H-bonding and/or to avoid NH2 clashes with neighboring atoms (incorporating a conservative score penalty which, for marginal cases, favors the assignment in the original coordinate file).  The programs Reduce, Probe, and Mage provide not only a suggested amide orientation, but also a numerical score comparison, a categorization of the marginal cases, and a direct visualization of all relevant interactions in both orientations.  Visual examn. allowed confirmation of the raw score assignment for about 40 % of those Asn/Gln flips placed within the "marginal" penalty range by the automated algorithm, while uncovering only a small no. of cases whose automated assignment was incorrect because of special circumstances not yet handled by the algorithm.  It seems that the H-bond and the at.-clash criteria independently look at the same structural realities: when both criteria gave a clear answer, they agreed every time.  But consideration of van der Waals clashes settled many addnl. cases for which H-bonding was either absent or approx. equiv. for the two main alternatives.  With this extra information, 86 % of all side-chain amide groups could be oriented quite unambiguously.  In the absence of further exptl. data, it would probably be inappropriate to assign many more than this.  Some of the remaining 14 % are ambiguous because of coordinate error or inadequacy of the theor. model, but the great majority of ambiguous cases probably occur as a dynamic mix of both flip states in the actual protein mol.  The software and the 100 coordinate files with all H atoms added and optimized and with amide flips cor. are publicly available.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC6MEkiSKy07Vg90H21EOLACvtfcHk0liCUmrW8ufHNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2ht7g%253D&md5=a3bd044a8652a5ac03e2eb7b9414c2e0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2401%26sid%3Dliteratum%253Aachs%26aulast%3DWord%26aufirst%3DJ.%2BM.%26aulast%3DLovell%26aufirst%3DS.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DAsparagine%2520and%2520glutamine%253A%2520using%2520hydrogen%2520atom%2520contacts%2520in%2520the%2520choice%2520of%2520side-chain%2520amide%2520orientation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D285%26spage%3D1735%26epage%3D1747%26doi%3D10.1006%2Fjmbi.1998.2401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Dobler, M.</span> <span class="citation_source-book">Bio<sup>X</sup></span>, a versatile molecular-modeling software; <span class="NLM_publisher-name">Biographics Laboratory 3R</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span><a href="http://www.biograf.ch/index.php?id=software" class="extLink">http://www.biograf.ch/index.php?id=software</a> (Updated Nov 8, 2014).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+Dobler&title=BioX"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDobler%26aufirst%3DM.%26btitle%3DBioX%26pub%3DBiographics%2520Laboratory%25203R%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Vedani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huhta, D. W.</span><span> </span><span class="NLM_article-title">A new force field for modeling metalloproteins</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">4759</span><span class="NLM_x">–</span> <span class="NLM_lpage">4767</span><span class="refDoi"> DOI: 10.1021/ja00168a021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00168a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;key=1%3ACAS%3A528%3ADyaK3cXktVaqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1990&pages=4759-4767&author=A.+Vedaniauthor=D.+W.+Huhta&title=A+new+force+field+for+modeling+metalloproteins&doi=10.1021%2Fja00168a021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A new force field for modeling metalloproteins</span></div><div class="casAuthors">Vedani, Angelo; Huhta, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4759-67</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A force field for the simulation of metalloproteins features a new potential function for modeling metal-ligand interactions.  This function includes s variables the metal-ligand sepns., the symmetry at the metal center, directionality of the metal-ligand bonds, ligand-metal charge transfer, and (for transition-metal ions) ligand-field stabilization.  The function was developed based on the anal. of accurate small-mol. crystal structures retrieved from the Cambridge Structural Database and incorporated into the mol. mechanics program Yeti which also includes directional terms for H-bonds and salt linkages in its force field energy expression.  The program then was used to model details of metal-coordination, H-bond network formation and protein-solvent interactions in native, complexed, and Co(II)-substituted human carbonic anhydrase I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMppUxyYGE4rVg90H21EOLACvtfcHk0liCUmrW8ufHNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktVaqsLs%253D&md5=107e319b852d73f13359ea3f40f99f14</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja00168a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00168a021%26sid%3Dliteratum%253Aachs%26aulast%3DVedani%26aufirst%3DA.%26aulast%3DHuhta%26aufirst%3DD.%2BW.%26atitle%3DA%2520new%2520force%2520field%2520for%2520modeling%2520metalloproteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1990%26volume%3D112%26spage%3D4759%26epage%3D4767%26doi%3D10.1021%2Fja00168a021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46','PDB','1T46'); return false;">PDB: 1T46</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HYY','PDB','2HYY'); return false;">PDB: 2HYY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00200">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78066"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00200">10.1021/acs.jmedchem.6b00200</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Table S1 listing the DiscoveRx’s KinomeScan selectivity profiling data of <b>13</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Compound data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_001.pdf">jm6b00200_si_001.pdf (518.73 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00200/suppl_file/jm6b00200_si_002.csv">jm6b00200_si_002.csv (3.61 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00200&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-8%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00200%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00200" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0e85c38d9d1ab","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
